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The era of “big data” has led to the generation of more biological data than any 
human could hope to process. This flood of data has necessitated the development of 
computational methods to assist in analysis, and has made it possible to begin to model 
complex biological systems. Machine learning methods represent one avenue for 
modeling, and allow for the identification of intricate and often cryptic sequence signals 
underlying many biological processes. 
In this dissertation, I present two machine learning models, RPIDisorder and 
MEDJED, which were developed to predict RNA-protein interaction partners (RPIPs) 
and DNA double-strand break (DSB) repair by the microhomology-mediated end joining 
(MMEJ) pathway, respectively. I also present the Gene Sculpt Suite, a set of freely 
available web-based software tools for precision gene editing.  
RPIDisorder uses signals from protein and RNA sequences (some of which have 
been previously utilized in published RNA-protein partner prediction methods), but it 
additionally exploits signal from disordered protein regions to predict interactions with 
greater specificity than has been possible before. RPIDisorder allows for the prediction of 
biologically relevant RNA-protein interaction networks, which in turn can assist in the 
development of clinical interventions for the numerous cancers and neurological and 
metabolic disorders associated with disruptions in RNA-protein interactions. RPIDisorder 
is freely available at www.rpidisorder.org. 
MEDJED (Microhomology-Evoked Deletion Judication EluciDation) uses signal 
within and surrounding short stretches of homologous DNA sequence (microhomologies) 
on either side of an introduced DSB to predict the extent to which a targeted genomic site 
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will be repaired using the MMEJ pathway. MEDJED is freely available at 
www.genesculpt.org/medjed/. 
The advent of gene editing nucleases including CRISPR/Cas systems, TALENs, 
and zinc finger nucleases has made it possible to insert, delete, and precisely edit DNA. A 
great deal of recent research has focused on improving the efficiency and precision of 
these nucleases by leveraging endogenous DSB repair pathways including non-
homologous end joining (NHEJ) and homologous recombination (HR). However, 
homology-mediated end joining pathways (HMEJ), including MMEJ and single-strand 
annealing (SSA), provide many advantages over NHEJ and HR. The Gene Sculpt Suite is 
a set of three web-based tools (GTagHD, MEDJED, and MENTHU) that leverage HMEJ 
pathways to enhance exogenous DNA knock-in (GTagHD) and produce more efficient 
and precise gene knock-outs (MEDJED and MENTHU). The Gene Sculpt Suite is freely 
available at www.genesculpt.org. 
Taken together, the results of these studies demonstrate that machine learning 
models can be valuable for identifying sequence signals that regulate macromolecular 
recognition, with numerous potential applications in both basic and applied research. 
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CHAPTER 1.    INTRODUCTION 
1.1 Identifying Complex Recognition Signals in Biological Sequences 
This work addresses two bioinformatics problems, which, superficially, seem very 
different: i) RNA-protein interaction (RPI) partner prediction, and ii) DNA double-strand 
break repair (DSB) prediction. RPI partner (RPIP) prediction focuses on determining whether 
a specific RNA and a specific protein will bind to each other, and thereby influence each 
other’s structure and function. DNA DSB repair prediction attempts to identify which tool(s) 
a cell will use to reforge broken DNA.  
These two problems are of a great deal of scientific interest. The first three papers 
describing computational RPIP prediction methodologies [Bellucci et al. 2011, Pancaldi & 
Bähler 2011, Muppirala et al. 2011], all published in 2011, have been cited collectively 305 
times [see Bellucci et al. Altmetrics, Pancaldi & Bähler Altmetrics, Muppirala et al. 
Altmetrics] as of April 01, 2019. In the eight years since, more than two dozen papers 
describing RPIP methodologies have been published. This topic is of particular interest due 
to the crucial roles RPIPs play in regulating gene transcription and translation [Wilusz et al. 
2009], post-transcriptional mRNA modification, stabilization, and regulation [Shi & Manley 
2015], retrotransposon silencing [Sarkar et al. 2016], the formation of functional 
ribonucleoprotein complexes including ribosomes, spliceosomes, small nucleolar 
ribonucleoproteins (snoRNPs) [Bachellerie et al. 2002], and signal recognition particles 
[Akopian et al. 2013], and dozens of other crucial processes. In addition, numerous diseases 
including a host of cancers [Darnell et al. 2010, He et al. 2019] and neurological disorders 
[Darnell et al. 2010, Laneve et al. 2019] including fragile X syndrome, paraneoplastic 
neurologic syndromes, spinal muscular atrophy [Lukong et al. 2008], and many more 
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diseases [Lukong et al. 2008, Cooper et al. 2009, Castello et al. 2013] are caused by 
disruptions in RNA-protein binding. 
In November 2018, two methods predicting DNA DSB repair sequence outcomes 
were published in Nature and Nature Biotechnology; these methods have been collectively 
cited 15 times as of April 01, 2019, and currently are both among the top 5% of research 
outputs scored by Altmetric [Shen & Arbab 2018 Altmetrics, Allen & Crepaldi 2018 
Altmetrics,]. A collaboration between the Essner, McGrail, Dobbs, Ekker, and Clark labs 
resulted in the creation of a new methodology (see Appendix B) that leverages biological 
signal in a DNA sequence to enhance gene editing outcomes by choosing sites likely to use 
microhomology-mediated end joining (MMEJ) to generate a predominant repair outcome. 
This paper has been viewed nearly 4,000 times and has been downloaded 2,267 times since it 
was published in September 2018 [Ata et al. 2018 Altmetrics], as of April 01, 2019. The 
MENTHU web tool presented in this dissertation (see Chapter 5), which implements this 
method, has been used 943 times by 481 people since January 25 of 2018 (see Appendix D). 
Our unpublished method, MEDJED, for predicting the extent to which a DSB site will utilize 
the MMEJ repair pathway (see Chapter 4), has been used 109 times by 65 people since 
April 1 of 2018 (see Appendix D), as of April 01, 2019.  
These seemingly disparate problems, at their most basic level, ask the same question: 
can we learn or identify signals in biological sequences sufficiently informative to predict 
macromolecular recognition?  
1.2 Why Machine Learning? 
With the era of “big data” in full swing, the sheer volume of data in need of analysis 
requires the development of computational tools to evaluate that information. Machine 
learning can not only make use of this wealth of data to create models, but also can provide 
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insight into the signals extracted, and thus allow the generation of testable hypotheses to 
interrogate the biological mechanisms that employ these signals.  
1.3 Specific Aims of This Research 
The specific aims of this research are as follows: 
1. Determine whether sequence signal from protein disorder can improve RNA-protein 
interaction prediction by increasing prediction specificity 
2. Develop methods for predicting which DNA DSB repair pathway will be utilization after 
introduction of a DSB at a specific genomic target site with a gene editing nuclease 
3. Design and implement freely available, easy-to-use, online and offline tools for 
predicting RPIPs and DNA DSB repair outcomes 
1.4 Organization of This Thesis 
This dissertation includes 6 Chapters and 4 Appendices: 
Chapter 1 describes the motivation for this research and outlines the specific aims of 
this dissertation. This chapter does not include a literature review because that is provided in 
Chapter 2 and Appendix A. 
Chapter 2 consists of a Wikipedia-style review entitled “RNA-Protein Interaction 
Prediction” (Mann CM, Dobbs D (2019) PLoS Genet.) in preparation for submission to the 
PLoS Genetic’s Topic Pages collection. Topic Pages are peer-reviewed, citable, and 
PubMed-indexed, and help serve the public by providing high-quality and easily accessible 
overviews of scientific topics. I was invited to create this Topic Page by PLoS Genetics 
Topic Pages Collection Editor Thomas Shafee. This chapter describes the features, 
mathematical models, and datasets used by methods for predicting RNA-protein interaction 
partners. Drena Dobbs and I came up with the idea for this study. I researched, wrote and 
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revised the article. This chapter serves as a brief overview of the current status of the RNA-
protein partner prediction field. 
Chapter 3 is a manuscript in preparation for submission to Bioinformatics, entitled 
“RPIDisorder: A Method for Predicting RNA-Protein Interaction Partners Using Intrinsic 
Protein Disorder” (Mann CM, Walia R, Dobbs D, Bioinformatics). The preliminary 
manuscript describes a new machine learning method for predicting RNA-protein interaction 
partners. Rasna Walia created a dataset used in this study. I conceived the study, carried out 
the experiments and analysis, created the web tool and webserver, and wrote the manuscript. 
Chapter 4 describes MEDJED (Microhomology Evoked Deletion Judication 
Elucidation), a machine learning method for predicting the extent to which a DNA DSB site 
will undergo microhomology-mediated end joining (MMEJ) repair. While this work is likely 
not of sufficient novelty to be published separately (due to the recent publication of methods 
that perform functions similar to MEDJED [Shen & Arbab et al. 2018, Allen & Crepaldi et 
al. 2018], MEDJED is included in the Gene Sculpt Suite (described in Chapter 5), which is 
described in a manuscript under review for inclusion in the annual webserver issue of Nucleic 
Acids Research. This chapter describes the creation and motivation behind MEDJED, 
implications of results obtained to date, and future directions. Gabriel Martínez-Gálvez 
collaborated in developing the idea for MEDJED and performed statistical analyses of certain 
features (not included in Chapter 4). I wrote the entire chapter and performed all of the 
experiments and analyses described in it. 
Chapter 5 is a manuscript in press at Nucleic Acids Research (2019 webserver issue) 
entitled “The Gene Sculpt Suite: A set of tools for genome editing” (Mann CM, Martínez-
Gálvez G, Welker JM, Wierson WA, Ata H, Almeida MP, Clark KJ, Essner JJ, McGrail M, 
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Ekker SC, Dobbs D (2019) Nucleic Acids Res. Webserver Issue). The version included here 
has been modified to match the format of this dissertation. This manuscript describes the 
Gene Sculpt Suite (www.genesculpt.org), a collection of three web tools (GTagHD, 
MEDJED, and MENTHU) created in conjunction with the McGrail (ISU), Essner (ISU), 
Clark (Mayo Clinic), and Ekker (Mayo Clinic) labs. Jordan Welker, Wes Wierson, and Maira 
Almeida, under the supervision of Jeff Essner and Maura McGrail, conceived the GeneWeld 
methodology, which GTagHD was designed to facilitate. Hiro Ata (Mayo Clinic), under the 
supervision of Stephen Ekker, conceived the methodology implemented by MENTHU. 
Gabriel Martínez-Gálvez and I conceived of and performed experiments required to create 
MEDJED. Gabriel Martínez-Gálvez helped program the TALEN and overhang-related 
features in MENTHU and contributed to the manuscript. Martínez-Gálvez, Welker, Wierson, 
Ata, Almeida, Clark, Essner, McGrail, Ekker, and Dobbs edited the manuscript. Dobbs, 
Essner, McGrail, Ekker, and Clark supervised and guided the research. I created the model 
used in the MEDJED web tool, performed feature selection, created the dataset used to train 
MEDJED, wrote most of the MENTHU webserver code, created the code used to analyze the 
data and wrote most of the manuscript. I am solely responsible for creating, administering, 
and maintaining the Gene Sculpt Suite webserver, creating and programming the GTagHD 
web tool, programming the MEDJED web tool, Docker-izing all of the web tools, and 
designing and writing the documentation and all content for the Gene Sculpt Suite webpages 
and GitHub READMEs. 
Chapter 6 summarizes my contributions to the fields of RNA-protein interaction 
prediction and gene editing and discusses future directions for these areas of research. 
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Appendix A consists of an invited peer-reviewed methods chapter (Computational 
Prediction of RNA-Protein Interactions. Mann CM, Muppirala UK, Dobbs D. (2017) 
Methods in Molecular Biology: Promoter Associated RNA. Ed. Napoli S.) The manuscript 
reviews computational methods for predicting RNA-protein interaction partners and instructs 
readers in how to use these methods. I wrote the instructions for using the described methods 
and for interpreting their output. Usha Muppirala created figures and assisted in writing the 
introduction and instructions. Drena Dobbs wrote the introduction and notes. 
Appendix B is a published manuscript entitled “Robust Activation of 
Microhomology-Mediated End Joining for Precision Gene Editing Applications” (Ata H, 
Ekstrom TL, Martínez-Gálvez G, Mann CM, Dvornikov AV, Schaefbauer KJ, Ma AC, Dobbs 
D, Clark KJ, Ekker SC (2018) PLoS Genet. 14(9) e1007652.) I created the MENTHU web 
tool, which implements the methodology described in the manuscript, and assisted in data 
analysis and processing. I wrote the section of the manuscript describing MENTHU, with 
input from Gabriel Martínez-Gálvez and Drena Dobbs. Martínez-Gálvez and I also 
performed validation tests of the MENTHU algorithm. 
Appendix C is a pre-print manuscript entitled “GeneWeld: a method for efficient 
targeted integration directed by short homology” (Wierson WA, Welker JM, Almeida MP, 
Mann CM, Webster DA, Weiss TJ, Torrie ME, Vollbrecht MK, Lan M, McKeighan KC, Ming 
Z, Wehmeier A, Mikelson CS, Haltom JA, Kwan KM, Shien C, Balciunas D, Ekker SC, Clark 
KJ, Webber BR, Moriarity B, Solin SL, Carlson DF, Dobbs DL, McGrail M, Essner JJ. 
(2019) Submitted to Development.) I created the GTagHD web tool, which designs 
oligonucleotides for use in the GeneWeld protocol. I wrote the section of the manuscript 
describing the GTagHD web tool, with input from Drena Dobbs. 
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Appendix D consists of usage statistics for the Gene Sculpt Suite web tools, 
including page uses and global distribution of users. 
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CHAPTER 2.    RNA-PROTEIN INTERACTION PREDICTIONS WIKI PAGE 
This chapter is a Wikipedia-style review in preparation for submission to the PLoS 
Genetic’s Topic Pages collection. Topic Pages are Wikipedia-style articles that are peer-
reviewed, citable, and PubMed-indexed. After review at PLoS, they are also submitted to 
Wikipedia. The original PLoS peer-reviewed page is assigned a DOI and can be viewed in its 
original format even if the Wikipedia page is later amended. In this article, I describe the 
features and methods used in a subset of RNA-protein interaction prediction methods. The 
methods described were selected on the basis of open-source code availability and the 
quality of the paper describing the method. Thus, catRAPID [Belluci et al. 2011], a high-
profile prediction method, is not described here because its code was only recently made 
available and requires submitting a license request which, amongst other considerations, 
requires the licensee to provide a tax identification number. Because this software is 
proprietary and not open source, it is not described in this entry.  
Introduction 
RNA-protein partner prediction is a field that uses bioinformatics and computational 
biology techniques to predict physical and/or chemical interactions between specific RNA 
and protein molecules (RNA-protein interaction “partners”, or RPIPs). RNAs and proteins 
that interact are often referred to as “binding”, and those that do not interact are referred to as 
“non-binding.” For recent reviews of RNA-protein interaction prediction methods, see [Si et 
al. 2015, Ferre et al. 2016, Mann et al. 2017, Zhang SW et al. 2017, Zhang H et al. 2019]. 
While it is also of interest to predict the amino acids and ribonucleotides directly interacting 
in an RNA-protein interaction (RPI), we refer to this as the “interface” prediction problem, 
and methods for predicting these interactions are not discussed here. For recent reviews of 
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RNA-protein interface prediction methods, see [Si et al. 2015, Xue et al. 2015, Walia et al. 
2017, Jung et al. 2019]. 
Machine learning methods for predicting RNA-protein interactions work because 
they can “capture” signal for binding through judicious encoding of information about the 
protein and RNA.  Predictive models are created by extracting this information (features) 
from known RNA-protein interactions and training a mathematical model (or creating a 
scoring system) to identify novel interactions based on these features. Here we discuss 
features and models used in open-source RNA-protein interaction prediction methods. 
Significance 
RNA-protein interactions (RPIs) play critical roles in numerous biological processes. 
These roles include (but are not limited to):  
• The structural stabilization of functional RNA-protein complexes, including 
ribosomes and spliceosomes 
• Gene transcription and translation 
• Retrotransposon silencing through the action of Piwi-interacting RNAs 
(piRNA) 
• mRNA localization, transport, and degradation 
Disruptions in these interactions can therefore lead to a variety of diseases and 
disorders, including an array of cancers [Darnell 2010], fragile X syndrome [De Boulle et al. 
1993], amyotrophic lateral sclerosis (ALS) [Zhao et al. 2018], and dyskeratosis congenita 
[Mason & Bessler 2011]. Thus, identifying disruptions in RNA-protein interactions provides 
an avenue for identifying potential new treatments that correct these disruptions.  
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There are many methods for experimentally characterizing RPIPs, including 
structural determination methods such as X-ray crystallography [Shi 2014], nuclear magnetic 
resonance (NMR) spectroscopy [Ke & Doudna 2004, Marion 2013, Yadav & Lukavsky 
2016], small-angle x-ray scattering [Kikhney & Svergun 2015, Vestergaard 2016, Chen et al. 
2018], cryogenic electron microscopy (cryo-EM) [Bai et al. 2015], and liquid 
chromatography with tandem mass spectrometry [Tacheny et al. 2013], and assays such as 
Northwestern blots, gel mobility shift assays, filter retention assays, RIP-ChIP [Keene et al. 
2006], and various cross-linking immunoprecipitation (CLIP) [Ule et al. 2003] methods 
including high-throughput sequencing of RNA isolated by crosslinking immunoprecipitation 
(HITS-CLIP/CLIP-Seq) [Licatalosi et al. 2008], photoactivatable ribonucleoside-enhanced 
crosslinking and immunoprecipitation (PAR-CLIP) [Hafner et al. 2010], and individual-
nucleotide resolution UV cross-linking and immunoprecipitation (iCLIP) [König et al. 2010]. 
Because it can be time consuming, difficult, and/or expensive to perform these experiments 
for all proteins and RNAs of interest, computational predictions of such interactions are 
valuable and can dramatically decrease the search space of biologically relevant potential 
interactions. 
Features 
Predicting RPIPs requires capturing sufficient information about both the protein and 
RNA in a way that allows the information to be used as input for machine learning 
algorithms or scoring systems to generate predictive models. Many different protein and 
RNA features have been utilized; features commonly used by prediction methods are 
described here. 
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Sequence Based Features 
Structural data for RNA-protein complexes is currently limited, and can be difficult to 
obtain, so many prediction methods rely on sequence-derived features.  
Sequence composition 
Sequence composition is one of the most commonly used features in prediction 
models. Because a protein’s primary sequence ultimately determines its tertiary structure, the 
amino acid sequence of a protein, in conjunction with the RNA sequence to which it binds, 
contains signal that may be sufficient to predict an RNA-protein interaction. Sequence 
composition features can capture physical (e.g., size, shape) and chemical (e.g., charge, 
hydrophobicity) properties of both the and protein primary structure and the RNA primary 
structure, which are important determinants of molecular recognition. 
Most machine learning methods require feature vectors of a set length, i.e., each 
instance used to train the model must have the same features and interactions to be predicted 
must have the same features. The sequence composition is thus commonly captured using a 
frequency-based representation that does not vary with sequence length. 
Reduced alphabets (see Fig. 2-1.2) are frequently used for representing protein 
sequences to help limit the size of the feature set to help to alleviate the curse of 
dimensionality. Common methods for alphabet reduction include defining groups of amino 
acids based on physical, chemical, or biochemical properties [Muppirala et al. 2011, 
Akbaripour-Elahabad et al. 2016, Pan et al. 2016, Mann et al. 2019], or groupings based on 
RNA interaction propensity [Jain et al. 2018]. 
Sequence composition for both proteins and RNAs has frequently been encoded using 
conjoint k-mers (see Fig. 2-1.3). In the conjoint k-mer representation, an N x M feature set, S, 
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is generated, where N is the k-mer length, M is the alphabet size, and Snm is the frequency of 
occurrence of the corresponding sequence.  
 
Figure 2-1 Illustration of a conjoint triad representation of a protein sequence. 1) Drosophila 
peptide tarsal-less AA protein sequence [UniProt A3RLR1] represented using the 1-letter 
amino acid code. 2) Alphabet reduction using a 7-letter alphabet based on Muppirala et al. 
2011 and Shen et al. 2007. Each amino acid group is represented by a colored block. 3) In a 
conjoint triad feature representation, each continuous block of three amino acids (p1, p2, etc.) 
is identified. 4) The frequency of each possible triad (f1, f2, etc.) is calculated by dividing the 
number of times a triad appears by the length of the sequence (e.g., p1 appears once in the 
32-nt long sequence, so the corresponding feature (f27) is 1/32, or 0.03125) 
Many published PRIP prediction methods utilize a conjoint triad representation 
(shown in Fig. 2-1) for the protein sequence [Muppirala et al. 2011, Akbaripour-Elahabad et 
al. 2016, Pan et al. 2016, Mann et al. 2019] and a conjoint tetrad representation for the RNA 
sequence [Muppirala et al. 2011, Akbaripour-Elahabad et al. 2016, Pan et al. 2016, Mann et 
al. 2019]. Some methods use a conjoint pentad representation for both RNA and protein [Jain 
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et al. 2018], based on the number of amino acids and nucleotides typically involved in the 
binding interfaces in RNA-protein complexes. 
Sequence motifs 
Some methods make use of sequence motifs. In RPIP prediction, these short stretches 
of ribonucleotide or amino acids are generally extracted from the binding interfaces of 
structurally characterized RNA-protein complexes, and a binary feature indicating their 
presence or absence is employed. 
rpiCool collated previously reported short protein [Pancaldi & Bähler 2011, Casetello 
et al 2012] and RNA sequence motifs [Pancaldi & Bähler 2011, Castello et al. 2012, Jiang et 
al. 2013, Ray et al. 2013] that were over-represented in interfaces of RNA-protein 
complexes, and created a feature vector encoding the frequency of every possible 
combination of RNA and protein sequence motifs [Akbaripour-Elahabad et al. 2016]. 
Hydrophobicity and hydrophilicity 
Hydrophobicity and hydrophilicity are important features of RNA-protein interactions 
and help capture the physical and chemical properties of protein sequences, which may 
provide signal for discerning partner-specific RNA-protein interactions.  
The lncPro method uses hydrophobicity and hydrophilicity as an approximation for 
van der Waals forces and hydrogen bonding propensities of the amino acids in protein 
sequences [Lu et al. 2013]. 
Structure-based Features 
Although structural data for ribonuleoproteins (RNPs) is limited at present, some 
methods utilize structure-based features. 
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Protein secondary structure 
Protein secondary structure is used to capture potential signal from secondary 
structural elements such as alpha helices, beta sheets, and coils, based on the premise that 
these structural elements may reflect propensities for sequence-specific RNA binding. Some 
methods, e.g., Lu et al. 2013, use Chou-Fasman and/or Deleage-Roux [Deleage & Roux 
1987] propensities of amino acids to identify and/or predict these secondary structural 
elements within the tertiary protein structure. 
In cases where experimentally determined protein secondary structure information is 
not available, secondary structure can be predicted using computational methods. 
Protein disorder 
Intrinsic protein disorder plays an important role in mediating RNA-protein 
interactions [Järvelin et al. 2016]. RPIDisorder uses information including the location of 
disorder within protein sequences, as well as the hydrophobicity, hydrophilicity, and charges 
of the disordered and ordered amino acids in the sequence [Mann et al. 2019]. 
For proteins where disorder information is not available, disorder must be predicted. 
RNA secondary structure 
As with protein secondary structure, RNA secondary structure is frequently utilized 
for RPIP prediction under the assumption that if RNA binding is sequence specific, then 
features that distinguish ribonucleotides must be accessible to proteins for recognition. RNA 
secondary structure is frequently represented simply by encoding whether ribonucleotides are 
present in double- or single-stranded regions [Lu et al. 2013]. 
In cases where RNA secondary structure information is unavailable (i.e., most of the 
time), RNA secondary structure can be predicted using computational methods. Many RPIP 
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prediction methods use tools from the ViennaRNA software package to predict RNA 
secondary structure [Lu et al. 2013]. 
Feature Dimensions 
Because prediction models require a set number of features, the feature values used in 
prediction must not vary with RNA or protein sequence length. This requires that features be 
“normalized” based on sequence length, use a frequency-based measure, or undergo some 
sort of vector transformation (e.g., lncPro uses Fourier Transform [Lu et al. 2013]), possibly 
with truncation, to ensure that every RNA-protein pair has the same number of features. 
Models 
Machine Learning Methods 
Random forests 
Random forest classifiers are very commonly used in RPI prediction, in part due to 
the easily-interpretable feature selection process, which allows for the examination of 
features important to the model for generating biological hypotheses [Muppirala et al. 2011, 
Mann et al. 2019]. 
Gradient boosting 
Gradient boosting using decision trees has also been applied with success to the RPIP 
problem [Jain et al. 2018]. In this methodology, a weak classifier is made stronger iteratively 
by leveraging the residual error in subsequent classifiers to build a stronger model. 
Support vector machines 
Support vector machines (SVM) are frequently used in sequence-based biological 
prediction problems, e.g., [Muppirala et al. 2011]. While SVMs can separate interacting and 




As deep learning becomes more popular, the use of artificial neural networks for 
predicting RPIPs has increased.  
Stacked auto encoders are a variation on convolutional neural networks. With auto 
encoders, the input features are encoded and then decoded into output with the goal of 
minimizing the error between input and output. In RPIP prediction, the encoder is given 
features derived from known RNA-protein interactions. The encoder is then trained to 
minimize error from the input through the encoding stages to the decoding stages to the 
output. Thus, when new instances are introduced, the encoder has been trained to assign 
weights to important interaction features, and then decodes the input by assigning labels to 
interacting vs non-interacting classes [Pan et al. 2016]. This method produces results similar 
to Principal Components Analysis (PCA), which can be used to reduce the complexity of and 
interpret high-dimensional datasets. 
Multi-classifier methods 
Some methods use a combination of various algorithms and architectures. While 
some use logistic regression functions to combine the output of multiple models, others use 
stacked ensembles, e.g., [Pan et al. 2016], in which a neural network is trained using the 
output of other prediction models as features. 
Scoring Systems 
Some RPIP prediction approaches use scoring systems rather than machine learning 
models. 
For example, lncPro uses a matrix-based approach to combine related features, then 
maps the resulting scores to a 0-100 scale and uses the arithmetic mean to calculate a final 
score for the interaction [Lu et al. 2013]. 
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Datasets 
In order to create reliable prediction models, high quality datasets are required for 
training models and for testing their efficacy. These datasets are usually derived from 
existing RPIP structure or sequence databases. 
Dataset Creation 
Structure-derived datasets 
Structure-derived datasets are extracted from three-dimensional structural information 
available for the relatively small number of RNA-protein complexes for which high 
resolution 3D structures are available. An RNA and protein are considered to “interact” if 
they possess heavy atoms (i.e., non-hydrogen atoms) that lie within a certain distance cutoff. 
Frequently used distances are 5 Å and 8 Å [Muppirala et al. 2011, Jain et al. 2018]. Shorter 
distances are sometimes employed based on the assumption that a shorter cutoff distance 
corresponds to a stronger bond, and thus a “stronger” interaction signal; longer distances are 
chosen to accommodate long-range and/or weaker interactions [Jain et al. 2018]. 
Structure-derived datasets have several limitations: to date, all published structure-
based datasets contain RNA-protein complexes that can be crystallized and thus are 
considered to be biased towards more stable complexes and structurally ordered proteins and 
RNAs. Additionally, the technical difficulty, time, and expense involved in crystallizing 
RNA-protein complexes has limited the size of structure datasets. For example, as of April 
04, 2019, the Protein Data Bank (PDB) [Berman et al. 2000], the largest structural database 
for RNP complexes, contained only 2461 complexes that included both protein and RNA 
chains (2852 complexes if structures that also contain DNA and DNA/RNA hybrids are 
included); of these, 1,037 correspond to ribosomes or ribosomal components. Because certain 
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complexes such as ribosomal and spliceosomal components are heavily represented in these 
datasets, redundancy removal further reduces the size of these datasets.  
Many RNPs in the PDB also have “synthetic” components. For example, a protein 
may be crystallized in complex with a synthetic bait RNA (e.g., poly-U sequence), so that the 
resulting complex does not correspond to a naturally occurring interaction.  Care must be 
taken to ensure that the training dataset contains biologically relevant interactions. 
Datasets from high-throughput experiments 
Other types of experimentally-validated datasets are extracted from published high-
throughput experiments for which data are deposited in online databases. NPInter [Yuan et 
al. 2014] is one such database; the most current release (v3.0) contains 186,433 RNA-protein 
interactions curated from high- and low-throughput experiments [Hao et al. 2016]. 
Non-redundant datasets 
To avoid biasing datasets towards a particular type of RNA-protein interaction, the 
generation of many datasets includes a redundancy removal step, in which proteins and 
RNAs are clustered into groups based on sequence identity, and only a single representative 
interaction from each group is retained [Muppirala et al. 2011, Jain et al. 2018]. For example, 
a protein from cluster P1 and an RNA from cluster R1 will be retained, but any subsequent 
P1- R1 pairings will be discarded. Conversely, a protein from cluster 1 can be included in 
multiple interactions, as long as the RNAs to which it is paired are from different clusters. 
Various sequence identity thresholds are used to reduce redundancy; some datasets use very 
stringent thresholds (e.g., sequence identity cannot be greater than 30% [Muppirala et al. 
2011]), whereas others use very lax thresholds (100% identity [Jain et al 2018]). 
20 
Experimentally-validated negative training datasets 
A few methods (not discussed here) have employed datasets that include negative 
instances (i.e., pairs of specific RNAs and proteins that do not interact) supported by 
experimental validation [Livi & Blanzieri 2014, Armaos et al. 2017]. Unfortunately, these 
datasets are only available upon author request [Armaos et al. 2017], are limited in scope to 
RNAs that interact with one or two proteins [Livi & Blanzieri 2014], and/or have some of the 
same problems as computationally-generated “pseudo-negative” datasets [Livi & Blanzieri 
2014, Armaos et al. 2017].  “Pseudo-negative” datasets as those generated based on the 
assumption that because an interaction is not represented in the dataset from which the 
“positive” interactions are extracted, then that interaction does not occur. Some attempts have 
been made to use PDB structural data to generate negative datasets that may be “better” than 
those generated by simply randomly pairing the RNAs and proteins represented in the 
positive interaction dataset. Some datasets [Suresh et al. 2015] define RNA and protein 
chains as non-interacting if they come from the same structure, are non-redundant with 
interacting RNAs and proteins in the same structure, and do not themselves interact [Suresh 
et al. 2015]; others [Jain et al. 2018] also employ redundancy reduction via sequence identity 
thresholds when randomly pairing RNAs and proteins from the positive set. The latter 
approach still has some of the shortcomings of pseudo-negative datasets because they cannot 
guarantee that the RNA and protein in question do not interact, just that they do not interact 
in the particular complex examined. As always, the difficulty in generating high-quality 
negative datasets is that absence of evidence is not evidence of absence.  
Publicly Available Datasets 
Currently, there are several publicly available “benchmark” datasets (see Table 2-1), 







Table 2-1 Table of publically available benchmark datasets. 
Dataset Derivation Protein Type RNA Type Data Source 
RPI2241 [Muppirala et al. 2011] Structure-derived N/A N/A Protein Data Bank 
RPI369 [Muppirala et al. 2011] Structure-derived non-ribosomal 
non-
ribosomal Protein Data Bank 
RPI1807 [Suresh et al. 2015] Structure-derived N/A N/A Protein Data Bank 
RPI13254 [Pancaldi & Bähler 
2013] non-structure-derived yeast mRNA 
[Pancaldi & Bähler 
2013] 
RPI13243 [Muppirala et al. 2011] non-structure-derived N/A mRNA [Hogan et al. 2008] 
RPI367 [Wang et al. 2013] non-structure-derived N/A ncRNA NPInter v2.0 




Because of the lack of gold-standard datasets at present, is difficult to rigorously 
compare the prediction performance of different RPIP methods.  Often, several methods have 
been trained on the same benchmark dataset, which is used as a test dataset by other methods 
and vice versa. Compounding this problem is the tendency for researchers to compare the 10-
fold cross-validation results for their own method with results obtained on independent test 
sets for other methods [Lu et al. 2013, Akbaripour-Elahabad et al. 2016, Pan et al. 2016]. 
This is problematic because a method trained on a particular dataset will almost always 
outperform methods that were not trained on that particular dataset simply because the 
method trained on the dataset is generally tuned to that specific dataset, regardless of the 
method’s generalizability to other datasets. Thus, results from such flawed evaluation 
methods tend to over-estimate the performance of the method. 
Independent test sets have been appropriately used to compare methods, but these test 
sets frequently include a very limited number of proteins and/or RNAs.  It is thus difficult to 
gauge whether a method is in fact “the best” in predicting RPIPs or simply has the best 
performance for a particular RNA and/or protein. 
Finally – and unfortunately - many methods are not available as a webserver, and/or 
code for running the method offline is not freely available, making it impossible to replicate 
or verify the performance of the method or to rigorously test it against other methods; such 
methods are not included here. See Table 2-2 for a list of methods for which a webserver is 








Table 2-2 Table of RNA-protein interaction prediction methods with publically available code 
Method Name RNA Class Features Model Webserver Download
IPMiner 






Stacked Auto Encoder with 




[Lu et al. 2013]
lncRNAs
(reportedly) hydrogen bonding, 









combines RNA-binding protein motifs and 
protein-binding RNA motifs 
with conjoint polyad representation and 
reduced alphabet
Random Forest N/A http://biocool.ir/rpicool.html
RPIDisorder 




via conjoint polyads; 
predicted disordered protein regions









[Jain et al. 
2018]
all RNAs conjoint polyad representation gradient boosting http://xrpi.ddns.net/ https://universe.bits-pilani.ac.in/goa/aduri/xRPI
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Databases of Known Interactions 
Several valuable databases contain known RNA-protein interactions. These databases 
can be grouped into structure and sequence-based databases. The structure databases contain 
3D structural information (i.e., atomic coordinates) for the protein and RNA in the complex. 
Sequence-based databases generally contain identifiers or sequences for RNAs and proteins 
found to bind each other in high-throughput experiments. 
Structure-based Databases: 
Protein Data Bank 
The Protein Data Bank (PDB) [Berman et al. 2000] contains structures for proteins, 
nucleic acids, and protein-nucleic acid complexes. As of April 4 2019, it included 2,852 
RNA-protein complexes. Most of these structures were generated using x-ray 
crystallography, electron microscopy, or NMR. 
Nucleic Acid Database  
The Nucleic Acid Database (NDB) [Berman et al. 1992, Coimbatore Narayanan et al. 
2014] contains nucleic acid structures, many in complex with proteins or ligands. As of April 
4, 2019, it included 2,257 RNA-protein complexes. Most of these structures are generally 
also represented in the PDB. 
Sequence-based Databases: 
ENCODE 
The ENCODE (Encyclopedia of DNA Elements) database contains the results of 
more than 40 types of high-throughput assays from more than 14,600 experiments [The 
Encode Consortium 2012]. While the database consists primarily of DNA binding and 
transcription assays, it also includes the results from ~700 RNA-binding assays. The results 




The Gene Expression Omnibus database [Edgar et al. 2002] contains the results of 
high-throughput expression analyses. It contains more than 4,300 data sets, many of which 
are RNA-binding or protein-binding assays. These datasets can be downloaded and mined for 
RNA-protein interactions. 
NPInter 
The NPInter v3.0 database contains RNA-RNA, RNA-DNA, and RNA-protein 
interactions curated from high-throughput datasets and literature mining [Hao et al. 2016]. It 
contains more than 186,000 RNA-protein interactions. It is possible to download interaction 
data for specific RNAs, proteins, and organisms. Many datasets used for RPIP prediction 
have been derived from the NPInter v2.0 database [Yuan et al. 2014], the predecessor to the 
NPInter v3.0 database [Hao et al. 2016].  
POSTAR2 
The POSTAR2 database (formerly known as CLIPdb and POSTAR) contains high-
throughput experimental data specifically focused on RNA-protein interactions from six 
species [Zhu et al. 2019]. The database is derived from ENCODE RNA- and protein- binding 
assays, which are processed by POSTAR2 to identify interacting RNAs and proteins. 
POSTAR2 includes data for more than 280 RNA-binding proteins. 
UniProt 
The UniProt database provides protein sequence, structural, and functional 
information [The UniProt Consortium 2019]. While UniProt was not created with the goal of 
collating RNA-protein interactions, it is possible to search the database using Gene Ontology 
terms corresponding to RNA-binding functions, and thus identify RNA-binding proteins and 





RNA-binding protein database 
DNA-binding protein 
Protein-protein interaction 
Protein-protein interaction prediction 
 
Methods published in suspected predatory journals or journals run by suspected 
predatory publishers were not considered. A journal or publisher was considered to be 
“suspected predatory” if it appeared on Jeffrey Beall’s list (https://beallslist.weebly.com/), 
the Stop Predatory Journals site (https://predatoryjournals.com), or if it appears to have 
been removed from Beall’s list due to threatening Beall (MDPI, Frontiers). Methods that do 
not offer standalone code or whose standalone code was difficult to obtain (e.g., catRAPID 
[Belluci et al. 2011]) were also excluded.  
Thus, while there are >30 published RNA-protein partner prediction methods, this 
article discusses only RPISeq [Muppirala et al. 2011], lncPro [Lu et al. 2013], IPMiner 
[Pan et al. 2016], rpiCool [Akbaripour-Elahabad et al. 2016], XRPI [Jain et al. 2018], and 
RPIDisorder [Mann et al. 2019]. See Table 2-2 for a description of these methods. Please 




Table 2-3 Table of published RNA-protein interaction prediction methods. This table will not 
be included in the Wiki article. 
 
 




RNA-protein similarity network https://bmcbioinformatics.biomedcentral.com/articles/10.1186/s12859-018-2586-3
catRAPID lncRNAs
protein secondary structure, 
RNA secondary structure, 
van der waals approximation, 
hydrogen bonding approximation https://www.nature.com/articles/nmeth.1611
catRAPID omics lncRNAs catRAPID, catRAPID fragments https://academic.oup.com/bioinformatics/article/29/22/2928/314358
CFRP ncRNA
sequence composition, 
geometric and harmonic mean and power 
operation 
features of the conjoint n-mer 
representations https://www.frontiersin.org/articles/10.3389/fgene.2019.00018/full
CTF+CGR RPISeq and "chaos game representation" https://www.tandfonline.com/doi/full/10.1080/21655979.2018.1470721




RNA-protein similarity network https://www.frontiersin.org/articles/10.3389/fgene.2018.00239/full
lncPro lncRNAs
(reportedly) hydrogen bonding, van der 
waals, 
RNA-secondary structure propensity, 








RNA-protein similarity network https://www.hindawi.com/journals/bmri/2015/671950/
LPI-NRLMF lncRNAs https://doi.org/10.18632/oncotarget.21934
LPLNP lncRNAs https://www.sciencedirect.com/science/article/pii/S0925231217313899
Oli, OliMo, OliMoSS https://bmcbioinformatics.biomedcentral.com/articles/10.1186/1471-2105-15-123
omiXcore
same as catRAPID signature to identify RNA-
binding proteins, 
then identify interaction regions https://academic.oup.com/bioinformatics/article/33/19/3104/3868478





combines RNA-binding protein motifs and 
protein-binding RNA motifs 





protein sequence/structure composition via 
protein blocks combined with reduced 
alphabet monad representation
RNA sequence/secondary composition via 




RPISeq N/A conjoint polyad representation
RPITER https://www.mdpi.com/1422-0067/20/5/1070/htm
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CHAPTER 3.    RPIDisorder: A METHOD FOR PREDICTING RNA-PROTEIN 
PARTNERS USING INTRINSIC PROTEIN DISORDER 
Abstract 
RNA-protein interactions play crucial structural and regulatory roles in biological 
systems. Disruptions in RNA-protein interactions are associated with a variety of cancers and 
diseases and identifying RNAs and protein that bind each other offers a pathway for devising 
therapeutic corrections for these diseases. Computational methods for predicting RNA-
protein interactions can aid in identifying relevant biological interactions.  
RPIDisorder is a novel method for predicting RNA-protein interaction partners using 
sequence composition and intrinsic protein disorder features. Intrinsic protein disorder is 
implicated in sequence-specific RNA-binding, and while disorder information has previously 
been used to predict RNA-protein interfaces, it has not previously been utilized in predicting 
RNA-protein binding partners. In this study, we found that disorder information enhances 
prediction specificity while maintaining a level of sensitivity comparable to other state-of-
the-art methods. On an independent dataset of 11,281 interacting and 971 non-interacting 
RNA-protein partners, RPIDisorder achieved a True Positive Rate (TPR) of 94.3%, Precision 
95.6%, Matthews Correlation Coefficient (MCC) 68.4%, AUC 93.5%, and False Positive 
Rate (FPR) of just 14.4%. RPIDisorder is available online at www.rpidisorder.org, and 
available for download at https://github.com/Dobbs-Lab/RPIDisorder/. 
Introduction 
RNA-Protein Interactions Play Important Biological Roles 
RNA-protein interactions (RPIs) play critical regulatory, structural, and functional 
roles in cellular biology [Re et al. 2013]. In addition to their vital role in assembling and 
stabilizing functional ribonucleoprotein complexes (RNPs) such as ribosomes, spliceosomes, 
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small nucleolar RNPs [Bachellerie et al. 2002], and signal recognition particles [Akopian et 
al. 2013], RPIs are also involved in virtually every step of gene expression [Morris and 
Mattick 2014]. This involvement includes regulating gene activation and silencing (e.g., the 
Polycomb Repressive Complex 2 (PRC2) protein interacts with ncRNAs including HOTAIR 
and COLDAIR to repress gene expression [Wu et al. 2013, Rinn et al. 2007, Heo & Sung 
2011]), transcription [Wilusz et al. 2009], alternative splicing [Chen & Manley 2009], post-
transcriptional mRNA modification, stabilization [Staton et al. 2000], and regulation 
[Glisovic et al. 2008, Shi & Manley 2015, Goldstrohm et al. 2018], translation [Czernilofsky 
et al. 1974, Spierer & Zimmerman 1976, Noller 1984], and RNA and protein localization 
[Johnston 2005].  
RPIs also play crucial roles in immune response. The interaction of lincRNA-Cox2 
(long intergenic non-coding RNA Cox2) with the RNP A/B and A2/B1 regulates 
inflammatory response to infection [Carpenter et al. 2013], CRISPR/Cas bacterial immune 
systems bind to guide RNAs in order to target viral invaders [Wiedenheft et al. 2011], and 
RNA interference relies on the formation of the RNA-Induced Silencing Complex (RISC) to 
target pathogen mRNAs for degradation [reviewed in Susi 2007]. Additionally, RPIs play 
crucial roles in the replication of RNA viruses; e.g., HIV-1 mRNAs cannot be exported out 
of an infected cell nucleus without the export activity of the Rev protein, which binds to the 
RNA’s rev response element (RRE) [Fischer et al. 1995].  
Examples of Disruptions in Regulatory RNA-Protein Interaction Networks that Lead to 
Disease 
Disruption of RNA-protein interaction networks have been implicated in numerous 
human diseases [Khalil & Rinn 2011]. For example, mutations in RNA-binding proteins 
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involved in RNA metabolism have been linked to amyotrophic lateral sclerosis (ALS) [Zhao 
et al. 2018].  
In vertebrates, the protein dyskerin binds to telomerase RNA (TERC) at an H/ACA 
snoRNA-like sequence near its 3’ end. Mutations in the dyskerin PUA RNA-binding domain 
(and in a region near the N-terminus that folds into close proximity with the PUA domain), 
as well as mutations in the H/ACA sequence in TERC, can lead to dyskeratosis congenita, a 
progressive degenerative illness caused by shortening of the telomeres [Mason & Bessler 
2011]. The ncRNA Hox Transcript Antisense RNA (HOTAIR) 5’ region binds to the 
Polycomb Repressive Complex 2 (PRC2) protein, while HOTAIR’s 3’ region binds to the 
LSD1/CoRST/REST complex; this complex coordinates histone modifications to silence 
Hox-D locus genes [Tsai et al. 2010]. Disruptions in HOTAIR regulation lead to the 
silencing of genes controlling suppression of metastasis; high HOTAIR expression levels are 
strongly associated with metastasis and mortality in breast cancer [Gupta et al. 2010]. 
Fragile X Mental Retardation Protein (FMRP) binds to a host of mRNAs; meta-
analysis of four studies [Ashley et al. 1993, Ashley et al. 1993, Brown et al. 2001, Miyashiro 
et al. 2003] revealed that FMRP binds ~4% of the transcriptome in mouse brains [Blackwell 
et al. 2010]). Among these targets, 40 have been summarized by Pasciuto and Bagni 
[Pasciuto & Bagni 2014], and include the mRNAs encoding FMRP, serine/threonine-protein 
kinase LMTK1 (gene AATK), amyloid precursor protein (APP), activity-regulated 
cytoskeleton-associated protein (ARC), calcium/calmodulin-dependent protein kinase type II 
alpha chain (CAMK2A), postsynaptic density protein 95 (DLG4), gamma-aminobutyric acid 
receptor subunit delta (GABRD), voltage-gated potassium channel subunit KV3.1 and Kv4.2 
(KCNC1 and KCND2), microtubule-associated protein 1B (MAP1B), myelin basic protein 
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(MBP), and matrix metalloproteinase 9 (MMP9). Every one of these proteins has been linked 
to neurological disorders, including but not limited to: fragile X syndrome (FXS), autism, 
schizophrenia, bipolar disorder, Parkinson’s disease, Alzheimer’s disease, and epilepsy, 
and/or cancer or immune disorders [Pasciuto and Bagni 2014].  
A single point mutation in the FMR1 gene coding the KH2 RNA-binding domain of 
FMRP induces an I304N missense mutation sufficient to cause Fragile X Syndrome (FXS) 
[DeBoulle et al. 1993], although FXS is most commonly caused by a trinucleotide repeat 
expansion in the 5’-UTR region, which leads to transcriptional repression of the FMRP 
protein [Verkerk et al. 1991, Yu et al. 1991, Moore et al. 2004]. Interestingly, the I304N 
mutation is likely pathogenic because, rather than abrogating FMRP binding to its mRNA 
target, it appears to prevent FMRP mRNA association with polyribosomes [Feng 1997, 
Mazroui 2003].  Since FMRP regulates mRNA through suppressing mRNA translation, its 
inability to associate with polyribosomes leads to runaway translation of FMRP-mRNA 
regulation targets, and subsequently causes FXS [Phan et al. 2011]. The mRNAs FMRP 
regulates, in contrast, appear to be determined by interaction of the RGG box in the FMRP 
C-terminus with complex secondary structures in the target mRNAs (particularly G-rich 
complex secondary structures) [Ozdilek 2017], including G-quadruplexes [Phan et al. 2011]. 
Interestingly, FMRP binds the FMRP-mRNA in the purine-rich region encoding the RGG 
box in a high-affinity interaction that is most likely mediated by the FMRP RGG domain 
[Schaefferet al. 2001]. Thus, in a truly poetic example of RNA-protein auto-regulation, the 
binding of the RGG region within the FMRP protein to the RGG encoding region of the 
FMRP mRNA allows FMRP to suppress the production of additional FMRP. 
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Intrinsic Protein Disorder May Play a Role in Determining RNA-Protein Interaction 
Specificity 
Intrinsically disordered proteins (IDPs) are proteins that lack any fixed structure 
[reviewed in Uversky 2017]. Some proteins may be conditionally disordered – that is, they 
adopt a fixed structure only under certain conditions [Hausrath & Kingston 2017]. Also, 
proteins can contain intrinsically disordered regions (IDRs), which are stretches of amino 
acids that lack a fixed structure within an otherwise ordered protein structure [Oldfield & 
Dunker 2014].  
IDRs have previously been established to play important roles in RNA-protein 
interactions [reviewed in Järvelin et al. 2016], including those whose dysregulation is 
implicated in disease states [Uversky et al. 2008]. Tompa and Csermely found that IDRs are 
often found in RNA chaperone proteins, and that loss of these IDRs leads to loss of 
chaperone function [Tompa & Csermely 2004]. Järvelin et al. collated more than 40 proteins 
that interface with RNA through an IDR, demonstrating the importance of these regions in 
RNA-binding [Järvelin et al. 2016], and some RNA-protein interface predictors have utilized 
protein disorder to great effect [Peng & Kurgan 2015]. Buljan et al. showed that IDPs 
frequently correspond to non-constitutively expressed exons [Buljan et al. 2012], indicating 
that alternative splicing of proteins could drastically alter RNA-binding properties and thus 
enhance their functional diversity [Niklas et al. 2015]. Complexes of RNA with disordered 
proteins often form membrane-less organelles (RNP bodies), including stress granules and 
Cajal bodies, and these couplings appear to drive the formation of some liquid-liquid phase 
separations [Brangwynne et al. 2015]. Castello et al. showed that disordered regions enhance 
sequence-specific RNA binding [Castello et al. 2012], likely due in part to the 
conformational flexibility of the disordered protein regions. Additionally, IDPs generally 
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contain several stretches of charged amino acids; these regions are frequently negatively 
charged and uncompensated, resulting in a high net charge [Uversky 2019], which may 
further aid in mediating RPIs. Taken altogether, these advances indicate information from 
disordered protein regions could therefore provide valuable signal for predicting RNA-
protein interactions with enhanced specificity. 
Why Predict RPIs? 
Although there are several methods available for experimentally characterizing RPIs 
(including high-throughput methods described in Chapter 2), these methods can be time 
consuming, difficult to implement and scale, and expensive. Most structure-based methods 
[reviewed in Jones 2016] (including NMR spectroscopy [reviewed in Marion 2013, Yadav & 
Lukavsky 2016], x-ray crystallography [reviewed in Shi 2014, Ke & Doudna 2004], small-
angle x-ray scattering [reviewed in Kikhney & Svergun 2015, Vestergaard 2016, Chen et al. 
2018], and cryo EM [reviewed in Bai et al. 2015]) are not high-throughput and thus can’t be 
scaled effectively. Non-structure-based methods such as RIP-ChIP [Keene et al. 2006], CLIP 
[Ule et al. 2003] and its variants, liquid chromatography with tandem mass spectrometry 
[Tacheny et al. 2013], and gel mobility shift assays [Gagnon & Maxwell 2010] are more 
high-throughput, but even these methods can only identify interactions between a single 
protein and a transcriptome, or a single RNA and a proteome. The GRCh38.p13 human 
reference genome assembly contains 20,465 coding genes, 22,229 non-coding genes, and 
208,689 gene transcripts [Zerbino et al. 2018]; these numbers imply ~4.7 billion potential 
RNA-protein interactions in the human interactome alone. The number of proteins to be 
screened for interactions cannot simply be reduced by eliminating proteins that lack a 
canonical RNA-binding domain (RBD), as many proteins without a known RBD still bind 
RNA [Baltz et al. 2012, Castello et al. 2012, Moore et al. 2018].  
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Thus, the sheer scale of identifying all RNA-protein interaction partners necessitates 
the development of computational prediction methods. Computational methods can 
substantially decrease the search space of possible RNA-protein interactions, allowing 
researchers interested in a particular biological process or disease to focus their investigative 
efforts. Analysis of the computational models can aid in efforts to generate testable 
hypotheses to identify underlying biological mechanisms of RNA-protein recognition. 
Available RPI Prediction Methods 
A plethora of RPI prediction methods are available, including methods for predicting 
interfacial residues in RNA-protein complexes (the interface prediction problem) [reviewed 
in Si et al. 2015, Xue et al. 2015, Walia et al. 2017, Jung et al. 2018] and methods for 
predicting whether or not a given RNA-protein pair interacts (the partner prediction 
problem) [recently reviewed in Zhang & Fan 2017, Moore & ‘t Hoen [sic] 2019]. This 
research focuses on the partner prediction problem, for which a Wiki-style review is provided 
in Chapter 2 (see Table 2-2 for an overview of available methods) and a published Methods 
in Molecular Biology protocol is provided in Appendix A. In general, existing methods for 
predicting RNA-protein interaction partners (RPIPs) perform adequately, but there is 
considerable room for improvement - especially in the specificity of predictions - if these are 
to be of practical utility in identifying and characterizing RNA-protein interaction networks. 
At present, it is difficult to judge which published methods are “best.”  Many authors 
have compared the results of their n-fold cross-validation experiments on a particular dataset 
to the performance of other methods on the same dataset (which did not benefit from n-fold 
cross-validation on that same dataset). This type of comparison can be very misleading 
because a method trained on a particular dataset is expected to outperform a method that has 
not been trained using that dataset.  
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Many published methods are specifically focused on predicting ncRNA-protein 
interactions (including ACCBN [Zhu et al. 2019], catRAPID [Bellucci et al. 2011], 
catRAPIDomics [Agostini et al. 2013], CFRP [Dai et al. 2019], IPMiner [Pan et al. 2016], 
IRWNRLPI [Zhao et al. 2018a], lncPro [Lu et al. 2013], LPBNI [Ge et al. 2016], LPI-
BNRPA [Zhao et al. 2018b], LPI-ETSLP [Hu et al. 2017], LPI-FKLKRRR [Shen et al. 
2019], LPIHN [Li et al. 2015], LPI-NRLMF [Liu et al. 2017], LPLNP [Zhang et al. 2018], 
and RPI-PRED [Suresh et al. 2015]). While ncRNA interactions are certainly important in 
many regulatory roles, gene expression is also subject to extensive regulation by both non-
specific [Rissland 2017] and sequence-specific mRNA-protein interactions [Donlin-Asp et al. 
2017], so methods for predicting interactions of mRNAs with proteins should not be 
neglected. 
Here we present RPIDisorder, a method for predicting RNA-protein interaction using 
both sequence composition and information regarding intrinsically disordered protein 
regions. We compare the performance of RPIDisorder to RPISeq, a previously published 
prediction method that uses sequence composition features alone [Muppirala et al. 2011], and 
to RPIMotif, an unpublished method that outperforms RPISeq [Walia 2014] by exploiting 
interfacial motifs drawn from the Protein Data Bank (PDB) [Berman et al. 2000], in 
conjunction with sequence composition features. Compared to RPISeq and RPIMotif, 
RPIDisorder has comparable performance in detecting interacting RNA-protein partners but 
is much better at also correctly identifying non-interacting RNA-protein pairs than either 
RPISeq or RPIDisorder, demonstrating its superior utility for detecting biologically relevant 
RPIPs. To illustrate this, in addition to benchmark performance evaluations, we describe a 
case study on the clinically important and highly disordered protein, FMRP (fragile X mental 
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retardation protein), in which RPIDisorder outperforms both RPISeq and RPIMotif in 
correctly identifying its interactions with RNA. 
Methods 
Datasets 
RPI2241 structure-derived dataset (RPI-PDB) 
For training, we used the RPI2241 structure-derived dataset (RPI-PDB) created by 
Muppirala et al. [Muppirala et al. 2011]. The RPI-PDB dataset includes a total of 2241 
positive interactions derived from 952 protein and 443 RNA interacting chains, which were 
extracted from 943 unique PDB structures (extracted prior to 2012) [Muppirala et al. 2011]. 
An RNA and protein chain were considered “interacting” if a ribonucleotide and amino acid 
possessed atoms within an 8Å cutoff distance of each other. The negative interaction set of 
2241 interactions was created by randomly pairing the proteins and RNAs in the positive set 
and removing any known interacting pairs. These positive and negative datasets have been 
used as training sets for several RPIP prediction methods, including RPIMotif [Walia 2014] 
RPI12252* NPInter-derived dataset (RPI-NPInter*) 
For validation, we used the RPI12252 high-throughput dataset (RPI-NPInter). This 
dataset was created by Walia [Walia 2014] and contains 11,281 interacting RNA-protein 
pairs and 971 non-interacting pairs. The positive (interacting) set was derived from the 
NPInter v2.0 database [Yuan et al. 2014]. RPI-NPInter, in contrast to RPI-PDB, contains a 
large number of interactions identified through high-throughput experiments or curated from 
the literature. The negative examples in the dataset were generated by pairing 971 proteins 
determined to be non-RNA binding by Kumar et al. [Kumar et al. 2011], with an equal 




Results reported here were obtained using RPI-NPInter, except that a single 
interaction from the interacting set was removed because DISOPRED3 was unable to make 
predictions on it (the reason for this has not yet been determined.) The dataset lacking this 
single interaction is designated RPI12252*, or for simplicity and readability, RPI-NPInter*. 
FMRP119 case-study test dataset (RPI-FMRP) 
We created a test dataset for a detailed case study to demonstrate the efficacy of 
RPIDisorder in predicting interactions for a highly disordered protein, as well as its ability to 
predict protein interactions not just with ncRNA, but with mRNA as well. FMRP (see 
Introduction) contains a highly disordered RGG domain which is necessary for highly 
specific interactions with its regulatory mRNA targets. Thus, FMRP makes for an ideal case 
study.  
 The FMRP119 (RPI-FMRP) dataset consists of 75 mRNA 5’-UTR, CDS, or 3’-UTR 
regions bound by FMRP, and 44 negative examples created by identifying unbound 5’-UTR, 
CDS, and 3’-UTR regions in mRNAs containing another region bound by FMRP; these 
interactions were collected from a PAR-CLIP [Hafner et al. 2010] dataset created by Ascano 
et al. [Ascano et al. 2012] and collated by Anderson et al. [Anderson et al. 2016].  
We partnered the 75 mRNA regions obtained from the Ascano study with a truncated 
FMRP protein corresponding to the amino acid sequence encompassing residues 434-632 of 
the FMRP Isoform-1 sequence, which is highly disordered [The UniProt Consortium 2019]. 
The mRNA-binding RGG domain spans residues 527 to 552 in the canonical sequence 
[Vasilyev et al. 2015]. Using the full-length FMRP sequence leads to predictions of 
indiscriminate binding, while using the C-terminal region containing the RGG box leads to 






We utilized 599 features initially proposed by [Muppirala et al. 2011] and 
subsequently used in numerous studies (e.g., CFRP [Dai et al. 2019], CTF-CGR [Wang et al. 
2018], RPITER [Peng et al. 2019], Wang method [Wang et al. 2013]), to encode the 
sequence composition of the protein and RNA sequences (see Supp. Tables 3-1 and 3-2 for a 
complete list of these protein and RNA features). In this representation (originally used in 
protein-protein interaction prediction [Shen et al. 2007]), the protein sequence complexity is 
diminished by representing it using a reduced alphabet of 7-letters based on dipole moment, 
sidechain volume, and di-sulfide bonding: {Ala, Gly, Val}, {Ile, Leu, Phe, Pro}, {Tyr, Met, 
Thr, Ser}, {His, Asn, Gln, Tpr}, {Arg, Lys}, {Asp, Glu}, and {Cys} [Shen et al. 2007]. A 
sliding window of 3 amino acids (representing a conjoint triad) is then applied to the entire 
reduced sequence, and the frequency of each triad is calculated (see Fig. 2-1 in Chapter 2). 
The protein is thus represented by a 343-length vector (7 x 7 x 7). The RNA sequence is 
represented using conjoint tetrads for a vector of length 256 (4 x 4 x 4 x 4). Muppirala et al. 
chose these lengths because they worked very well; subsequent groups have similarly found 
these k-mer lengths useful [Muppirala et al. 2011]. 
Protein disorder prediction 
Rather than using structural information present in the PDB to identify IDRs, we used 
IDRs predicted using DISOPRED3 software [Jones and Cozzetto 2015] in training and 
testing our model. We chose this approach because proteins and/or protein regions that are 
disordered in their unbound state may become structured upon binding to RNA. This 
phenomenon is known to occur in many RNPs, including ribosomal RNA-protein 
interactions [Draper & Reynaldo 1999] and fragile-X mental retardation protein (FMRP), in 
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which the highly disordered C-terminus region has been crystallized only in conjunction with 
RNA [Vasilyev et al. 2015]; even NMR visualization required stabilization with RNA [Phan 
et al. 2011]. Thus, using structural data in the PDB from RNA-protein complexes may fail to 
accurately capture disorder information. Additionally, most RNA-protein complexes have no 
structural data available and future predictions would require predicting protein disorder. The 
signal captured by DISOPRED3 in the training dataset may translate better to subsequent 
predictions. 
DISOPRED3 software was chosen for predicting protein disorder because it: 1) 
performed well in multiple Critical Assessment of Protein Structure Prediction (CASP) 
challenges (ranked 2nd in CASP9 [Monastyrskyy et al. 2011] and CASP10 [Monastyrskyy et 
al. 2014]), 2) is actively maintained and offline-code is available (which is useful for creating 
prediction methods), 3) predicts disordered and ordered amino acids with residue-level 
resolution.  
Protein disorder features 
We developed a set of features that capture the location of predicted disorder within 
the protein and the physicochemical properties of the disordered residues. The rationale for 
using the location of IDRs within the linear sequence is that proteins that bind RNAs in a 
sequence-specific manner may have IDRs in regions distinct from those proteins that non-
specifically bind RNAs. Physicochemical properties of amino acids were used because 
sequence-specific RNA-protein interactions generally require that amino acids contact the 
ribonucleotide face rather than the backbone (or bind RNA in the major groove, where it can 
distinguish between ribonucleotide bases) [Steitz 1999], and thus may have distinct 
properties compared to proteins which bind RNA through the backbone [Jones 2001].  
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In total, we defined 27 disorder-based features. The first feature, D1, is simply the 
percentage of the amino acid sequence predicted to be disordered. Features D2-D15 (14 
features) capture the location of disorder within the protein sequence; D2-D5 correspond to 
the percentage of residues in each quarter of the linear sequence that are predicted to be 
disordered, while D6-D15 correspond to the percentage of residues in each tenth of the 
sequence that are predicted to be disordered. (See Fig. 3-1) 
An additional 12 features capture the physical and/or chemical properties of the 
predicted disordered residues: ordPos, ordNeg, and ordNeut, are the percentages of amino 
acids that are positively or negatively charged, or neutral, respectively; disPos, disNeg, and 
disNeut, are the percentages predicted to be disordered that are positively or negatively 
charged, or neutral, respectively; ordPhilic, ordPhobic, ordMod, disPhilic, disPhobic, and 
disMod, are the proportion of the predicted ordered and disordered residues that are 
hydrophilic, hydrophobic, and moderately hydrophobic. 
 
Figure 3-1. After the disordered residues in a sequence have been predicted using 
DISOPRED3, the sequence is divided into quarters, and the percentage of each quarter of the 




Machine Learning Models 
Machine learning experiments were performed using Weka v3.8 [Frank et al. 2016] 
and R v3.4.4 implemented in RStudio IDE v1.0.143. Random forests in R were created using 
the randomForest package [Liaw & Wiener 2002]. We examined several machine learning 
classifiers in Weka, including Naïve Bayes and logistic regression (not shown), before 
determining that superior performance was achieved using the Weka random forest classifier, 
which implements a variant of Breiman’s algorithm [Breiman 2001] that selects features 
based on information gain [Frank et al. 2016]. Classifiers were selected based on 
maximization of the specificity while maintaining sensitivity and Matthews Correlation 
Coefficient (MCC) comparable to available methods (see Performance Metrics). 
After training models using several different forest sizes, node depths, and random 
feature pools (not shown), a model with 500 trees, maximum node depth of 3, and random 
feature pool of 5 was selected. Training was performed using 10-fold cross-validation on the 
RPI-PDB dataset, validation was performed on the independent RPI-NPInter* dataset, and a 
case study was performed on the RPI-FMRP dataset. Random forest classifiers trained using 
the randomForest package, which implements the Breiman algorithm [Breiman 2001] (and 
selects features at each node using node impurity) [Liaw & Wiener 2002], were also 
evaluated. Weka offers finer parameter tuning than the randomForest package and the final 
Weka model outperforms the best randomForest model, so this is the model that is ultimately 
used for RPIDisorder. 
Performance Metrics 
We used RPI-NPInter* as a validation set to tune the RPIDisorder model, and further 
tested RPIDisorder on the completely independent RPI-FMRP dataset. The metrics utilized 
are described below; TP = True Positives (correctly identified interacting instances), TN = 
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True Negatives (correctly identified non-interacting instances), FP = False Positives (non-
interacting instances incorrectly predicted to interact), and FN = False Negatives (interacting 
instances incorrectly predicted to not interact). The reported metrics represent the weighted 
average of the interacting and non-interacting classes. 
True positive rate (sensitivity, recall) 
The true positive rate (TPR), also known as the sensitivity or recall, represents how 
well the classifier identifies interacting RNAs and proteins. Values closer to one indicate a 
better TPR. 




False positive rate 
The false positive rate represents how bad the classifier is at distinguishing non-
interactions from interactions. Values closer to zero indicate a better FPR. 





The specificity represents how good a classifier is at identifying non-interacting 
instances and is equal to 1-FPR. Values closer to one indicate a better specificity. 




Note that machine learning literature frequently defines specificity as “the probability 
that a positive prediction is correct” [Baldi et al. 2000], i.e., specificity = TP / (TP+FP); we 
refer to this as “precision”, described below. Here we use “specificity” in the medical 
statistics sense, where it refers to the ability of a classifier to correctly predict the negative 




The precision is the proportion of predicted interactions which were actually 
interactions. Values close to 1 indicate better performance. 





The F-measure (aka the F1 score or F-score) is the harmonic mean of precision and 
recall, and as such is of more use than accuracy for gauging performance on unbalanced 
datasets. However, as the F-measure does not utilize TN, it is of limited utility for gauging if 
a classifier is better at distinguishing the non-interacting class. If precision and recall are both 
perfect (i.e., equal to 1), then the F-measure will also be 1, and thus scores closer to 1 
indicate a better classifier. 




2 ∗ 𝑝𝑟𝑒𝑐𝑖𝑠𝑖𝑜𝑛 ∗ 𝑟𝑒𝑐𝑎𝑙𝑙
𝑝𝑟𝑒𝑐𝑖𝑠𝑖𝑜𝑛 + 𝑟𝑒𝑐𝑎𝑙𝑙
 
Area under the receiver operating characteristic curve 
The Area Under the Receiver Operating Characteristic curve (AUC of ROC or 
simply AUC; see Fig. 3-2) shows the trade-off between the TPR and FPR when using 
varying “score thresholds” to discriminate the interacting and non-interacting classes. Binary 
random forest classifiers output the proportion of the decision trees which “voted” to classify 
an RNA-protein pair as interacting; the score threshold is the proportion of trees which must 
vote to classify an RNA-protein pair as interacting for it to receive this prediction. E.g., if a 
threshold of 40% is chosen, then >40% of the decision trees in the model must output the 
“interacting” class. The ROC curve graphs the TPR vs the FPR for these varying thresholds. 
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The Area Under the Curve (AUC) is closer to 1 for better classifiers; worse classifiers are 
close to 0.5. 
 
Figure 3-2 Example ROC curves. A hypothetical perfect classifier (orange) would have 
100% TPR and 0% FPR, regardless of threshold, which gives an AUC of 1. A random 
(binary) classifier will have 50% TPR and 50% FPR, regardless of threshold, which produces 
an AUC of 0.5. Better classifiers will not have a large trade-off between TPR and FPR, 
producing ROC curves with a high TPR when the FPR is low, leading to an AUC closer to 1 
(gray). Worse classifiers will not have as high a TPR when the FPR is low, leading to smaller 
AUCs closer to 0.5 (yellow). 
Accuracy 
The accuracy is the overall proportion of correctly predicted interactions and non-
interactions. Accuracy is very easily skewed in unbalanced datasets (i.e., the number of 
instances belonging to each class is very unequal) – if a dataset is mostly interacting RNAs 
and proteins, and a classifier simply predicts the majority class in every instance, it will 
appear to have a high accuracy, even though such a classifier will only perform well if the 
population distribution of the classes heavily favors the majority class. Thus, accuracy should 
never be reported as the sole performance metric. Scores closer to 1 indicate higher accuracy. 
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𝐴𝑐𝑐𝑢𝑟𝑎𝑐𝑦 =  
𝑇𝑃 + 𝑇𝑁
𝑇𝑃 + 𝑇𝑁 + 𝐹𝑃 + 𝐹𝑁
 
Matthews correlation coefficient 
The Matthews correlation coefficient [Matthews 1975] (MCC) provides insight into 
the overall quality of a binary classifier. It represents the correlation between the predicted 
and observed classes and essentially functions as the Pearson correlation coefficient for 
binary variables [Boughorbel et al. 2017]. Additionally, the MCC tends to work very well as 
a metric for performance on unbalanced datasets [Boughorbel et al. 2017 ]. Values range 
from -1 to 1; 0 represents no correlation between the predicted and observed classes, and 1 
represents perfect performance. Classifiers with a between 0 and 1 therefore have positive 
correlation between their predictions and reality. 
𝑀𝐶𝐶 =  
(𝑇𝑃 ∗ 𝑇𝑁) − (𝐹𝑃 ∗ 𝐹𝑁)




As Weka v3.8 does not support determining feature importance directly within a 
created model, I also trained a classifier using the R randomForest package to approximate 
the feature importance within the Weka classifier. 
The randomForest package and Weka implementations of the random forest classifier 
differ mainly in that while Weka selects features from the random pool at each node using an 
information gain attribute, the randomForest package selects features on the basis of increase 
in node purity (Gini) – i.e., how well a feature separates classes at each node. Weka also does 
not provide a way to determine a feature’s direct importance to a particular model, but 
randomForest has very robust feature importance tools. I therefore created a disorder model 
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in randomForest and retrieved the importance features for that model. Although this does not 
directly show that these disorder features are of the same importance in the Weka model, this 
approach serves as an approximation of the importance of disordered features in the 
RPIDisorder model.  
Results and Discussion 
Performance on the RPI-PDB Training Dataset 
We trained several machine learning models on the RPI-PDB training dataset using 
several different classification methods including Naïve Bayes, logistic regression, and 
random forest. These models were initially created using the Weka 3.8 default parameter 
settings. Minimal parameter tuning (not shown) was performed to determine that of these 
algorithms, the random forest classifier performed best, and further tuning was performed 
using this classifier.  
The default random forest parameters in Weka 3.8 use a forest of 100 trees, do not 
impose a maximum node depth constraint, and use the following formula to choose the 
number of random features to examine at each node: 
𝑁𝑢𝑚. 𝑅𝑎𝑛𝑑𝑜𝑚 𝐹𝑒𝑎𝑡𝑢𝑟𝑒𝑠 = ⌊𝑙𝑜𝑔2(𝑁𝑢𝑚 𝐹𝑒𝑎𝑡𝑢𝑟𝑒𝑠)⌋ + 1 
Since the conjoint triad + conjoint tetrad + disorder feature vector has 626 features, the 
default Weka 3.8 random forest classifier considered 10 randomly selected features at each 
node. 
 After extensive parameter tuning based on performance on the RPI12252* validation 
set (not shown), the final RPIDisorder model uses the Weka 3.8 random forest classifier with 
maximum node depth of 3, random feature pool of 5, and a forest of 500 trees (increasing the 
forest to 1000 trees does not impact performance; data not shown).  
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 I created additional random forest classifiers using the R randomForest package 
[Liaw & Wiener 2002]. The R randomForest implementation does not allow specification of 
the maximum node depth but does allow tuning of the number of trees and the random 
feature pool size. The best randomForest classifier had a forest of 1000 trees and random 
feature pool size of 2. 
 The performances of the Weka 3.8 default parameter random forest, tuned R 
randomForest classifier, and tuned Weka classifier are shown in Fig. 3-3.  
 
Figure 3-3 RPI-PDB 10-fold cross-validation results for three random forest classifiers. The 
Weka 3.8 random forest classifier with default parameters is in yellow. A parameter-tuned R 
randomForest classifier is in purple. The parameter-tuned RPIDisorder model is in light blue. 
The R randomForest method AUC is not reported. 
Parameter Tuning 
Although the default Weka random forest classifier performed best on 10-fold cross-
validation and the R randomForest model had comparable metrics (except for MCC), 
RPIDisorder had a much lower TPR and MCC and higher FPR. This is likely because the 
lack of a maximum node depth constraint allowed overfitting to the RPI2241 dataset for the 
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default Weka and R randomForest models. However, the tuned Weka random forest 
classifier performs far better on the RPI-NPInter* validation set (see Fig. 3-4) than the other 
methods. 
On the RPI-NPInter* validation set, the three methods have comparable TPR, 
precision, recall, F-measure, and accuracy, largely due to the unbalanced nature of the RPI-
NPInter dataset, which has ~10x as many interacting pairs as non-interacting pairs. However, 
the tuned RPIDisorder classifier has far superior FPR and specificity, which produces a better 
MCC overall than the other two classifiers. 
 
Figure 3-4 RPI-NPInter validation performance of the Weka random forest classifier with 
default parameters (yellow), tuned R randomForest classifier (purple), and the tuned 
RPIDisorder model (blue). 
Comparison to Other Methods on RPI-NPInter* Dataset 
Walia created the RPIMotif method, which utilizes the same conjoint triad protein 
representation and conjoint tetrad RNA representation which RPISeq and RPIDisorder 
utilize, but additionally scans potential RNA and protein partners for bi-partite interfacial 
sequence motifs pulled from the interfaces of RNA-protein complex structures in the PDB 
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[Walia 2014]. RPIMotif was also validated on the RPI-NPInter dataset (i.e., the final 
RPIMotif model was selected based on its performance on this dataset), which makes for a 
fair performance comparison between RPIMotif and RPIDisorder on this dataset (see Fig. 3-
5). Although RPISeq was not validated on RPI-NPInter, Walia tested it on RPI-NPInter, and 
we include it here for completeness.  
 
Figure 3-5 RPI-NPInter/RPI-NPInter* performance comparison between RPISeq (gray), 
RPIMotif (red), and RPIDisorder (blue) on the dataset. All three methods were trained on 
RPI2241. RPIDisorder results do not include a single interacting instance for which 
DISOPRED3 did not return results (denoted as RPI-NPInter*). RPISeq and RPIMotif include 
the full RPI-NPInter dataset. 
All three methods have comparable TPR, Precision, Recall, F-Measure, and accuracy. 
However, RPIDisorder has a much lower FPR (14.4%) than either RPISeq (FPR 63%) or 
RPIMotif (FPR 29%), resulting in a slightly larger MCC (0.684) than RPIMotif (0.64) and a 
much larger MCC than RPISeq (0.40).  
RPIDisorder also has a similar AUC of ROC in comparison with RPIMotif and a 
better AUC than RPISeq (see Fig. 3-6). RPIDisorder achieves an AUC of 0.92, which is the 
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same as RPIMotif’s reported AUC on this test set, while RPISeq has a reported AUC of 0.87. 
The AUC of ROC curves show that RPISeq consistently has a curve below RPIDisorder and 
RPIMotif, indicating that its high TPR does come at the cost of a higher FPR. RPIMotif’s 
AUC curve shows that RPIMotif has a better TPR than RPIDisorder up until the FPR hits 
0.08%; after this point, RPIDisorder has better TPR and FPR than RPIMotif. 
 
Figure 3-6 Area Under the Receiver Operating Characteristic Curves (AUC of ROC) for 
RPISeq (gray), RPIMotif (red), and RPIDisorder (blue). AUCs are 0.87, 0.92, and 0.92 for 
RPISeq, RPIMotif, and RPIDisorder, respectively. Curve created in R using ggplot2 
[Wickham 2016] with code provided courtesy of Kris De Brabanter. 
Characterization of Order and Disorder in the RPI-PDB and RPI-NPInter* Datasets 
The RPI-PDB dataset is a structurally-derived dataset from the PDB [Berman et al. 
2000], while the RPI-NPInter* dataset was derived from the NPInter v2.0 database [Yuan et 
al. 2014], which contains ncRNA-protein interactions identified by high-throughput 
experiments. Since the RPI-PDB dataset only used RNP structures generated by x-ray 
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crystallography, it contains only those structures capable of being crystallized, which 
requires a stable RNP conformation. Thus, this dataset is biased towards ordered structures, 
as can be seen from the predicted protein disorder frequency in the RPI2241 dataset (Fig. 3-
7). 
 
Figure 3-7 Histogram of the proportion of sequence predicted to be disordered for proteins in 
the RPI-PDB dataset (disorder feature D1). The y-axis is the proportion of all protein 
sequences within the dataset that have a particular level of sequence disorder. 
The RPI-PDB dataset skews heavily towards sequences that have no or low predicted 
disorder levels (>80% of sequences are predicted to have 20% or fewer of their amino acids 
be disordered), and no sequences are predicted to be more than 60% disordered. In contrast, 
the RPI-NPInter* dataset has a very different distribution of predicted disorder levels. 
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Comparatively few (<40%) of the RPI12252 protein sequences are predicted to have 20% or 
fewer disordered amino acids, with numerous sequences predicted to be >80% disordered 
(see Fig. 3-8). 
 
Figure 3-8 Histogram of the proportion of sequence predicted to be disordered for proteins in 
the RPI-NPInter* dataset (disorder feature D1). The y-axis is the proportion of all protein 
sequences within the dataset that have a particular level of sequence disorder. 
Interestingly, the two datasets do not just have differing levels of sequence disorder – 
they also, perhaps crucially, differ in where these disordered residues occur. In the RPI-PDB 
dataset, most of the disordered residues are predicted to occur in N- and C-termini of the 
protein (see Fig. 3-9), though there are proteins predicted to have high levels of disorder in 
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the middle of protein sequences as well, indicating possible cases where a disordered protein 
transitions from disordered to ordered upon RNA binding. 
 
Figure 3-9 Boxplots of the predicted proportion of disordered residues in regions of RPI2241 
proteins (disorder features D6-D15). The protein sequences are divided into tenths, and the 
proportion of the first tenth, second tenth, etc. which is predicted to be disordered is 
determined (see Methods and Materials). The boxes represent the 25th, median, and 75th 
percentiles; the whisker boundaries are 1.5 * the interquartile range above and below the 25th 
and 75th percentiles. 
In stark contrast, the RPI-NPInter* dataset sees heavily disordered regions in the 
middle of proteins, including the 7th, 8th, and 9th sequence 10ths, in addition to the N- and C- 
termini (see Fig. 3-10). Interestingly, the median disorder level in the RPI-NPInter* regions 
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corresponding to the 2nd and 5th tenths of the sequence is highly ordered, with ~75% of 
proteins containing little to no disordered residues in these regions. This may explain why the 
tenths division worked so well in the model. 
 
Figure 3-10 Boxplots of the predicted proportion of disordered residues in regions of 
RPI12252* proteins (disorder features D6-D15). The protein sequences are divided into 
tenths, and the proportion of the first tenth, second tenth, etc. which is predicted to be 
disordered is determined (see Methods and Materials). 
These results indicate that the PDB tends to have highly ordered structures which 
may be disordered at the N- and C-termini (and it is likely that many RPI-PDB interactions 
are drawn from structures missing residues from these regions which could not be 
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crystallized.) The non-structurally determined RPI-NPInter* dataset, in contrast, can include 
highly disordered sequences incapable of being crystallized which are nonetheless flexible 
enough to conform to and bind RNA tightly and with specificity [Varadi et al. 2015]. These 
examinations show that there are large differences in the degree and distribution of 
disordered residues in PDB complexes vs NPInter complexes.  
Interestingly, while the datasets differ in how much and where the disorder occurs, 
they show a great deal of similarity in the physicochemical properties of both the ordered and 
disordered residues (see Figs. 3-11 and 3-12). 
The predicted ordered residues are nearly identically distributed for RPI-PDB and 
RPI-NPInter*, with differences only in the proportion of positively charged and neutral 
residues predicted to be ordered. The RPI-NPInter* dataset has a slightly larger proportion of 
uncharged residues; this may be due to the propensity of flexible linker groups to be formed 
from uncharged residues [Chen et al. 2013], thus resulting in fewer ordered PDB examples. 
The predicted disordered residues show a much greater variance in distribution, 
though the medians are still similar for the hydrophilic, moderately hydrophilic, and 
negatively charged residues, and a small difference between the positively charged medians. 
Nonetheless, there are large differences in the medians for the hydrophobic and neutral 
residues, where the RPI12252* dataset has larger proportions than RPI2241. The elevated 
proportion of neutral residues in the RPI12252* dataset is likely due to the same 
phenomenon described above, but the hydrophobic elevation is surprising, as hydrophobic 
regions tend to promote order as the protein folds to bury these regions [Uversky 2011]. It is 
thus unexpected for the more disordered RPI12252* dataset proteins to (on average) contain 
more of these residues than the structured RPI2241 dataset. However, the same 
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hydrophobicity which drives protein folding [Dill 1990] may also encourage disorder-order  
transition in proteins upon RNA-binding, and the RPI12252* dataset may be capturing RPIs 
where the protein undergoes a disorder-order transition upon binding, while the RPI2241 
dataset may lack a similar proportion of crystallized RNPs. 
Altogether, this demonstrates that while there are differences in locations of 
disordered regions in the RPI2241 and RPI12252* datasets, the physicochemical properties 
of the amino acids within those regions are similar enough to apply signal learned from the 
RPI2241 dataset to the RPI12252* dataset. 
Performance on FMRP119 Testing Dataset 
To compare the performance of RPIDisorder, RPISeq, and RPIMotif on an 
independent test set, we evaluated the performance of the three classifiers using the 
FMRP119 (RPI-FMRP) dataset, which consists of 119 RNA-protein interactions for the 
Fragile X Mental Retardation Protein (FMRP). FMRP contains 3-4 RNA-binding domains: at 
least two (and possibly three) KH domains [Myrick et al. 2015], and an RGG domain located 
within the heavily disordered region near the C-terminus. The FMRP RGG box is responsible 
for sequence-specific binding to mRNA targets, particularly targets containing G-quadruplex 
structural motifs [Darnell et al. 2001]; in fact, specific arginines in the RGG box are 
important for binding different RNAs [Blackwell et al. 2010]. These qualities make FMRP 
an ideal case study for demonstrating the practical utility of RPIDisorder for predicting 
mRNA-protein interactions involving a highly disordered protein. 
The RPI-FMRP dataset pairs a truncated FMRP sequence corresponding to the 
disordered C-terminus region containing the RGG domain responsible for mRNA-binding 
specificity. While Ascano et al. did not specifically determine if this region was responsible 











Figure 3-11 Boxplots of the proportion of predicted ordered residues within the RPI2241 dataset proteins (gray) and the RPI12252* 












Figure 3-12 Boxplots of the proportion of predicted disordered residues within the RPI2241 dataset proteins (gray) and the RPI12252* 




demonstrated that FMRPs containing the I304N point mutation in the KH2 domain (and the 
corresponding mutation in the KH1 domain) bind to specific mRNA nearly as well as 
wildtype FMRP [Darnell et al. 2001], indicating that the KH domains are likely not involved 
in determining FMRP’s mRNA partners. The RGG domain and C-terminus region appear to 
be primarily responsible for determining specific FMRP-mRNA interactions [Blackwell et al. 
2010, Ozdilek 2017]. Thus, pairing the C-terminal FMRP region with the regions of the 
mRNA Ascano et al. [Ascano et al. 2012] found it to bind appears to be a valid approach. 
In fact, using the full-length FMRP protein sequence including KH domain regions 
led RPISeq, RPIMotif, and RPIDisorder to all predict indiscriminate binding for both the 
positive and negative instances for RPI-FMRP (not shown). This is very likely due to the fact 
that the RPI-PDB dataset, which all the previously mentioned methods were trained on, 
includes over a thousand ribosomal-RNA/ribosomal-protein interactions, including S3 
ribosomal protein paired with the 16S ribosomal RNA – for example, chain C (S3) and chain 
A (16S rRNA) from PDB structure 2E5L (Thermus thermophilus 30S ribosomal subunit) are 
paired in the RPI-PDB training dataset. The thermophilus 16S ribosomal subunit is heavily 
G-rich (35.67% of the sequence is composed of guanines), and the QGRS software 
(Quadruplex forming G-Rich Sequences) [Kikin et al. 2006], which identifies putative G-
quadruplex forming regions in nucleic acid sequences, identifies a whopping 515 
(overlapping) potential quadruplex-forming G-rich sequences. This approximates to 1 
potential QGRS every 3.37 amino acids in the thermophilus 16S ribosomal subunit. The KH 
domains in both the thermophilus S3 and FMRP proteins are predicted to be ordered 
(incidentally, the KH domains in FMRP may actually bind directly to the ribosome to allow 
FMRP to repress translation [Harigaya & Parker 2014].) Thus, from a sequence and structure 
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standpoint, the classifiers could very easily have learned from the RPI-PDB dataset that 
ordered KH domains will bind to G-rich RNA regions, and lack necessary additional KH 
interactions to predict KH domain binding specificity. 
 
Figure 3-13 Performance comparison of RPISeq (gray), RPIMotif (red), and RPIDisorder 
(blue) on the FMRP119 dataset.  
Ultimately, on the RPI-FMRP dataset (using the truncated C-terminus region of the 
FMRP protein), RPIDisorder had a lower TPR (79.0%), but comparable precision, F-
measure, and accuracy (78.7%, 78.7%, 79%, respectively; see Fig. 3-13) compared to 
RPISeq (TPR 88.0%, precision 76.7%, F-measure 78.7%, and accuracy 75.6%) and 
RPIMotif (TPR 89.3%, precision 78.8%, F-measure 83.6%, accuracy 78.2%). On the other 
hand, RPIDisorder had a much lower false positive rate (26.4%) than both RPISeq (45.5%) 
and RPIMotif (40.9%), leading to a marginally better MCC (0.541 vs RPISeq 0.459 and 
RPIMotif 0.517). 
We also generated AUC of ROC curves for this dataset (see Fig. 3-14). Although all 
the classifiers achieve similar AUCs for this dataset, RPIMotif actually has a slightly larger 
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AUC than either RPIDisorder or RPISeq, despite the fact that RPIDisorder has a much better 
specificity/FPR and marginally better MCC and accuracy. This is likely due to the small size 
of the FMRP dataset and that it is somewhat imbalanced (75 interacting examples and 44 
non-interacting examples), leading to a better AUC when achieving a high TPR. 
 
Figure 3-14 Area Under the Receiver Operating Characteristic Curves (AUC of ROC) for 
RPISeq (gray), RPIMotif (red), and RPIDisorder (blue). AUCs are 0.86, 0.90, and 0.88 for 
RPISeq, RPIMotif, and RPIDisorder, respectively. Curves created in R using ggplot2 
[Wickham 2016] with code provided courtesy of Kris De Brabanter. 
Contributions of Disordered Features 
Identifying which of the predicted disorder features and physicochemical properties 
contribute most to the improved prediction of RPIPs obtained using RPIDisorder could 
provide insights into mechanisms of specific RNA-protein recognitions. Although it is not 
possible to extract feature importance directly from the RPIDisorder Weka model, it is 
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possible to examine feature importance within the R randomForest model, which can (with 
caution) be used to approximate the importance of the features in the Weka model. 
Disorder Feature Importance 
 
Figure 3-15 Comparison of the four importance measures reported by R randomForest: The 
importance of features in identifying the interacting RNA-protein class (Interacting), the non-
interacting RNA-protein class (Non-interacting), the mean decrease in model accuracy 
(MDA), and the mean decrease in node impurity (Gini) produced by the feature. 
R's randomForest package provides two metrics for identifying a feature’s importance 
to a random forest model: mean decrease in accuracy (MDA) and mean increase in node 
impurity (Gini). The MDA is determined by calculating the out-of-bag (OOB) prediction 
error, then randomly permuting the values of a particular feature in the OOB data instances 
and computing the difference in error and averaging these values over all trees before 
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normalizing using the standard deviation of the differences in error [Liaw & Wiener 2018]. 
The MDA therefore demonstrates the effect a particular feature has on a model’s accuracy; if 
there is a large decrease in accuracy from randomly permuting the variable, then it must be 
important in accurate classification. R randomForest can also generate the MDA for class-
specific labels (e.g., the importance of a feature for determining the “Interacting” and 
“Noninteracting” classes) and give an idea of a feature’s importance in determining 
interacting RNA-protein partners and determining non-interacting RNAs and proteins. 
The Gini measures the total increase in node purity (i.e., how well a particular feature 
“splits” the data between interacting and non-interacting classes) for a feature averaged over 
the trees in the random forest. If a feature produces a large increase in node purity, this is an 
indicator that it splits the classes well and is therefore important. This metric can also be 
determined for class-specific labels. 
Feature importance was assessed using the top performing R randomForest classifier, 
which achieves TPR 87.0%, FPR 12.0%, Specificity 88.0%, Precision 87.8%, F-Measure 
87.4%, Accuracy 87.5%, and MCC 0.749 in training on RPI-PDB, and TPR 96.8%, FPR 
34.1%, Specificity 65.9%, Precision 97.2%, F-Measure 97%, Accuracy 94.4%, and MCC of 
0.610 on RPI-NPInter*.  An overview of the results of feature importance assessment is 
shown in Fig. 3-15. Detailed analyses focused on each class of importance features are 
provided in the following sections. 
Features important for identifying the “Interacting” (positive) class  
A boxplot of feature importance for all features, conjoint triad protein features, 
conjoint tetrad features, and disorder features is shown in Fig. 3-16 and the most important 
features (top 5) are summarized in Table 3-1. Fig. 3-16 shows that the protein features (in 
red) and disorder features (in gray) were both more important than RNA (in blue) for 
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identifying the “interacting” (positive) class, with median values of 9.08% for protein and 
11.17% for disorder.   
As shown in Table 3-1, of the 5 features most important for determining the 
interacting class as determined by MDA, 3 are disorder features. Of the top 30 features (the 
top 5% of features overall), nine (29%) are disorder features (see Supp. Table S3-3), even 
though disorder features make up only 4.2% of the total feature count. The top three features 
for determining the interacting class were: ordPos, the percentage of residues predicted to be 
ordered and positively charged; D1, the percentage of the total sequence predicted to be 
disordered; and D5, the percentage of the final quarter of the sequence predicted to be 
disordered.  Thus, protein and disorder features are more important in identifying the 
positive/interacting class than RNA features. This contrasts with features important for 
identifying the non-interacting class (see Fig. 3-17), where the median importance of RNA 
features (5.67%) is on par with that of protein features (5.27%); and both RNA and protein 
features are less important than disorder importance (6.38%). 
Features important for identifying the “Non-Interacting” (negative) class  
Of the top 5 features most important for determining the non-interacting class (as determined 
by MDA), there are four disordered features (Table 3-2). Disordered features make up 16.1% 
(5/31) of the top of features for identifying the non-interacting class (see Supp. Table 3-4).  
Disorder features D1 and D5 are both very important, although ordPos, the percentage of 
residues predicted to be ordered that are positively charged is only the 5th most important 
feature, whereas ordNeg, the percentage of predicted ordered residues that are negatively 
charged is ranked most important. Note that disNeg, the percentage of predicted disordered 
residues that are negatively charged is also of elevated importance. Because sequence-
specific RNA-protein binding may require interaction between the protein and the RNA face, 
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rather than the backbone, the disposition of the negatively charged residues may be important 
in mediating these interactions [Jones 2001]. 
 
Figure 3-16 Feature importance (Mean Decrease in Accuracy, %) for identifying interacting 
RNA-protein pairs. The collective importance of all features for identifying the interacting 
class is in white. The protein features (P1-P343) are in red. The RNA features (R1-R56) are 
highlighted in blue. The disorder features (D1-D15, ordPhilic, ordMod, ordPhobic, ordPos, 
ordNeg, ordNeut, disPhilic, disMod, disPhobic, disPos, disNeg, and disNeut) are in gray.   
Table 3-1: Importance metrics for the R randomForest classifier, ordered in descending order 
based on Interacting importance, for the top 5 Interacting features. Disordered features are 
highlighted in blue. Protein conjoint triad features start with a “P”. See “Methods” for 
description of disorder features. The first three columns are the Mean Decrease in Accuracy 
(%) for determining the Interacting class, Non-interacting class, and overall MDA, 
respectively.  
 
Interacting Nonint MeanDecreaseAccuracy MeanDecreaseGini
ordPos 14.46 8.70 14.92 3.69
D1 13.66 8.94 14.17 2.96
D5 13.36 8.84 14.63 2.61
P251 13.28 8.68 13.97 2.36
P57 13.10 6.94 13.82 2.59
P11 13.05 6.00 13.28 1.67
P201 12.97 6.29 12.67 2.14
P152 12.79 4.75 12.03 1.86
D2 12.78 6.71 13.10 2.57
P225 12.75 7.78 12.67 2.35
P101 12.73 7.68 13.35 2.16
P62 12.71 6.92 12.18 2.05
P8 12.63 5.32 11.80 2.12
P127 12.59 7.60 12.91 2.04
P61 12.58 7.71 12.54 2.43
ordPhillic 12.56 6.71 12.20 3.38
P106 12.39 6.01 12.27 1.62
disNeut 12.37 5.64 11.92 2.16
P29 12.31 8.30 13.11 2.06
P12 12.30 7.59 12.08 2.34
disMod 12.30 6.89 13.23 2.14
P275 12.27 6.72 12.61 1.59
P13 12.27 7.66 12.90 2.00
P5 12.22 7.98 13.37 2.11
P257 12.22 5.41 12.19 1.73
P32 12.21 6.35 12.37 1.48
P212 12.16 5.59 13.03 1.80
P90 12.06 6.30 12.44 1.59
ordNeut 12.05 7.20 11.72 3.93
D6 11.99 7.45 12.22 2.66





Figure 3-17 Feature importance for identifying non-interacting RNA-protein pairs. The 
collective importance of all features for identifying the non-interacting class is in white. The 
protein features (P1-P343) are highlighted in red. The RNA features (R1-R56) are 
highlighted in blue. The disorder features (D1-D15, ordPhilic, ordMod, ordPhobic, ordPos, 
ordNeg, ordNeut, disPhilic, disMod, disPhobic, disPos, disNeg, and disNeut) are in gray.   
Table 3-2 Importance metrics for the R randomForest classifier, ordered in descending order 
based on Non-interacting importance (Nonint), for the top 5 non-interacting features. 
Disordered features are highlighted in blue. Protein conjoint triad features start with a “P”. 
RNA conjoint tetrad features start with an “R”. See “Methods” for description of disorder 
features. 
 
Interacting Nonint MeanDecreaseAccuracy MeanDecreaseGini
ordNeg 10.78 9.71 12.16 3.42
D1 13.66 8.94 14.17 2.96
D5 13.36 8.84 14.63 2.61
R173 5.98 8.77 9.61 1.98
ordPos 14.46 8.70 14.92 3.69
P251 13.28 8.68 13.97 2.36
R208 4.82 8.63 8.51 2.13
R41 6.22 8.62 9.87 2.12
R189 5.88 8.35 7.81 1.98
P29 12.31 8.30 13.11 2.06
R190 6.01 8.23 7.82 2.44
P16 10.74 8.05 10.86 2.07
P5 12.22 7.98 13.37 2.11
R113 5.36 7.97 7.94 3.50
P33 11.73 7.94 11.75 2.28
disNeg 11.89 7.94 12.83 2.13
P58 9.43 7.92 10.55 2.52
P36 11.35 7.89 11.49 2.79
P79 9.45 7.79 9.83 2.19
P225 12.75 7.78 12.67 2.35
R206 4.35 7.78 6.84 1.68
R254 6.25 7.78 8.43 2.57
R58 4.13 7.77 6.99 4.12
R196 6.04 7.72 7.77 2.23
P61 12.58 7.71 12.54 2.43
P99 11.23 7.71 11.75 2.20
P82 10.20 7.69 10.18 2.59
P101 12.73 7.68 13.35 2.16
R47 4.47 7.67 6.10 1.72
P100 11.21 7.66 12.21 2.29
P13 12.27 7.66 12.90 2.00
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Feature importance based on Mean Decrease in Accuracy 
The overall MDA for each feature (Fig. 3-18) is fairly similar to the Interacting MDA 
(Fig. 3-16); in fact, the top five features (ordPos, D5, D1, P251, and P57) are the same 
between the two measures, though the exact order is slightly different (see Table 3-3). Of the 
top 5% of most important features as measured by MDA (see Supp. Table S3-5), 9/31 (29%) 
are disordered features. Between the Interacting, Non-interacting, and overall MDA, disorder 
features tend to be of high importance for the model. 
 
 
Figure 3-18 Feature importance ranked by Mean Decrease in Accuracy. The collective 
importance of all features is in white. The protein features (P1-P343) are in red. The RNA 
features (R1-R56) are in blue. The disorder features (D1-D15, ordPhilic, ordMod, ordPhobic, 
ordPos, ordNeg, ordNeut, disPhilic, disMod, disPhobic, disPos, disNeg, and disNeut) are in 
gray.   
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Table 3-3 Importance metrics for the R randomForest classifier, ordered in descending order 
based on overall Mean Decrease in Accuracy, for the top 5 MDA features. Disordered 
features are highlighted in blue. Protein conjoint triad features start with a “P”. See 




Figure 3-19 Feature importance ranked by decrease in node impurity. The collective 
importance of all features is in white. The protein features (P1-P343) are in red. The RNA 
features (R1-R56) are in blue. The disorder features (D1-D15, ordPhilic, ordMod, ordPhobic, 
ordPos, ordNeg, ordNeut, disPhilic, disMod, disPhobic, disPos, disNeg, and disNeut) are in 
gray.   
Interacting Nonint MeanDecreaseAccuracy MeanDecreaseGini
ordPos 14.46 8.70 14.92 3.69
D5 13.36 8.84 14.63 2.61
D1 13.66 8.94 14.17 2.96
P251 13.28 8.68 13.97 2.36
P57 13.10 6.94 13.82 2.59
P5 12.22 7.98 13.37 2.11
P101 12.73 7.68 13.35 2.16
P11 13.05 6.00 13.28 1.67
disMod 12.30 6.89 13.23 2.14
P29 12.31 8.30 13.11 2.06
D2 12.78 6.71 13.10 2.57
P108 11.66 7.50 13.08 1.71
P212 12.16 5.59 13.03 1.80
P127 12.59 7.60 12.91 2.04
P13 12.27 7.66 12.90 2.00
disNeg 11.89 7.94 12.83 2.13
P201 12.97 6.29 12.67 2.14
P225 12.75 7.78 12.67 2.35
P30 11.82 6.24 12.65 2.07
P275 12.27 6.72 12.61 1.59
P61 12.58 7.71 12.54 2.43
disPhillic 11.82 7.05 12.53 2.34
P90 12.06 6.30 12.44 1.59
P4 11.37 6.13 12.42 1.67
P55 11.64 6.28 12.40 1.81
P32 12.21 6.35 12.37 1.48
P106 12.39 6.01 12.27 1.62
D6 11.99 7.45 12.22 2.66
P100 11.21 7.66 12.21 2.29
ordPhillic 12.56 6.71 12.20 3.38
P257 12.22 5.41 12.19 1.73
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The mean decrease in node impurity measures how important a feature is for splitting 
the interacting and non-interacting classes. A larger mean decrease in node impurity means a 
feature is more important. The disorder features have mean decrease in node impurity of 
2.16. However, only one disorder feature (ordNeut) is among the top 5 most important 
features as measured by Mean Decrease in Gini (see Table 3-4), although the disorder 
features make up 16% of the top 5% of features as ranked by mean decrease in node impurity 
(see Supp. Table S3-6).  
Table 3-4 Importance metrics for the R randomForest classifier, ordered in descending order 
based on Mean Decrease in Node Impurity (MeanDecreaseGini), for the top 5 features. 
Disordered features are highlighted in blue. RNA conjoint tetrad features start with an “R”. 
See “Methods” for description of disorder features. 
 
Conclusion 
RPIDisorder is a machine learning classifier for predicting RNA-protein interactions 
using sequence composition and predicted disorder information. On the basis of several 
different performance evaluation metrics, RPIDisorder outperforms the previous state-of-the-
art sequence composition-based method, RPISeq [Muppirala et al. 2011]. The performance 
of RPIDisorder in detecting RPIPs is comparable to that of the motif-based method, 
RPIMotif [Walia 2014], and it is superior to RPIMotif in correctly identifying non-
interacting RNA-protein pairs. 
Notably, even though the training dataset (RPI-PDB) was derived from PDB 
structures and is therefore biased toward proteins that are predominantly structured, it 
Interacting Nonint MeanDecreaseAccuracy MeanDecreaseGini
R6 5.42 5.39 6.08 5.57
R33 4.44 4.63 5.21 4.30
R58 4.13 7.77 6.99 4.12
R120 5.27 5.47 5.98 4.10
ordNeut 12.05 7.20 11.72 3.93
R150 5.73 6.26 6.59 3.89
R31 5.24 6.02 6.30 3.84
R242 5.36 7.05 6.29 3.80
R49 4.62 7.19 6.90 3.74
ordPos 14.46 8.70 14.92 3.69
R113 5.36 7.97 7.94 3.50
R115 4.53 4.78 4.99 3.47
R106 5.88 5.58 6.61 3.46
R194 5.16 4.68 5.67 3.43
R34 5.21 3.17 5.33 3.43
ordNeg 10.78 9.71 12.16 3.42
R64 5.71 5.47 7.26 3.38
ordPhillic 12.56 6.71 12.20 3.38
ordPhobic 11.55 7.31 11.64 3.36
R202 4.75 4.07 5.41 3.33
R102 5.06 3.88 5.42 3.30
R230 5.11 4.55 5.47 3.27
R14 5.23 6.80 6.72 3.26
R54 4.71 6.11 5.45 3.24
R96 4.67 4.52 5.24 3.22
R65 6.16 5.10 6.78 3.22
R5 4.53 3.96 4.73 3.20
R21 5.00 6.03 6.02 3.19
R105 5.76 2.79 5.81 3.18
R117 5.00 6.55 5.64 3.18
R222 4.72 6.49 6.07 3.15
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contains enough disorder-based signal to generate a model that makes reliable predictions on 
two datasets (RPI-NPInter* and RPI-FMRP) with a much higher proportion of disordered 
structures. On the other hand, the failure of RPIDisorder, RPIMotif, and RPISeq to predict 
interactions between the full-length FMRP protein and the RPI-FMRP dataset demonstrates 
the need for better training datasets.  
All of the feature importance results suggest that disorder-based features are 
important for distinguishing interacting and non-interacting RNA-protein pairings. Thus, 
RPIDisorder can make highly specific predictions on a broad range of RNPs and RNA-
protein interaction networks, including those containing highly disordered proteins, and 
proteins that interact with diverse ncRNAs and mRNAs. 
Future Directions 
Future work on RPIDisorder will include the generation of a true negative dataset 
derived from human protein PAR-CLIP experiments deposited in ENCODE [ENCODE 
Project Consortium 2012] (in progress), to evaluate whether PRIP prediction performance 
can be further improved. Also, a rigorous evaluation of RPIDisorder will require direct 
comparison of its performance with methods published recently by other groups, using 
carefully selected benchmark datasets. 
Availability 
RPIDisorder will soon be available at www.rpidisorder.org, and is available for 
download at https://github.com/Dobbs-Lab/RPIDisorder.com. All datasets and code 
necessary for reproducing these results are available at 




I would like to thank the Dill-PICL lab for their valuable discussions on the 
RPIDisorder interface.  
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Table S3-1 Protein conjoint triads utilized in RPIDisorder. The “Feature Label” is the name 
given to the feature in the vector. The “Feature” column contains the combination of amino 
acids whose frequency is represented by the Feature Label. The protein groups are {A,G,V}, 
{I,L,F,P}, {Y,M,T,S}, {H,N,Q,W}, {R,K}, {D,E}, and {C}.  
Label Feature Label Feature 
P1 {A,G,V}  {A,G,V}  {A,G,V} P31 {A,G,V}  {R,K}  {Y,M,T,S} 
P2 {A,G,V}  {A,G,V}  {I,L,F,P} P32 {A,G,V}  {R,K}  {H,N,Q,W} 
P3 {A,G,V}  {A,G,V}  {Y,M,T,S} P33 {A,G,V}  {R,K}  {R,K} 
P4 {A,G,V}  {A,G,V}  {H,N,Q,W} P34 {A,G,V}  {R,K}  {D,E} 
P5 {A,G,V}  {A,G,V}  {R,K} P35 {A,G,V}  {R,K}  {C} 
P6 {A,G,V}  {A,G,V}  {D,E} P36 {A,G,V}  {D,E}  {A,G,V} 
P7 {A,G,V}  {A,G,V}  {C} P37 {A,G,V}  {D,E}  {I,L,F,P} 
P8 {A,G,V}  {I,L,F,P}  {A,G,V} P38 {A,G,V}  {D,E}  {Y,M,T,S} 
P9 {A,G,V}  {I,L,F,P}  {I,L,F,P} P39 {A,G,V}  {D,E}  {H,N,Q,W} 
P10 {A,G,V}  {I,L,F,P}  {Y,M,T,S} P40 {A,G,V}  {D,E}  {R,K} 
P11 {A,G,V}  {I,L,F,P}  {H,N,Q,W} P41 {A,G,V}  {D,E}  {D,E} 
P12 {A,G,V}  {I,L,F,P}  {R,K} P42 {A,G,V}  {D,E}  {C} 
P13 {A,G,V}  {I,L,F,P}  {D,E} P43 {A,G,V}  {C}  {A,G,V} 
P14 {A,G,V}  {I,L,F,P}  {C} P44 {A,G,V}  {C}  {I,L,F,P} 
P15 {A,G,V}  {Y,M,T,S}  {A,G,V} P45 {A,G,V}  {C}  {Y,M,T,S} 
P16 {A,G,V}  {Y,M,T,S}  {I,L,F,P} P46 {A,G,V}  {C}  {H,N,Q,W} 
P17 {A,G,V}  {Y,M,T,S}  {Y,M,T,S} P47 {A,G,V}  {C}  {R,K} 
P18 
{A,G,V}  {Y,M,T,S}  
{H,N,Q,W} P48 {A,G,V}  {C}  {D,E} 
P19 {A,G,V}  {Y,M,T,S}  {R,K} P49 {A,G,V}  {C}  {C} 
P20 {A,G,V}  {Y,M,T,S}  {D,E} P50 {I,L,F,P}  {A,G,V}  {A,G,V} 
P21 {A,G,V}  {Y,M,T,S}  {C} P51 {I,L,F,P}  {A,G,V}  {I,L,F,P} 
P22 {A,G,V}  {H,N,Q,W}  {A,G,V} P52 {I,L,F,P}  {A,G,V}  {Y,M,T,S} 
P23 {A,G,V}  {H,N,Q,W}  {I,L,F,P} P53 {I,L,F,P}  {A,G,V}  {H,N,Q,W} 
P24 
{A,G,V}  {H,N,Q,W}  
{Y,M,T,S} P54 {I,L,F,P}  {A,G,V}  {R,K} 
P25 
{A,G,V}  {H,N,Q,W}  
{H,N,Q,W} P55 {I,L,F,P}  {A,G,V}  {D,E} 
P26 {A,G,V}  {H,N,Q,W}  {R,K} P56 {I,L,F,P}  {A,G,V}  {C} 
P27 {A,G,V}  {H,N,Q,W}  {D,E} P57 {I,L,F,P}  {I,L,F,P}  {A,G,V} 
P28 {A,G,V}  {H,N,Q,W}  {C} P58 {I,L,F,P}  {I,L,F,P}  {I,L,F,P} 
P29 {A,G,V}  {R,K}  {A,G,V} P59 {I,L,F,P}  {I,L,F,P}  {Y,M,T,S} 




Table S3-1 (continued) 
Label Feature Label Feature 
P61 {I,L,F,P}  {I,L,F,P}  {R,K} P100 {Y,M,T,S}  {A,G,V}  {I,L,F,P} 
P62 {I,L,F,P}  {I,L,F,P}  {D,E} P101 {Y,M,T,S}  {A,G,V}  {Y,M,T,S} 
P63 {I,L,F,P}  {I,L,F,P}  {C} P102 {Y,M,T,S}  {A,G,V}  {H,N,Q,W} 
P64 {I,L,F,P}  {Y,M,T,S}  {A,G,V} P103 {Y,M,T,S}  {A,G,V}  {R,K} 
P65 {I,L,F,P}  {Y,M,T,S}  {I,L,F,P} P104 {Y,M,T,S}  {A,G,V}  {D,E} 
P66 {I,L,F,P}  {Y,M,T,S}  {Y,M,T,S} P105 {Y,M,T,S}  {A,G,V}  {C} 
P67 {I,L,F,P}  {Y,M,T,S}  {H,N,Q,W} P106 {Y,M,T,S}  {I,L,F,P}  {A,G,V} 
P68 {I,L,F,P}  {Y,M,T,S}  {R,K} P107 {Y,M,T,S}  {I,L,F,P}  {I,L,F,P} 
P69 {I,L,F,P}  {Y,M,T,S}  {D,E} P108 {Y,M,T,S}  {I,L,F,P}  {Y,M,T,S} 
P70 {I,L,F,P}  {Y,M,T,S}  {C} P109 {Y,M,T,S}  {I,L,F,P}  {H,N,Q,W} 
P71 {I,L,F,P}  {H,N,Q,W}  {A,G,V} P110 {Y,M,T,S}  {I,L,F,P}  {R,K} 
P72 {I,L,F,P}  {H,N,Q,W}  {I,L,F,P} P111 {Y,M,T,S}  {I,L,F,P}  {D,E} 
P73 {I,L,F,P}  {H,N,Q,W}  {Y,M,T,S} P112 {Y,M,T,S}  {I,L,F,P}  {C} 
P74 {I,L,F,P}  {H,N,Q,W}  {H,N,Q,W} P113 {Y,M,T,S}  {Y,M,T,S}  {A,G,V} 
P75 {I,L,F,P}  {H,N,Q,W}  {R,K} P114 {Y,M,T,S}  {Y,M,T,S}  {I,L,F,P} 
P76 {I,L,F,P}  {H,N,Q,W}  {D,E} P115 {Y,M,T,S}  {Y,M,T,S}  {Y,M,T,S} 
P77 {I,L,F,P}  {H,N,Q,W}  {C} P116 {Y,M,T,S}  {Y,M,T,S}  {H,N,Q,W} 
P78 {I,L,F,P}  {R,K}  {A,G,V} P117 {Y,M,T,S}  {Y,M,T,S}  {R,K} 
P79 {I,L,F,P}  {R,K}  {I,L,F,P} P118 {Y,M,T,S}  {Y,M,T,S}  {D,E} 
P80 {I,L,F,P}  {R,K}  {Y,M,T,S} P119 {Y,M,T,S}  {Y,M,T,S}  {C} 
P81 {I,L,F,P}  {R,K}  {H,N,Q,W} P120 {Y,M,T,S}  {H,N,Q,W}  {A,G,V} 
P82 {I,L,F,P}  {R,K}  {R,K} P121 {Y,M,T,S}  {H,N,Q,W}  {I,L,F,P} 
P83 {I,L,F,P}  {R,K}  {D,E} P122 {Y,M,T,S}  {H,N,Q,W}  {Y,M,T,S} 
P84 {I,L,F,P}  {R,K}  {C} P123 {Y,M,T,S}  {H,N,Q,W}  {H,N,Q,W} 
P85 {I,L,F,P}  {D,E}  {A,G,V} P124 {Y,M,T,S}  {H,N,Q,W}  {R,K} 
P86 {I,L,F,P}  {D,E}  {I,L,F,P} P125 {Y,M,T,S}  {H,N,Q,W}  {D,E} 
P87 {I,L,F,P}  {D,E}  {Y,M,T,S} P126 {Y,M,T,S}  {H,N,Q,W}  {C} 
P88 {I,L,F,P}  {D,E}  {H,N,Q,W} P127 {Y,M,T,S}  {R,K}  {A,G,V} 
P89 {I,L,F,P}  {D,E}  {R,K} P128 {Y,M,T,S}  {R,K}  {I,L,F,P} 
P90 {I,L,F,P}  {D,E}  {D,E} P129 {Y,M,T,S}  {R,K}  {Y,M,T,S} 
P91 {I,L,F,P}  {D,E}  {C} P130 {Y,M,T,S}  {R,K}  {H,N,Q,W} 
P92 {I,L,F,P}  {C}  {A,G,V} P131 {Y,M,T,S}  {R,K}  {R,K} 
P93 {I,L,F,P}  {C}  {I,L,F,P} P132 {Y,M,T,S}  {R,K}  {D,E} 
P94 {I,L,F,P}  {C}  {Y,M,T,S} P133 {Y,M,T,S}  {R,K}  {C} 
P95 {I,L,F,P}  {C}  {H,N,Q,W} P134 {Y,M,T,S}  {D,E}  {A,G,V} 
P96 {I,L,F,P}  {C}  {R,K} P135 {Y,M,T,S}  {D,E}  {I,L,F,P} 
P97 {I,L,F,P}  {C}  {D,E} P136 {Y,M,T,S}  {D,E}  {Y,M,T,S} 
P98 {I,L,F,P}  {C}  {C} P137 {Y,M,T,S}  {D,E}  {H,N,Q,W} 
P99 {Y,M,T,S}  {A,G,V}  {A,G,V} P138 {Y,M,T,S}  {D,E}  {R,K} 
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Table S3-1 (continued) 
Label Feature Label Feature 
P139 {Y,M,T,S}  {D,E}  {D,E} P178 {H,N,Q,W}  {R,K}  {Y,M,T,S} 
P140 {Y,M,T,S}  {D,E}  {C} P179 {H,N,Q,W}  {R,K}  {H,N,Q,W} 
P141 {Y,M,T,S}  {C}  {A,G,V} P180 {H,N,Q,W}  {R,K}  {R,K} 
P142 {Y,M,T,S}  {C}  {I,L,F,P} P181 {H,N,Q,W}  {R,K}  {D,E} 
P143 {Y,M,T,S}  {C}  {Y,M,T,S} P182 {H,N,Q,W}  {R,K}  {C} 
P144 {Y,M,T,S}  {C}  {H,N,Q,W} P183 {H,N,Q,W}  {D,E}  {A,G,V} 
P145 {Y,M,T,S}  {C}  {R,K} P184 {H,N,Q,W}  {D,E}  {I,L,F,P} 
P146 {Y,M,T,S}  {C}  {D,E} P185 {H,N,Q,W}  {D,E}  {Y,M,T,S} 
P147 {Y,M,T,S}  {C}  {C} P186 {H,N,Q,W}  {D,E}  {H,N,Q,W} 
P148 {H,N,Q,W}  {A,G,V}  {A,G,V} P187 {H,N,Q,W}  {D,E}  {R,K} 
P149 {H,N,Q,W}  {A,G,V}  {I,L,F,P} P188 {H,N,Q,W}  {D,E}  {D,E} 
P150 {H,N,Q,W}  {A,G,V}  {Y,M,T,S} P189 {H,N,Q,W}  {D,E}  {C} 
P151 {H,N,Q,W}  {A,G,V}  {H,N,Q,W} P190 {H,N,Q,W}  {C}  {A,G,V} 
P152 {H,N,Q,W}  {A,G,V}  {R,K} P191 {H,N,Q,W}  {C}  {I,L,F,P} 
P153 {H,N,Q,W}  {A,G,V}  {D,E} P192 {H,N,Q,W}  {C}  {Y,M,T,S} 
P154 {H,N,Q,W}  {A,G,V}  {C} P193 {H,N,Q,W}  {C}  {H,N,Q,W} 
P155 {H,N,Q,W}  {I,L,F,P}  {A,G,V} P194 {H,N,Q,W}  {C}  {R,K} 
P156 {H,N,Q,W}  {I,L,F,P}  {I,L,F,P} P195 {H,N,Q,W}  {C}  {D,E} 
P157 {H,N,Q,W}  {I,L,F,P}  {Y,M,T,S} P196 {H,N,Q,W}  {C}  {C} 
P158 {H,N,Q,W}  {I,L,F,P}  {H,N,Q,W} P197 {R,K}  {A,G,V}  {A,G,V} 
P159 {H,N,Q,W}  {I,L,F,P}  {R,K} P198 {R,K}  {A,G,V}  {I,L,F,P} 
P160 {H,N,Q,W}  {I,L,F,P}  {D,E} P199 {R,K}  {A,G,V}  {Y,M,T,S} 
P161 {H,N,Q,W}  {I,L,F,P}  {C} P200 {R,K}  {A,G,V}  {H,N,Q,W} 
P162 {H,N,Q,W}  {Y,M,T,S}  {A,G,V} P201 {R,K}  {A,G,V}  {R,K} 
P163 {H,N,Q,W}  {Y,M,T,S}  {I,L,F,P} P202 {R,K}  {A,G,V}  {D,E} 
P164 {H,N,Q,W}  {Y,M,T,S}  {Y,M,T,S} P203 {R,K}  {A,G,V}  {C} 
P165 {H,N,Q,W}  {Y,M,T,S}  {H,N,Q,W} P204 {R,K}  {I,L,F,P}  {A,G,V} 
P166 {H,N,Q,W}  {Y,M,T,S}  {R,K} P205 {R,K}  {I,L,F,P}  {I,L,F,P} 
P167 {H,N,Q,W}  {Y,M,T,S}  {D,E} P206 {R,K}  {I,L,F,P}  {Y,M,T,S} 
P168 {H,N,Q,W}  {Y,M,T,S}  {C} P207 {R,K}  {I,L,F,P}  {H,N,Q,W} 
P169 {H,N,Q,W}  {H,N,Q,W}  {A,G,V} P208 {R,K}  {I,L,F,P}  {R,K} 
P170 {H,N,Q,W}  {H,N,Q,W}  {I,L,F,P} P209 {R,K}  {I,L,F,P}  {D,E} 
P171 {H,N,Q,W}  {H,N,Q,W}  {Y,M,T,S} P210 {R,K}  {I,L,F,P}  {C} 
P172 {H,N,Q,W}  {H,N,Q,W}  {H,N,Q,W} P211 {R,K}  {Y,M,T,S}  {A,G,V} 
P173 {H,N,Q,W}  {H,N,Q,W}  {R,K} P212 {R,K}  {Y,M,T,S}  {I,L,F,P} 
P174 {H,N,Q,W}  {H,N,Q,W}  {D,E} P213 {R,K}  {Y,M,T,S}  {Y,M,T,S} 
P175 {H,N,Q,W}  {H,N,Q,W}  {C} P214 {R,K}  {Y,M,T,S}  {H,N,Q,W} 
P176 {H,N,Q,W}  {R,K}  {A,G,V} P215 {R,K}  {Y,M,T,S}  {R,K} 
P177 {H,N,Q,W}  {R,K}  {I,L,F,P} P216 {R,K}  {Y,M,T,S}  {D,E} 
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Table S3-1 (continued) 
Label Feature Label Feature 
P217 {R,K}  {Y,M,T,S}  {C} P256 {D,E}  {I,L,F,P}  {H,N,Q,W} 
P218 {R,K}  {H,N,Q,W}  {A,G,V} P257 {D,E}  {I,L,F,P}  {R,K} 
P219 {R,K}  {H,N,Q,W}  {I,L,F,P} P258 {D,E}  {I,L,F,P}  {D,E} 
P220 {R,K}  {H,N,Q,W}  {Y,M,T,S} P259 {D,E}  {I,L,F,P}  {C} 
P221 {R,K}  {H,N,Q,W}  {H,N,Q,W} P260 {D,E}  {Y,M,T,S}  {A,G,V} 
P222 {R,K}  {H,N,Q,W}  {R,K} P261 {D,E}  {Y,M,T,S}  {I,L,F,P} 
P223 {R,K}  {H,N,Q,W}  {D,E} P262 {D,E}  {Y,M,T,S}  {Y,M,T,S} 
P224 {R,K}  {H,N,Q,W}  {C} P263 {D,E}  {Y,M,T,S}  {H,N,Q,W} 
P225 {R,K}  {R,K}  {A,G,V} P264 {D,E}  {Y,M,T,S}  {R,K} 
P226 {R,K}  {R,K}  {I,L,F,P} P265 {D,E}  {Y,M,T,S}  {D,E} 
P227 {R,K}  {R,K}  {Y,M,T,S} P266 {D,E}  {Y,M,T,S}  {C} 
P228 {R,K}  {R,K}  {H,N,Q,W} P267 {D,E}  {H,N,Q,W}  {A,G,V} 
P229 {R,K}  {R,K}  {R,K} P268 {D,E}  {H,N,Q,W}  {I,L,F,P} 
P230 {R,K}  {R,K}  {D,E} P269 {D,E}  {H,N,Q,W}  {Y,M,T,S} 
P231 {R,K}  {R,K}  {C} P270 {D,E}  {H,N,Q,W}  {H,N,Q,W} 
P232 {R,K}  {D,E}  {A,G,V} P271 {D,E}  {H,N,Q,W}  {R,K} 
P233 {R,K}  {D,E}  {I,L,F,P} P272 {D,E}  {H,N,Q,W}  {D,E} 
P234 {R,K}  {D,E}  {Y,M,T,S} P273 {D,E}  {H,N,Q,W}  {C} 
P235 {R,K}  {D,E}  {H,N,Q,W} P274 {D,E}  {R,K}  {A,G,V} 
P236 {R,K}  {D,E}  {R,K} P275 {D,E}  {R,K}  {I,L,F,P} 
P237 {R,K}  {D,E}  {D,E} P276 {D,E}  {R,K}  {Y,M,T,S} 
P238 {R,K}  {D,E}  {C} P277 {D,E}  {R,K}  {H,N,Q,W} 
P239 {R,K}  {C}  {A,G,V} P278 {D,E}  {R,K}  {R,K} 
P240 {R,K}  {C}  {I,L,F,P} P279 {D,E}  {R,K}  {D,E} 
P241 {R,K}  {C}  {Y,M,T,S} P280 {D,E}  {R,K}  {C} 
P242 {R,K}  {C}  {H,N,Q,W} P281 {D,E}  {D,E}  {A,G,V} 
P243 {R,K}  {C}  {R,K} P282 {D,E}  {D,E}  {I,L,F,P} 
P244 {R,K}  {C}  {D,E} P283 {D,E}  {D,E}  {Y,M,T,S} 
P245 {R,K}  {C}  {C} P284 {D,E}  {D,E}  {H,N,Q,W} 
P246 {D,E}  {A,G,V}  {A,G,V} P285 {D,E}  {D,E}  {R,K} 
P247 {D,E}  {A,G,V}  {I,L,F,P} P286 {D,E}  {D,E}  {D,E} 
P248 {D,E}  {A,G,V}  {Y,M,T,S} P287 {D,E}  {D,E}  {C} 
P249 {D,E}  {A,G,V}  {H,N,Q,W} P288 {D,E}  {C}  {A,G,V} 
P250 {D,E}  {A,G,V}  {R,K} P289 {D,E}  {C}  {I,L,F,P} 
P251 {D,E}  {A,G,V}  {D,E} P290 {D,E}  {C}  {Y,M,T,S} 
P252 {D,E}  {A,G,V}  {C} P291 {D,E}  {C}  {H,N,Q,W} 
P253 {D,E}  {I,L,F,P}  {A,G,V} P292 {D,E}  {C}  {R,K} 
P254 {D,E}  {I,L,F,P}  {I,L,F,P} P293 {D,E}  {C}  {D,E} 
P255 {D,E}  {I,L,F,P}  {Y,M,T,S} P294 {D,E}  {C}  {C} 
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Table S3-1 (continued) 
Feature Feature Label Feature 
P295 {C}  {A,G,V}  {A,G,V} P320 {C}  {H,N,Q,W}  {R,K} 
P296 {C}  {A,G,V}  {I,L,F,P} P321 {C}  {H,N,Q,W}  {D,E} 
P297 {C}  {A,G,V}  {Y,M,T,S} P322 {C}  {H,N,Q,W}  {C} 
P298 {C}  {A,G,V}  {H,N,Q,W} P323 {C}  {R,K}  {A,G,V} 
P299 {C}  {A,G,V}  {R,K} P324 {C}  {R,K}  {I,L,F,P} 
P300 {C}  {A,G,V}  {D,E} P325 {C}  {R,K}  {Y,M,T,S} 
P301 {C}  {A,G,V}  {C} P326 {C}  {R,K}  {H,N,Q,W} 
P302 {C}  {I,L,F,P}  {A,G,V} P327 {C}  {R,K}  {R,K} 
P303 {C}  {I,L,F,P}  {I,L,F,P} P328 {C}  {R,K}  {D,E} 
P304 {C}  {I,L,F,P}  {Y,M,T,S} P329 {C}  {R,K}  {C} 
P305 {C}  {I,L,F,P}  {H,N,Q,W} P330 {C}  {D,E}  {A,G,V} 
P306 {C}  {I,L,F,P}  {R,K} P331 {C}  {D,E}  {I,L,F,P} 
P307 {C}  {I,L,F,P}  {D,E} P332 {C}  {D,E}  {Y,M,T,S} 
P308 {C}  {I,L,F,P}  {C} P333 {C}  {D,E}  {H,N,Q,W} 
P309 {C}  {Y,M,T,S}  {A,G,V} P334 {C}  {D,E}  {R,K} 
P310 {C}  {Y,M,T,S}  {I,L,F,P} P335 {C}  {D,E}  {D,E} 
P311 {C}  {Y,M,T,S}  {Y,M,T,S} P336 {C}  {D,E}  {C} 
P312 {C}  {Y,M,T,S}  {H,N,Q,W} P337 {C}  {C}  {A,G,V} 
P313 {C}  {Y,M,T,S}  {R,K} P338 {C}  {C}  {I,L,F,P} 
P314 {C}  {Y,M,T,S}  {D,E} P339 {C}  {C}  {Y,M,T,S} 
P315 {C}  {Y,M,T,S}  {C} P340 {C}  {C}  {H,N,Q,W} 
P316 {C}  {H,N,Q,W}  {A,G,V} P341 {C}  {C}  {R,K} 
P317 {C}  {H,N,Q,W}  {I,L,F,P} P342 {C}  {C}  {D,E} 
P318 {C}  {H,N,Q,W}  {Y,M,T,S} P343 {C}  {C}  {C} 





Table S3-2 RNA conjoint tetrads utilized in RPIDisorder. The “Label” is the name given to 
the feature in the vector. The “Feature” column contains the combination of amino acids 
whose frequency is represented by the Label.  
Label Feature Label Feature Label Feature Label Feature 
R1 AAAA R31 AUGC R61 AGGA R91 UUCC 
R2 AAAU R32 AUGG R62 AGGU R92 UUCG 
R3 AAAC R33 ACAA R63 AGGC R93 UUGA 
R4 AAAG R34 ACAU R64 AGGG R94 UUGU 
R5 AAUA R35 ACAC R65 UAAA R95 UUGC 
R6 AAUU R36 ACAG R66 UAAU R96 UUGG 
R7 AAUC R37 ACUA R67 UAAC R97 UCAA 
R8 AAUG R38 ACUU R68 UAAG R98 UCAU 
R9 AACA R39 ACUC R69 UAUA R99 UCAC 
R10 AACU R40 ACUG R70 UAUU R100 UCAG 
R11 AACC R41 ACCA R71 UAUC R101 UCUA 
R12 AACG R42 ACCU R72 UAUG R102 UCUU 
R13 AAGA R43 ACCC R73 UACA R103 UCUC 
R14 AAGU R44 ACCG R74 UACU R104 UCUG 
R15 AAGC R45 ACGA R75 UACC R105 UCCA 
R16 AAGG R46 ACGU R76 UACG R106 UCCU 
R17 AUAA R47 ACGC R77 UAGA R107 UCCC 
R18 AUAU R48 ACGG R78 UAGU R108 UCCG 
R19 AUAC R49 AGAA R79 UAGC R109 UCGA 
R20 AUAG R50 AGAU R80 UAGG R110 UCGU 
R21 AUUA R51 AGAC R81 UUAA R111 UCGC 
R22 AUUU R52 AGAG R82 UUAU R112 UCGG 
R23 AUUC R53 AGUA R83 UUAC R113 UGAA 
R24 AUUG R54 AGUU R84 UUAG R114 UGAU 
R25 AUCA R55 AGUC R85 UUUA R115 UGAC 
R26 AUCU R56 AGUG R86 UUUU R116 UGAG 
R27 AUCC R57 AGCA R87 UUUC R117 UGUA 
R28 AUCG R58 AGCU R88 UUUG R118 UGUU 
R29 AUGA R59 AGCC R89 UUCA R119 UGUC 






Table S3-2 (continued) 
Label Feature Label Feature Label Feature Label Feature 
R121 UGCA R156 CUCG R191 CGGC R226 GCAU 
R122 UGCU R157 CUGA R192 CGGG R227 GCAC 
R123 UGCC R158 CUGU R193 GAAA R228 GCAG 
R124 UGCG R159 CUGC R194 GAAU R229 GCUA 
R125 UGGA R160 CUGG R195 GAAC R230 GCUU 
R126 UGGU R161 CCAA R196 GAAG R231 GCUC 
R127 UGGC R162 CCAU R197 GAUA R232 GCUG 
R128 UGGG R163 CCAC R198 GAUU R233 GCCA 
R129 CAAA R164 CCAG R199 GAUC R234 GCCU 
R130 CAAU R165 CCUA R200 GAUG R235 GCCC 
R131 CAAC R166 CCUU R201 GACA R236 GCCG 
R132 CAAG R167 CCUC R202 GACU R237 GCGA 
R133 CAUA R168 CCUG R203 GACC R238 GCGU 
R134 CAUU R169 CCCA R204 GACG R239 GCGC 
R135 CAUC R170 CCCU R205 GAGA R240 GCGG 
R136 CAUG R171 CCCC R206 GAGU R241 GGAA 
R137 CACA R172 CCCG R207 GAGC R242 GGAU 
R138 CACU R173 CCGA R208 GAGG R243 GGAC 
R139 CACC R174 CCGU R209 GUAA R244 GGAG 
R140 CACG R175 CCGC R210 GUAU R245 GGUA 
R141 CAGA R176 CCGG R211 GUAC R246 GGUU 
R142 CAGU R177 CGAA R212 GUAG R247 GGUC 
R143 CAGC R178 CGAU R213 GUUA R248 GGUG 
R144 CAGG R179 CGAC R214 GUUU R249 GGCA 
R145 CUAA R180 CGAG R215 GUUC R250 GGCU 
R146 CUAU R181 CGUA R216 GUUG R251 GGCC 
R147 CUAC R182 CGUU R217 GUCA R252 GGCG 
R148 CUAG R183 CGUC R218 GUCU R253 GGGA 
R149 CUUA R184 CGUG R219 GUCC R254 GGGU 
R150 CUUU R185 CGCA R220 GUCG R255 GGGC 
R151 CUUC R186 CGCU R221 GUGA R256 GGGG 
R152 CUUG R187 CGCC R222 GUGU     
R153 CUCA R188 CGCG R223 GUGC     
R154 CUCU R189 CGGA R224 GUGG     





Supplemental Disorder Feature Tables 
Table S3-3 Importance metrics for the R randomForest classifier, ordered in descending 
order based on Interacting importance, for the top 5% Interacting features. Disordered 
features are highlighted in blue. Protein conjoint triad features start with a “P”. See 
“Methods” for description of disorder features. The first three columns are the Mean 
Decrease in Accuracy (%) for determining the Interacting class, Non-interacting class, and 
overall MDA, respectively.  
 
Interacting Nonint MeanDecreaseAccuracy MeanDecreaseGini
ordPos 14.46 8.70 14.92 3.69
D1 13.66 8.94 14.17 2.96
D5 13.36 8.84 14.63 2.61
P251 13.28 8.68 13.97 2.36
P57 13.10 6.94 13.82 2.59
P11 13.05 6.00 13.28 1.67
P201 12.97 6.29 12.67 2.14
P152 12.79 4.75 12.03 1.86
D2 12.78 6.71 13.10 2.57
P225 12.75 7.78 12.67 2.35
P101 12.73 7.68 13.35 2.16
P62 12.71 6.92 12.18 2.05
P8 12.63 5.32 11.80 2.12
P127 12.59 7.60 12.91 2.04
P61 12.58 7.71 12.54 2.43
ordPhillic 12.56 6.71 12.20 3.38
P106 12.39 6.01 12.27 1.62
disNeut 12.37 5.64 11.92 2.16
P29 12.31 8.30 13.11 2.06
P12 12.30 7.59 12.08 2.34
disMod 12.30 6.89 13.23 2.14
P275 12.27 6.72 12.61 1.59
P13 12.27 7.66 12.90 2.00
P5 12.22 7.98 13.37 2.11
P257 12.22 5.41 12.19 1.73
P32 12.21 6.35 12.37 1.48
P212 12.16 5.59 13.03 1.80
P90 12.06 6.30 12.44 1.59
ordNeut 12.05 7.20 11.72 3.93
D6 11.99 7.45 12.22 2.66
P85 11.91 5.88 11.82 2.02
99 
 
Table S3-4 Importance metrics for the R randomForest classifier, ordered in descending 
order based on Non-interacting importance (Nonint), for the top 5% of Non-interacting 
features. Disordered features are highlighted in blue. Protein conjoint triad features start with 
a “P”. RNA conjoint tetrad features start with an “R”. See “Methods” for description of 
disorder features. 
 
Interacting Nonint MeanDecreaseAccuracy MeanDecreaseGini
ordNeg 10.78 9.71 12.16 3.42
D1 13.66 8.94 14.17 2.96
D5 13.36 8.84 14.63 2.61
R173 5.98 8.77 9.61 1.98
ordPos 14.46 8.70 14.92 3.69
P251 13.28 8.68 13.97 2.36
R208 4.82 8.63 8.51 2.13
R41 6.22 8.62 9.87 2.12
R189 5.88 8.35 7.81 1.98
P29 12.31 8.30 13.11 2.06
R190 6.01 8.23 7.82 2.44
P16 10.74 8.05 10.86 2.07
P5 12.22 7.98 13.37 2.11
R113 5.36 7.97 7.94 3.50
P33 11.73 7.94 11.75 2.28
disNeg 11.89 7.94 12.83 2.13
P58 9.43 7.92 10.55 2.52
P36 11.35 7.89 11.49 2.79
P79 9.45 7.79 9.83 2.19
P225 12.75 7.78 12.67 2.35
R206 4.35 7.78 6.84 1.68
R254 6.25 7.78 8.43 2.57
R58 4.13 7.77 6.99 4.12
R196 6.04 7.72 7.77 2.23
P61 12.58 7.71 12.54 2.43
P99 11.23 7.71 11.75 2.20
P82 10.20 7.69 10.18 2.59
P101 12.73 7.68 13.35 2.16
R47 4.47 7.67 6.10 1.72
P100 11.21 7.66 12.21 2.29
P13 12.27 7.66 12.90 2.00
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Table S3-5 Importance metrics for the R randomForest classifier, ordered in descending 
order based on overall Mean Decrease in Accuracy, for the top 5% of features as determined 
by MDA. Disordered features are highlighted in blue. Protein conjoint triad features start 
with a “P”. See “Methods” for description of disorder features. 
 
Interacting Nonint MeanDecreaseAccuracy MeanDecreaseGini
ordPos 14.46 8.70 14.92 3.69
D5 13.36 8.84 14.63 2.61
D1 13.66 8.94 14.17 2.96
P251 13.28 8.68 13.97 2.36
P57 13.10 6.94 13.82 2.59
P5 12.22 7.98 13.37 2.11
P101 12.73 7.68 13.35 2.16
P11 13.05 6.00 13.28 1.67
disMod 12.30 6.89 13.23 2.14
P29 12.31 8.30 13.11 2.06
D2 12.78 6.71 13.10 2.57
P108 11.66 7.50 13.08 1.71
P212 12.16 5.59 13.03 1.80
P127 12.59 7.60 12.91 2.04
P13 12.27 7.66 12.90 2.00
disNeg 11.89 7.94 12.83 2.13
P201 12.97 6.29 12.67 2.14
P225 12.75 7.78 12.67 2.35
P30 11.82 6.24 12.65 2.07
P275 12.27 6.72 12.61 1.59
P61 12.58 7.71 12.54 2.43
disPhillic 11.82 7.05 12.53 2.34
P90 12.06 6.30 12.44 1.59
P4 11.37 6.13 12.42 1.67
P55 11.64 6.28 12.40 1.81
P32 12.21 6.35 12.37 1.48
P106 12.39 6.01 12.27 1.62
D6 11.99 7.45 12.22 2.66
P100 11.21 7.66 12.21 2.29
ordPhillic 12.56 6.71 12.20 3.38
P257 12.22 5.41 12.19 1.73
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Table S3-6 Importance metrics for the R randomForest classifier, ordered in descending 
order based on node impurity (MeanDecreaseGini), for the top 5% of features as determined 
by Gini. Disordered features are highlighted in blue. RNA conjoint tetrad features start with 




Interacting Nonint MeanDecreaseAccuracy MeanDecreaseGini
R6 5.42 5.39 6.08 5.57
R33 4.44 4.63 5.21 4.30
R58 4.13 7.77 6.99 4.12
R120 5.27 5.47 5.98 4.10
ordNeut 12.05 7.20 11.72 3.93
R150 5.73 6.26 6.59 3.89
R31 5.24 6.02 6.30 3.84
R242 5.36 7.05 6.29 3.80
R49 4.62 7.19 6.90 3.74
ordPos 14.46 8.70 14.92 3.69
R113 5.36 7.97 7.94 3.50
R115 4.53 4.78 4.99 3.47
R106 5.88 5.58 6.61 3.46
R194 5.16 4.68 5.67 3.43
R34 5.21 3.17 5.33 3.43
ordNeg 10.78 9.71 12.16 3.42
R64 5.71 5.47 7.26 3.38
ordPhillic 12.56 6.71 12.20 3.38
ordPhobic 11.55 7.31 11.64 3.36
R202 4.75 4.07 5.41 3.33
R102 5.06 3.88 5.42 3.30
R230 5.11 4.55 5.47 3.27
R14 5.23 6.80 6.72 3.26
R54 4.71 6.11 5.45 3.24
R96 4.67 4.52 5.24 3.22
R65 6.16 5.10 6.78 3.22
R5 4.53 3.96 4.73 3.20
R21 5.00 6.03 6.02 3.19
R105 5.76 2.79 5.81 3.18
R117 5.00 6.55 5.64 3.18
R222 4.72 6.49 6.07 3.15
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CHAPTER 4.    MEDJED: A MACHINE LEARNING REGRESSION MODEL FOR 
PREDICTING THE EXTENT OF MICROHOMOLOGY-MEDIATED END 
JOINING REPAIR IN RESPONSE TO DOUBLE-STRANDED DNA BREAKS 
Abstract 
The development of precise DNA editing nucleases that induce double-strand breaks 
(DSBs) - including zinc finger nucleases, TALENs, and CRISPR/Cas systems - has 
revolutionized gene editing and genome engineering. Endogenous DNA DSB repair 
mechanisms can be leveraged to improve editing efficiency and precision. While the non-
homologous end joining (NHEJ) and homologous recombination (HR) DNA DSB repair 
pathways have already been the subject of a great deal of investigation, an alternative 
pathway, microhomology-mediated end joining (MMEJ), remains relatively unexplored. 
However, the MMEJ pathway's ability to produce reproducible and efficient deletions in the 
course of repair makes it an ideal pathway for use in gene knockouts.  
MEDJED, (Microhomology Evoked Deletion Judication EluciDation) is a random 
forest machine learning-based method for predicting the extent to which the site of a targeted 
DNA DSB will be repaired using the MMEJ repair pathway. On an independent test set of 24 
HeLa cell DSB sites, MEDJED achieved a Pearson Correlation Coefficient (PCC) of 
81.36%, Mean Absolute Error (MAE) of 10.96%, and Root Mean Square Error (RMSE) of 
13.09%. This performance demonstrates MEDJED's value as a tool for researchers who wish 
to leverage MMEJ to produce efficient and precise gene knock outs. 
Introduction & Background 
One of the most important applications of gene editing technology is the creation of 
gene knockouts for understanding gene function; as of April 01, 2019, more than 11,800 
articles indexed in PubMed Central contain the word “knockout” in their title, and the 
103 
 
overwhelming majority describe or investigate phenotypes associated with gene knockouts 
[PubMed Central search]. 
In addition to basic research on gene function, gene knockouts are of critical 
importance in drug discovery and clinical applications. The creation of gene knockouts that 
recapitulate human disease phenotypes in model organisms, such as mice or zebrafish, allows 
for rapid and large-scale small molecule and chemical library screening to identify potential 
therapeutic agents [Parng et al. 2002, Dinda & Baraban 2015, Zuberi & Lutz 2016, Kithcart 
& MacRae 2017, Gehrig et al. 2018]. Gene knockouts have promising clinical applications in 
gene therapies to directly treat diseases. For example, tri-nucleotide repeat extension 
disorders (e.g., Huntington’s chorea [Shin et al. 2016]) could potentially be treated by 
knocking out the defective protein or excising repeated regions [Cox et al. 2015]. Several 
ongoing clinical studies are underway to examine the efficacy of knocking out the CCR5 
gene (which produces the receptor that macrophage-tropic HIV-1 uses to infect CD4+ T 
cells) in patient T cells [Case Western Reserve, City of Hope Medical].  
The ability to induce a double-strand break (DSB) in a gene using targeted nucleases 
such as CRISPR/Cas9 systems [Mali et al. 2013], transcription activator-like effector 
nucleases (TALENs) [Boch 2011], or zinc finger nucleases (ZFNs) [Kim et al. 1996], 
[reviewed in Chandrasegaran & Carroll 2016] and then leverage endogenous DNA repair 
pathways to knockout the gene through the process of repair, is highly desirable. 
DNA Double Strand Break (DSB) Repair in Gene Editing 
In the early days of gene editing, knockouts were generated through the introduction 
of a DNA fragment or construct containing a large region of sequence homology shared with 
the targeted endogenous DNA locus, but modified such that the targeted gene would become 
non-functional or deleted (e.g., by swapping the targeted gene for a drug-resistance gene) 
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[Smithies et al. 1985]. Successful homology-directed repair (HDR) at the homology site 
resulted in the incorporation of the desired modification into the endogenous gene locus, 
leading to a targeted knockout or knock-down. Unfortunately, this approach is highly 
inefficient [Vasquez et al. 2001]. Poly-allelic organisms frequently have un-edited alleles 
after this process; additionally, the homologous recombination (HR) repair pathway is active 
only during the S and G2 phases of the cell cycle, and even during those phases it is out-
competed by other DNA repair mechanisms such that it typically constitutes only ~0.1% of 
repair events in mouse-embryo derived stem cells [Thomas & Capecchi, 1987 Cell].  
With the discovery and development of DSB-inducing gene editing nucleases, 
including ZFNs, TALENs, and CRISPR/Cas9 enzymes, an alternative repair mechanism 
called non-homologous end joining (NHEJ) has gained popularity. NHEJ, in contrast to HR, 
is highly efficient at repairing DSBs. This is largely due to the fact that NHEJ directly ligates 
the broken DNA ends together without relying on a homologous template, or, indeed, any 
sort of quality control check [Pannunzio et al. 2018]. In the context of precision gene editing, 
NHEJ has been considered a largely error-prone, haphazard process that results in random 
short deletions and/or insertions (indels). Although NHEJ can correctly repair a DSB, it 
allows for repeated re-cutting of a target site until an error large enough to render the site un-
targetable by the nuclease occurs, leading to the “error-prone” nature of the pathway 
[Betermier et al. 2014]. Recent studies, however, suggest that not only is NHEJ not random 
[van Overbeek et al. 2016, Allen & Crepaldi et al. 2018, Shen & Arbab et al. 2018], but the 
created indels are generally reproducible and, in fact, somewhat predictable [Allen & 
Crepaldi et al. 2018, Shen & Arbab et al. 2018].  Even though these repair outcomes are 
predictable, a variety of indels may be generated at a particular locus [Allen & Crepaldi et al. 
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2018], and in-frame indels are not conducive to generating knockouts. Also, in model 
organisms such as zebrafish, founders are frequently mosaic, requiring a cumbersome 
outcrossing process to generate stable, non-mosaic knockout lines [Ata et al. 2018]. Finally, 
due to strict import/export controls, international distribution of such stable lines is expensive 
and time-consuming, leading many researchers to attempt to recreate already established 
lines within their own laboratories, adding to the amount of time research groups spend 
creating models rather than studying a gene of interest [Ekker et al. 2017 (personal 
communication)]. Therefore, it is highly desirable to create lines in a manner that can be 
quickly, efficiently, and inexpensively reproduced with high fidelity. 
In contrast to both the inefficient but precise HR pathway and the efficient but 
imprecise NHEJ pathway, the microhomology-mediated end joining (MMEJ) repair pathway 
seems almost tailor-made for creating reproducible gene knockouts. In the MMEJ 
mechanism, a DSB is repaired in four basic stages: 1) limited (<200 bp) 5’ to 3’ end-
resection of the broken DNA strands, resulting in 3’ single-stranded DNA overhangs, 2) base 
pairing of newly-exposed short regions (~2-25 nts) of sequence homology (microhomology 
arms) within the single- stranded overhangs, 3) excision of overhanging 3’ sequence 
proximal to the DSB site, and 4) ligation and repair of the DNA duplex [Seol et al. 2018]. By 
definition, MMEJ repair (in contrast to NHEJ, which can create insertions) always induces a 
short deletion corresponding to the intervening sequences between microhomology arms, as 
well as one of the arms itself (this is the excision step described in (3) above). Additionally, 
MMEJ-based repairs appear to produce less mosaicism than NHEJ-based repairs, and are 
highly reproducible [Allen & Crepaldi et al. 2018]. Thus, if MMEJ could be reliably induced, 
a gene knockout experiment could be designed to induce a DSB at a desired target site, 
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resulting in an out-of-frame deletion with enhanced probability of a successful gene 
knockout. 
Predicting Preferred Gene Knockout Sites 
Bae et al. [Bae et al. 2014] first devised a method for choosing preferred DSB sites 
likely to produce out-of-frame insertions and deletions by developing a scoring system to 
determine whether a site is located near microhomology arms capable of producing 
frameshift mutations upon repair. The Bae “Microhomology Finder” method works by 
enumerating all possible microhomology arms (≥2 bp in length) within a specified distance 
of a DSB site, and then determining the deletion pattern that would be produced by each pair 
of microhomology arms (i.e., the sequence of the repaired DSB if those microhomology arms 
were utilized). For each potential deletion pattern, a pattern score is calculated according to 




) × (𝑚𝑖𝑐𝑟𝑜ℎ𝑜𝑚𝑜𝑙𝑜𝑔𝑦 𝑖𝑛𝑑𝑒𝑥) 
where the deletion length is the number of nucleotides that would be deleted in the course of 
a repair event using a particular set of microhomology arms, divided by an empirically 
determined weighting factor of 20, and the microhomology index is the length of the 
microhomology arm added to the number of G and C residues it contains (e.g., the 
microhomology “CAGCCT” would have a microhomology index of 10, because it is 6 
nucleotides long and contains 1 G and 3 Cs). 
In the Bae approach, the pattern scores for all potential deletions associated with a 
particular target site are summed into the microhomology score, and the final out-of-frame 
score is determined by calculating the fraction of the microhomology score that corresponds 
to out-of-frame deletion patterns. A target site is recommended for gene knockouts if the out-
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of-frame score is >66% (i.e., 2/3 of the total microhomology score comes from out-of-frame 
deletion patterns). 
The Microhomology Finder tool tends to produce high-efficiency knockouts [Bae et 
al. 2014, Ekker et al. 2017 (personal communication)], and the out-of-frame score for a 
particular DSB site tends to correlate very well with the observed proportion of out-of-frame 
indels. 
Motivation for This Study 
The Bae results suggested that it may be possible (and is certainly desirable) to 
predict the actual repair outcome for a particular site, instead of just whether or not a site is 
likely to be a “good” site for generating gene knockouts. Thus, the ultimate goal of the 
current study was to create a machine learning model to predict the sequence outcomes of 
DSB repair, i.e., the probability of obtaining each of the potential MMEJ deletion patterns for 
a particular DSB site (this idea was conceived before it was demonstrated that NHEJ-based 
repair is non-random). Due to limitations imposed by the size of the dataset available at the 
time we initiated this study (see Materials and Methods), we decided to first tackle a smaller 
problem: Can we predict the extent to which a particular DSB site will be repaired using the 
MMEJ repair pathway – that is, the proportion of deletions observed that correspond to an 
MMEJ-deletion pattern – and thus assist users in picking targets likely to successfully create 
gene knockouts?  
Towards that end, we developed a machine learning model, MEDJED 
(Microhomology-Evoked Deletion Judication EluciDation), which predicts the proportion of 
deletions for a DSB site that match any of that site’s possible MMEJ-based repairs. MEDJED 
is freely available online at www.genesculpt.org/medjed/. MEDJED’s source code is 
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available for download at GitHub (https://github.com/Dobbs-Lab/MEDJED/), and the tool 
can also be used as a Docker image (https://hub.docker.com/r/cmmann/medjed/). 
Materials and Methods 
Dataset 
Bae et al. kindly provided a dataset of 92 DNA sequences targeted by CRISPR/Cas9 
nucleases for DSB [Bae et al. 2014]. All DSB targets were generated in HeLa cells. The data 
included the gRNA used to target the DNA sequence, and sequencing read data for each 
target. The read data had already undergone quality control and was de-duplicated, to 
generate a list of the unique amplicon sequences for each target along with a read count for 
the amplicon.  
Dataset processing 
I wrote an R script called Method for Assorting Amplicons Tidily, or MAAT, to sort 
the recovered amplicons for each target site and characterize features including the number 
of wildtype reads, single base insertions and deletions, deletions matching an MMEJ deletion 
pattern, deletions not matching an MMEJ deletion pattern, and total deletions (see Supp. 
Code 1). 
Because I was not provided with a list of wildtype sequences until much later, I 
designed MAAT to also attempt to identify the canonical wildtype sequence and any SNP 
variants. It does this by identifying the longest sequence(s) with the largest read count, and 
then identifying single base pair differences between the ‘canonical’ sequence and other 
amplicons of identical length. If wildtype sequences are known, MAAT can use these 
sequences instead of attempting to identify the wildtype sequence from the read data. 
During this process, three genes (RP3, CCR5, FLT3) were discarded due to low read 




Unfortunately, MAAT does not (yet) identify cases in which an imperfect 
microhomology arm match was used. It is possible for longer microhomology arms to 
tolerate 1-2 bp mismatches between the arms [Allen] – e.g., ‘GCCACCG’ might pair with 
‘CGGGGGC’, even though the center nucleotide is mismatched. Although this does not 
appear to occur frequently and requires long microhomology arms when it does occur [Allen 
& Arbab et al. 2018], it is possible that MAAT missed some of these instances in the Bae et 
al. dataset. 
Training and Validation Datasets 
We randomly divided the data into a training set of 75% of the data (66 gene targets) 
and a validation set of the remaining 23 targets. The IDs of the genes in the training and 
testing sets is provided in Supp. Table 1. 
Dataset Effects 
To determine the effect of the dataset on the model, we also randomly sampled 75% 
of the data, trained a classifier on these data, and then tested performance on the remaining 
25%. We did this 5000 times and examined the variance in performance metrics (see Fig. 4-
3).  
Features 
Based on the study performed by Bae et al. [Bae et al. 2014] and various features our 
group determined might be predictive, we generated an initial input vector of 29 features. 
These features included several “aggregate” features – i.e., features that aggregated 
information from all potential MMEJ repair patterns for a particular target. These aggregate 
features included the calculated minimum, maximum, mean, median, and standard deviation 
of: 1) the number of nucleotides deleted (deletion length), 2) the length of the 
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microhomology arm (microhomology arm length), 3) the GC content (number of guanines 
and cytosines divided by the total number of nucleotides) of the microhomology arm 
(microhomology GC content), 4) the number of nucleotides between the 3’ end of the 5’ 
microhomology arm and the DSB site (distance to cut site), and 5) the Bae et al. pattern 
score, for a total of 25 features. We also assessed an additional four features: 1) the GC 
content of the wildtype DNA sequence surrounding the DSB site, 2) the number of deletion 
patterns producing an out-of-frame deletion divided by the total number of deletion patterns, 
3) the Bae microhomology score, and 4) the Bae out-of-frame score. 
Model development 
We trained several classifiers using various classification algorithms including Naïve 
Bayes, logistic regression, generalized linear model, and random forest (not shown). Of 
these, the random forest classifier worked best. We used the R randomForest package to 
create the model and perform feature selection.  
Feature selection 
Feature importance was assessed using the R randomForest package. Due to the small 
size of the dataset relative to the dimension of features assessed, we performed feature 
selection to improve the model. The randomForest package assesses two measures of 
importance for regression models: 1) Mean increase in squared error (%IncMSE), which 
assesses the effect of randomly permuting a feature’s value on the error of the out-of-bag 
instances, and 2) the decrease in node impurity (IncNodePurity, assessed using the residual 
sum of squares) caused by splitting the data using a particular feature (averaged over all the 
trees in the random forest), which assesses how “close” using a particular feature gets the 
regression model to the observed value [Liaw & Wiener 2002]. If randomly permuting a 
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feature produces a large increase in MSE, or if it produces a large decrease in node impurity, 
then the feature is important to the model’s accuracy. 
Feature selection was performed by assessing feature importance, discarding features 
with negative %IncMSE (that is, randomly permuting these features improved model 
performance) and IncNodePurity of 0. A new model was created from the remaining 
features, and this process repeated iteratively until no features had negative %IncMSE and 
IncNodePurity of 0.  
Results and Discussion 
The best-performing model, hereafter referred to as “MEDJED”, uses 6 features, a 
forest of 5000 trees, random feature pool of 2, and imposes a maximum node constraint of 
nine nodes per tree. On the training set, it achieved a Pearson correlation coefficient (PCC) of 
81.36%, mean absolute error (MAE) of 10.96%, and root mean squared error (RMSE) of 
13.09%.  On the test set (which does not overlap with the training set), MEDJED achieved 
PCC of 85.20%, MAE of 10.26%, and RMSE of 12.02% (see Fig. 4-1). The “zeroR” 
prediction method, which “learns” the mean value of the training data and predicts that value 
for the test data, achieved an MAE of 18.98%, RMSE of 20.99%, and can’t produce a PCC 




Figure 4-1 MEDJED performance. On the independent test set, MEDJED achieves a Pearson 
Correlation Coefficient (PCC) of 81.36%, Mean Absolute Error (MAE) of 10.96%, and Root 
Mean Square Error (RMSE) of 13.09%. The MEDJED-predicted MMEJ repair proportion 
(x-axis) is graphed against the observed MMEJ repair proportion (y-axis). 
Feature Importance 
After feature selection, six features were included in MEDJED: the maximum pattern score, 
the standard deviation of the pattern score, the mean microhomology length, the standard 
deviation of the microhomology length, the minimum deletion length, and the maximum 
microhomology length (see Fig 4-2). The maximum pattern score is likely most important 
because it represents the “strength” of the strongest microhomology within range of a DSB 
site. Ata et al. [Ata et al. 2018] found that if: i) the deletion pattern with the highest score at a 
DSB site has a pattern score > 1.5 times larger than the pattern score of the next highest-
scoring deletion, and ii) the induced deletion is ≤ 5 bp, the DSB site tends to produce a 
single, predominant MMEJ repair outcome called a PreMA (predominant MMEJ allele), 
which makes up > 50% of the total repair outcomes. It is possible that MEDJED has learned 
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signal from these PreMA sites, especially given that the minimum deletion length was also 
among the important features. Interestingly, the minimum deletion length has no correlation 
on its own with the observed MMEJ outcomes (PCC 0.83%), although it does negatively 
correlate with the maximum pattern score (PCC 29.47%) as expected, because the maximum 
pattern score for a DSB site is frequently generated by deletion patterns producing short 
deletions. 
 
Figure 4-2 Importance measures of the six features in the MEDJED model. The percent 
increase in mean squared error is to the left (%IncMSE) while the increase in node purity 
(IncNodePurity) is to the right. The features are (top to bottom) the maximum pattern score, 
standard deviation of the pattern score, mean microhomology arm length, standard deviation 
of the microhomology arm length, minimum deletion length, and maximum microhomology 
arm length for the collection of MMEJ-based deletion patterns at the DSB site. 
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Interestingly, the standard deviation of the pattern score is also an important feature. 
Ata et al. formulated a “competition hypothesis” regarding Bae pattern scores and outcomes 
observed in gene editing experiments - i.e., if there are several microhomologies of similar 
“strength”, represented by similar pattern scores, then MMEJ appears to have trouble 
“deciding” which microhomology to use, and an alternative pathway might then repair the 
DSB instead [Ata et al. 2018]. If this is indeed the case, if the standard deviation of the 
pattern scores at a particular site is smaller (representing similar pattern scores), then we 
would expect to see a decrease in the MMEJ at that site.  
I plotted the standard deviation of the pattern score for each target site against the 
observed proportion of MMEJ-based deletions, and found a PCC of 56.47% (see Fig. 4-3), 
which shows that increasing standard deviation of the pattern scores at a particular deletion 
site correlates moderately well with its observed MMEJ deletion outcomes, thus providing 
support for the Ata et al. competition hypothesis. 
The correlation between the standard deviation of the microhomology arm lengths 
and repair outcomes (PCC 41.53%) lends further support to the competition hypothesis: a 
longer microhomology arm leads to a larger pattern score, and so if there is large variation in 
microhomology arm lengths, this implies large variation in microhomology arm strengths, 
and thus less competition for a single predominant MMEJ outcome. 
The remaining features are the mean and maximum microhomology arm lengths, 
which correlate moderately well with the observed MMEJ repair outcomes (PCC 40.00% and 
33.04%, respectively.) The importance of the mean and maximum microhomology arm 
lengths is likely due to MMEJ favoring long microhomologies for base pairing [Allen & 




Figure 4-3 Scatterplot of the standard deviation of the Bae et al. [Bae et al. 2014] pattern 
score plotted against the observed proportion of MMEJ deletions for 89 HeLa cell targets. 
Pearson correlation coefficient of 56.47%. 
Dataset Effects 
To determine if the model’s performance was a result of a fortunate split between 
examples in the training and testing set, I randomly divided the HeLa dataset into training 
and test sets 5000 times and then trained and tested random forest classifiers with MEDJED’s 
parameters (see Fig. 4-4). The mean absolute error (MAE) for these 5000 trees ranged from 
8.73% to 19.80%, with median 13.97% and mean of 14.02% compared to the final MEDJED 
model’s MAE of 10.26%. The root mean square error (RMSE) of the 5000 trees ranged from 
10.57% to 22.43%, with median 16.54% and mean 16.56%, compared to MEDJED’s RMSE 
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of 12.02%. The Pearson Correlation Coefficients of the 5000 trees ranged from just 11.20% 
to 91.03%, compared to MEDJED’s PCC of 85.20%. 
This demonstrates that while the final MEDJED model may benefit from some effects 
of the random split of the training and test data, the model is not a statistical outlier. 
 
Figure 4-4 Boxplot of the mean absolute error (MAE), Pearson Correlation Coefficient 
(PCC), and root mean squared error (RMSE) on test sets. The original dataset was randomly 
split into training (75%) and testing sets (25%) 5000 times, generating 5000 classifiers with 
the same parameters as the final MEDJED model; each classifier was then assessed on its 
respective test dataset. The median MAE was 13.97% with standard deviation of 1.6%. The 
median PCC was 63.06%, with standard deviation 12.39%. The median RMSE was 16.54% 




MEDJED is a machine learning regression model for predicting the extent to which a 
DSB site will undergo microhomology-mediated end joining. MEDJED is capable of 
predicting the extent of MMEJ-repair utilization in sequence deletion outcomes, and is 
available online at www.genesculpt.org/medjed/, and can be downloaded at 
https://github.com/Dobbs-Lab/medjed/. It is also available as a Docker image at 
https://hub.docker.com/r/cmmann/medjed. 
In November 2018 (several months after the development of MEDJED), a group from 
the Wellcome Sanger Institute [Allen & Crepaldi et al. 2018] and a group including scientists 
from the Broad Institute, the Massachusetts Institute of Technology, and Harvard Medical 
School [Shen & Arbab et al. 2018] both published methods, called FORECasT and inDelphi, 
respectively, for predicting the sequence of repair outcomes at DSB sites. The FORECasT 
method was demonstrated to achieve near the theoretical limit of prediction accuracy (i.e., 
the level of reproducibility between gene editing experiments) [Allen & Crepaldi et al. 2018]. 
FORECasT was trained using ~40,000 DSB sites constructed for the study [Allen and 
Crepaldi et al. 2018]; inDelphi was trained with ~4000 DSBs similarly generated for use in 
the study [Shen & Arbab et al. 2018]. The existence of these tools makes the further 
development of MEDJED to predict the sequence of repair outcomes unnecessary. 
What is of far more interest, however, is the potential MEDJED offers for 
understanding the biological mechanisms of DNA DSB repair. FORECasT requires 
enumerating all possible deletions and short insertions (<2 bp, within 3bp of the cut site), 
then calculating over 2,000 features for each possible sequence outcome [Allen & Crepaldi et 
al. 2018]. inDelphi must also enumerate potential sequence outcomes, then uses 
microhomology lengths and GC content (when applicable), and deletion lengths as input to 
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three separate neural networks [Shen & Arbab et al. 2018]. In contrast, MEDJED requires 
just 6 features calculated from only potential microhomologies (rather than enumerating all 
possible outcomes) in order to make predictions, and as a random forest regression model, it 
is possible to analyze and interpret these features to generate hypotheses (or provide support 
for a hypothesis, as with the competition hypothesis.)  
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Supp. Code 1 
See https://github.com/Dobbs-Lab/MAAT 




ABL1 FGFR2 PDGFRb BMX
ACK FGFR3 PYK2 CCK4
ALK FGFR4 RET EGFR
ARG FGR RON EphA1
AXL FLT1 ROR1 EphA6
BLK FLT3 ROR2 EphB1
BRK FLT4 ROS EphB2
CSK FMS RYK EphB4
CTK FRK SRC FES
DDR1 FYN SRM HER4/ErbB4
DDR2 HCK SYK JAK2
EphA10 HER2/ErbB2 TIE1 KDR
EphA2 HER3/ErbB3 TRKA KIT
EphA3 IGF1R TRKB LCK
EphA4 INSR TRKC LMR1
EphA5 IRR TXK LMR2
EphA7 ITK TYK2 MER
EphA8 JAK1 WEE1 MUSK
EphB3 JAK3 YES PDGFRa
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The discovery and development of DNA-editing nucleases (Zinc Finger Nucleases, 
TALENs, CRISPR/Cas systems) has given scientists the ability to precisely engineer or edit 
genomes as never before. Several different platforms, protocols, and vectors for precision 
genome editing are now available, leading to the development of supporting web-based 
software. Here we present the Gene Sculpt Suite, which comprises three tools: 1) GTagHD, 
which automatically designs and generates oligonucleotides for use with the GeneWeld 
knock-in protocol; 2) MEDJED, a machine learning method, which predicts the extent to 
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which a double-stranded DNA break site will utilize the microhomology-mediated repair 
pathway; and 3) MENTHU, a tool for identifying genomic locations likely to give rise to a 
single predominant microhomology-mediated end joining allele (PreMA) repair outcome. All 
tools in the Gene Sculpt Suite are freely available for download under the GPL v3.0 license 
and can be run locally on Windows, Mac, and Linux systems capable of running R and/or 
Docker. The Gene Sculpt Suite is also freely available online at www.genesculpt.org.  
Introduction 
Recent additions to the gene editing toolbox include methods for identification of off-
target sites (1, 2), strategies for improving nuclease specificity (3), and the expansion of 
nuclease targeting capabilities (4 - 7). Other approaches have focused on DNA double-strand 
break (DSB) repair by increasing the efficiency of homology directed repair 
(HDR)/homologous recombination (HR) or enhancing the precision of the non-homologous 
end joining (NHEJ) DNA repair pathway (8) (see Fig. 1A, Fig. 1B). However, relatively little 
work has been done to leverage homology-mediated end joining (HMEJ) pathways (Fig. 1C), 
including microhomology-mediated end joining (MMEJ) and single-strand annealing (SSA), 
and their potential to enhance the efficiency, precision, and reproducibility of gene-editing 
experiments. 
Gene knock-in research has focused on increasing the frequency of HDR/HR-based 
DSB repair to precisely integrate DNA cargo into a genomic locus, e.g., by modifying the 
Cas9 protein (9) or inhibiting NHEJ (10). However, these methods can be difficult to 
implement and can be highly inefficient, with only a few successful knock-ins per hundreds 
of attempts. In addition, HR is almost completely inhibited during the G1 phase of the cell 
cycle (11), which inhibits targeted integration in post-mitotic cells and decreases gene-editing 




Figure 5-1 DNA double-strand break (DSB) repair mechanisms. (A) Non-homologous end 
joining (NHEJ). The DNA DSB ends are bound by the Ku70-Ku80 heterodimer and undergo 
limited end-resection before DNA polymerases and ligases repair the break. This process 
may perfectly repair the DSB break, but more frequently introduces short indels (red). (B) 
Homology-directed repair (HDR). When a DSB is detected, homologous sequences (blue and 
orange segments), frequently provided by a sister chromatid are used as a template to repair 
the break (green). The resulting repair is usually precise. (C) Homology-mediated end joining 
(HMEJ). HMEJ is a catch-all term for repair that utilizes short regions of homology, 
including MMEJ and SSA. In both MMEJ and SSA, 5'-3' end-resection exposes single-
stranded DNA regions, where homologous sections (blue) anneal with one another for repair. 
The overhanging DNA strands (red) are then clipped, resulting in a short deletion. MMEJ 
and SSA are mechanistically similar but distinct pathways, utilizing different protein 
machinery. MMEJ also utilizes shorter regions of microhomology (~2-25bp) than SSA 
(>25bp). SSA end-resection can be extensive, so the pathway operates over larger nucleotide 
distances. 
has focused on NHEJ. This pathway has been thought to repair DNA DSBs in an apparently 
random and inherently error-prone fashion through the introduction of short indels. Recent 
work has demonstrated that these errors are not necessarily random and are frequently 
reproducible (12 - 14). Although there are now methods for predicting repair profiles (12,13), 
DSB sites that rely heavily on NHEJ - as opposed to MMEJ - often lead to highly mosaic 
DSB repair profiles, i.e., they do not display a single predominant repair outcome (12).  
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In contrast, the Gene Sculpt Suite (GSS) tools (GTagHD (15), MEDJED, and 
MENTHU (16)) leverage HMEJ, a catch-all term for repair methods such as MMEJ and 
SSA, which utilize short regions of sequence homology to repair DSBs. GTagHD aids 
researchers in implementing the GeneWeld protocol, which leverages HMEJ repair to 
introduce targeted knock-ins with efficiencies much higher than previously reported (15). 
MMEJ repairs frequently have highly predictable outcomes based on the ‘strength’ of the 
microhomology regions present (17). The relative strengths of these homologies can be used 
to identify predominant MMEJ allele (PreMA) reagents, i.e., nucleases that target sites likely 
to result in a single MMEJ-based deletion composing >50% of all repair outcomes (16). 
MENTHU and MEDJED are GSS tools designed to assist researchers in identifying PreMA 
reagents (16) and assessing the MMEJ potential of potential target sites, respectively.  
Results 
Availability and Implementation 
The GSS server is hosted on an Amazon Web Services Elastic Compute Cloud 
Ubuntu 16.04 LTS instance. Each tool was built in R (https://www.r-project.org/ ) using 
RStudio (https://www.rstudio.com/) and is an RShiny (https://shiny.rstudio.com/) application 
contained in a Docker (https://www.docker.com) image using the Open Analytics r-base 
image (https://hub.docker.com/r/openanalytics/r-base). When a user visits a GSS tool URL, 
ShinyProxy (https://www.shinyproxy.io) spins up a new container from that tool’s Docker 
image; the user can then securely interact within the confines of their container until they 
close their browser page (Fig. 2). ShinyProxy releases and deletes the container one minute 
after the browser connection has closed. This allows users to securely interact with the server 




Figure 5-2 Gene Sculpt Suite (GSS) Architecture. The GSS server uses ShinyProxy 
(https://www.shinyproxy.io/),, to administer the Docker images (solid blue line) for each 
GSS tool. When a user (blue circle) visits a GSS tool URL, ShinyProxy creates a Docker 
container (dashed blue line), which essentially is a temporary copy of the Docker image, and 
allows a user to securely interact within their own container. These containers are temporary, 
and deleted once a user leaves their URL. A new container is spun up for each unique user. 
Each tool in the Suite is also available for download via GitHub 
(https://github.com/Dobbs-Lab) and as a Docker image through Docker Hub 
(https://hub.docker.com/u/cmmann). These tools can be run locally on Windows, Linux, and 
Mac operating systems capable of running R v3.5.2 or later and/or Docker v18.06.1-ce or 
later. All tools are available at www.genesculpt.org, which also includes links to the GitHub 
and Docker Hub repositories. 
GTagHD 
GTagHD (pGTag Homology Designer) designs oligonucleotides for use with the 
GeneWeld protocol ((15); see Fig. 3). GeneWeld uses short sections of sequence homology 
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between a plasmid donor and a genomic locus to efficiently and precisely integrate the 
plasmid cargo into the specified locus, with minimal disruption to surrounding DNA. For 
additional details regarding the GeneWeld technology and its advantages over previous 
integration methods see Wierson et al. (15). 
 
Figure 5-3 GeneWeld integration scheme (15). Short homologous sequences from the 
integration site in the target genome (in blue and orange) are cloned into the flanking regions 
of the donor plasmid cargo (green). When the cargo is freed from the plasmid, the 
homologous regions promote the efficient and precise integration of the cargo into the 
genomic locus using homology-mediated end joining. 
Input  
GTagHD takes the genomic integration site with surrounding DNA sequence and a 
user-specified length of sequence homology between the plasmid donor and integration site 
as input. Users input the genomic locus as a pasted DNA sequence or GenBank, RefSeq, or 
Ensembl ID. The gRNA sequence used to target the integration site is input as the 20-
nucleotide guide (with no PAM sequence). GTagHD assumes a Cas9-like DSB will be 
generated 3 bp upstream of the PAM sequence, allowing flexibility in the choice of CRISPR 
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nuclease in targeting the genomic locus. We have developed two plasmid series for use with 
the GeneWeld protocol, and although we strongly recommend using these plasmids with 
GTagHD, the tool also supports custom plasmids and cargos, which require the gRNA 
sequence for freeing the cargo from the custom plasmid as the only additional input.  
Processing 
GTagHD identifies the integration site using the provided genomic gRNA sequence. 
GTagHD checks to ensure that this gRNA appears exactly once within the provided genomic 
DNA, but does not check for off-target sites within the rest of the genome; several tools 
(including CRISPRscan (18)) are available for this purpose. GTagHD extracts the user-
specified length of homologous sequence surrounding the integration site, automatically adds 
additional nucleotides to repair frameshifts caused by the DSB, adds restriction enzyme sites 
for cloning into the plasmid, accounts for custom plasmid gRNAs (if provided), and performs 
additional plasmid-series dependent processing. 
Output 
GTagHD outputs four oligonucleotide sequences: 5' “forward”, 5' “reverse”, 3' 
“forward”, and 3' “reverse”. The oligonucleotides sequences can be downloaded as a text file 
and are ready-to-order. The synthetic oligonucleotides can be easily cloned into a plasmid 
vector. If a user chooses to use a plasmid from the GeneWeld series, they can also download 
automatically-generated plasmid maps containing their incorporated oligonucleotides in A 
Plasmid Editor (ApE) format, which is compatible with the GenBank format (gb).  
Comparison to other methods 
The GeneWeld protocol was inspired by the PITCh protocol (19 - 20), which is also 
available for designing knock-in construct guides (http://www.mls.sci.hiroshima-
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u.ac.jp/smg/PITChdesigner/index.html). However, GTagHD has a few features that may 
make it more convenient for users than the PITCh designer 2.0 web tool (21). 
First, users can submit GenBank, RefSeq, and Ensembl IDs to specify their genomic 
locus, instead of copying and pasting whole sequences as in PITCh 2.0. When using an ID, 
GTagHD can automatically identify and repair frameshifts created by the DSB site to 
maintain the correct codon and keep the original sequence in frame and intact. PITCh 2.0 
requires users to manually specify the reading frame and corrects frameshifts by inserting 
“Cs” or by deleting a codon entirely, thus altering the original genomic sequence.  
Second, GTagHD identifies the DSB integration site in the genomic sequence from 
user-provided gRNA, and does not require users to manually scroll through the sequence to 
identify the location, as in PITCh 2.0.  
Finally, GTagHD does not require any information about the plasmid vector beyond 
(possibly) the gRNA sequence used to free the cargo, whereas PITCh 2.0 requires sequence 
context from the insert. 
MEDJED 
MEDJED (Microhomology Evoked Deletion Judication EluciDation) is a random 
forest machine learning-based method for predicting the extent to which a DSB site will 
undergo MMEJ repair. MEDJED was trained on 66 and tested on 23 CRISPR Cas9 sites in 
HeLa cells acquired from Bae et al. (17). As shown in Fig. 4, when comparing the predicted 
proportion of MMEJ-based deletions against the observed proportion of MMEJ-based 
deletions on an independent test set, MEDJED achieved a correlation coefficient of 85.2%, 




Figure 5-4 MEDJED performance. On a test set of 23 HeLa cell targets from (17), MEDJED 
achieves a Pearson Correlation Coefficient (PCC) of 85.2%, Mean Absolute Error (MAE) of 
10.3%, and Root Mean Square Error (RMSE) of 12.0%. The MEDJED-predicted MMEJ 
repair proportion (x-axis) is graphed against the observed MMEJ repair proportion (y-axis). 
Input 
MEDJED takes a pasted DNA sequence between 20 and 200 nucleotides in length as 
input and assumes the DSB occurs in the exact middle of the sequence. 
Processing 
MEDJED assess the strengths of all microhomologies present, utilizing features 
including the minimum deleted sequence length, the maximum, mean, and standard deviation 
of the microhomology arm lengths, and the maximum and standard deviation of the 





MEDJED returns a prediction of the proportion of deletion repair outcomes at the 
provided site expected to result from MMEJ-based repair. It also outputs the values of the six 
features used in predicting the MMEJ-based repair proportion, as well as a table of all the 
MMEJ-based deletion outcomes for the targeted site. These outputs can be downloaded 
individually or collectively as a zip file. 
Comparison to other methods 
The Microhomology-Predictor (http://www.rgenome.net/mich-calculator/, (17)), on 
which MEDJED is partially based, calculates an “out-of-frame” score for choosing DSB sites 
likely to generate out-of-frame deletions; if the score is above 66, the site is recommended 
for generating gene knockouts. Microhomology-Predictor does not, however, predict the 
extent of MMEJ at a particular site, and while the out-of-frame score tends to correlate 
closely with the observed proportion of out-of-frame repairs, it is not a probability of such 
events occurring.  
inDelphi (https://indelphi.giffordlab.mit.edu/, (13)) and FORECasT (Favoured 
Outcomes of Repair Events at Cas9 Targets, https://partslab.sanger.ac.uk/FORECasT, (12)) 
both predict expected “repair profiles” at a DSB site – that is, they enumerate all possible 
repair outcomes for a particular site (within a limited sequence window), and compute the 
probability of each outcome. inDelphi is notably feature-rich and offers the option to predict 
probabilities in different cell types; however, determining the probability of MMEJ-based 
repair for a particular site requires additional calculations on the part of the user. FORECasT, 
while simple to use, does not output an intuitive human-readable result, requiring users to 




MENTHU (Microhomology-mediated End joining kNockout Target Heuristic Utility) 
identifies sites likely to have a predominant microhomology-mediated end joining allele 
(PreMA) repair outcome (16). MENTHU expands on the Microhomology-Predictor tool 
algorithm (17), which produces a “pattern score” for each possible MMEJ-based deletion 
within a sequence. This score is based on the length, GC content, and deleted sequence 
length expected to be produced by the microhomology, with a higher score corresponding to 
a “stronger” microhomology. MENTHU evaluates the ratio between the two highest scoring 
deletions as a surrogate for relative competitiveness between microhomology sites in 
recruiting the MMEJ machinery, in order to identify “low competition” sites where a single 
microhomology pairing is likely to be predominant.  For additional details, see Ata et al. 
(16). 
Input 
MENTHU takes a user-specified CRISPR or TALEN nuclease and a target DNA 
region as input. Users can choose from a list of CRISPR nucleases or can specify custom 
nucleases by providing a Protospacer Adjacent Motif (PAM) sequence, distance between 
DSB site and PAM, and length of 5' overhangs (for nucleases producing sticky-end DSBs, 
like Cas12a). The genomic DNA target can be specified by pasting a DNA sequence or a 
GenBank, RefSeq, or Ensembl ID. MENTHU also allows users to specify exons to increase 
search speed and biological relevance of the results. 
Processing 
MENTHU scans the input DNA for selected nuclease target sites. For each matching 
site, MENTHU identifies all microhomology pairings within an 80 bp window centered at 
the DSB site and scores them according to the algorithm employed by Microhomology-
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Predictor (17). MENTHU then identifies sites in which the highest scoring predicted deletion 
has < 5 intervening nucleotides between the microhomology arms in the wildtype sequence 
and calculates the quotient between its pattern score and the next highest scoring 
microhomology. This ratio is the MENTHU score. 
Output 
MENTHU outputs a table of likely PreMA reagents in descending order of MENTHU 
score (Fig. 5). The table consists of ten columns. The “Target_Sequence” provides the gRNA 
or TALEN sequence needed to induce a DSB at a particular site. The “MENTHU_Score” 
column contains the computed MENTHU score. The “Frame_Shift” column indicates 
whether the PreMA deletion generates a frameshift. The “Tool_Type” provides the PAM 
sequence, in the case of CRISPR nucleases, and the length of the arms and spacer in the case 
of TALEN inputs. The “Strand” column indicates whether the Target_Sequence matches the 
forward or complement strand. The “Exon_ID” gives the exon in which the Target_Sequence 
site occurs, while the “DSB_Location” gives the position of the nucleotide directly to the left 
of the DSB site. The “Microhomology” column gives the sequence of the microhomology 
producing the deletion. The “PreMA_Sequence” column shows the top predicted MMEJ 
deletion sequence (PreMA) for the site. The “Context” column (not shown) gives the 
“wildtype” sequence corresponding to the PreMA region. The table is searchable, sortable, 
and can be downloaded in CSV format. Targets can be filtered to show only recommended 
sites (with MENTHU score >1.5). By default, all sites for which the top MMEJ deletion has 
<5 bp between microhomology arms in wildtype sequence are shown, although the results 
can be filtered to show only recommended sites (MENTHU score >1.5). Targets can also be 
filtered to display only T7-compatible gRNAs. 








Figure 5-5 Example MENTHU output table. Each row corresponds to a single DSB event. The “Target_Sequence” column contains 
the gRNA or TALEN sequence required to generate the DSB. The “MENTHU_Score” column gives the ratio between the 
Microhomology-Predictor pattern scores of the top two scoring microhomologies at the site; a DSB site is likely to produce a PreMA 
if the MENTHU Score is >1.5 (16). “The Frame_Shift” column indicates whether the most frequent expected deletion pattern induces 
a frameshift. The “Tool_Type” gives the PAM sequence for CRISPR nucleases, and the left arm length/spacer/right arm length 
combination for TALENs. The “Strand” column indicates whether the “Target_Sequence” occurs on the forward or complement 
strand. The “Exon_ID” provides the number of the exon in which the DSB site occurs; if no exon information is available, this value 
is 1. The “DSB_Location” provides the index of the nucleotide to the left of the DSB site within the entire nucleotide sequence. The 
“Microhomology” column contains the sequence of the microhomology arms used to generate the deletion. The “PreMA_Sequence” 
gives the sequence of the predicted predominant repair outcome. The “Context” column (not shown) gives the sequence window used 
for MENTHU score calculations. 
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Comparison to other methods 
The Microhomology-Predictor tool (17), FORECasT (12), and inDelphi (13) all assist 
users in choosing sites for gene knockout. However, MENTHU has several key features that 
may make it more convenient for some users. MENTHU utilizes the Pattern Score devised 
by Bae et al. and used in the Microhomology-Predictor tool (17). As previously described, 
the Microhomology–Predictor uses the Pattern Score to identify sites likely to produce a 
frameshift (and by extension, gene knockout). In contrast, MENTHU uses the ratio between 
Pattern Scores for various MMEJ-based deletion patterns to approximate “competition” 
between available microhomologies for use by the MMEJ repair machinery (16). This 
“competition score” is then used to reduce mosaicism in repair outcomes. Microhomology-
Predictor does not offer any insights into the level of mosaicism in repair outcomes. In 
addition, users can scan for only Cas9 NGG sites, whereas MENTHU has been validated 
using TALENs and offers the ability to search for a wide variety of PAMs. 
MENTHU provides several conveniences over FORECasT. The web interface for 
FORECasT does not allow for automatic analysis of multiple DSB sites along a sequence. It 
also only supports NGG PAMs; if a non-NGG PAM is of interest, it must be manually 
specified by its numeric location in the sequence. In contrast, MENTHU scans an input 
sequence for any targets matching one or more user-specified PAMs or TALENs 
automatically. In addition, while the FORECasT web interface outputs the predicted repair 
outcome probabilities for the single specified target site, the downloadable output of the tool 
consists of a machine-readable file containing a code specifying the deletion, rather than the 
actual sequence. Thus, while the ability of FORECasT to predict the sequence outcomes for a 
given DSB is useful, the current web tool is of limited utility for users who wish to locate 
those sites. 
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In contrast, inDelphi's web interface is very feature-rich and accepts any Cas9-like 
PAM. The “single” mode allows users to manually scan for PAM sites in five different cell 
lines and then outputs the likely mutation probability profile for each. inDelphi outputs 
additional information including the predicted frameshift probabilities, the predicted 
distribution of 1 bp insertions and of deletions up to 60 bp in length, the “precision” (the 
expected proportion of the most prevalent mutation outcome for a given DSB), a 
“microhomology strength” score, and the frameshift frequency, in addition to detailed 
information regarding the predicted outcomes.  
inDelphi can also be run in batch mode, allowing users to access features in “single” 
mode for every potential DSB site along an input sequence. Additionally, users can ask 
inDelphi to recommend gRNAs likely to produce a specified genotypic outcome, which 
MENTHU does not currently perform. However, this mode is limited to Cas9-like outcomes 
and pasted input DNA sequences only. inDelphi’s “gene” mode offers the “batch” mode 
treatment for precomputed human (hg38) and mouse (mm10) genes for SpCas9 only. In 
contrast, MENTHU has been validated in zebrafish models, and can perform expanded 
scanning within a gene or genomic region of interest based on accession ID, allowing for 
greater flexibility in target site scanning. 
Unlike FORECasT and inDelphi, MENTHU has been validated for TALEN 
platforms and supports scanning for PreMA TALEN sites. Additionally, while none of these 
tools (including MENTHU) have been validated for enzymes that generate staggered-DSBs, 
such as Cas12a/Cpf1, MENTHU can provide predictions for these sites based on our current 
understanding of MMEJ repair machinery (Fig 6). 
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Figure 5-6 Strategy for handling staggered-cutting nucleases. End-resection operates in a 5'-
3' fashion. 5' overhangs produced by a staggered-cutting nuclease will be removed during the 
resection phase. The eliminated sequence in the overhangs is thus unavailable for utilization 
in MMEJ. We can approximate the microhomologies available for use in MMEJ repair by 
creating a pseudostring DNA sequence made up of the 5' strand up until the DSB site 
(orange) concatenated to the 3’ strand (blue). The 5' overhangs (dashed lines) are effectively 
removed. This allows staggered DSBs to be treated identically to blunt DSBs, after the 5' 
overhangs are removed from the sequence. The “Context” column within the MENTHU 
results table (see Fig. 5) contains this pseudostring when a staggered-cutting nuclease is 
chosen. 
Ultimately, the intended functionality of MENTHU is different from that of inDelphi 
and FORECasT, which are designed to predict full mutational profiles resulting from specific 
DSBs. In contrast, MENTHU aims to identify target sites that are likely to result in a 
particular outcome. Genome engineers will find a more detailed description of editing 
outcomes in inDelphi and FORECasT, but more accessible targeting recommendations in 
MENTHU for a wider variety of nucleases and input DNA sequences. 
Discussion 
The tools in the Gene Sculpt Suite are designed to empower researchers to deploy 
MMEJ-based gene editing, which allows them to focus their efforts on the editing repair 
outcomes for functional genomics and gene therapy applications. They also enable users to 
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accurately design HMEJ-based targeted gene integration vectors by helping them design 
oligonucleotides to implement the highly efficient GeneWeld strategy for creating knock-in 
mutations, which has been reported to yield ~50% germline transmission rates (16).  
All tools in the GSS are under active development. Additional GeneWeld plasmid 
series are nearing completion (J Welker and J Essner, personal communication), and we will 
add tools for these to GTagHD as they are developed.  Work to further improve MENTHU 
performance in targeting intronic sequences and to validate MENTHU performance for 
editing with Cas12a systems is underway. We are also using MENTHU to investigate the 
frequency and occurrence of PreMA alleles (15) in various genomes and producing genome 
browser tracks to display precomputed PreMA sites for the entire human genome. 
Data Availability 
The Gene Sculpt Suite is freely available online through www.genesculpt.org.  
Each tool is also freely available for download under a GPL v3.0 license at their 
respective GitHub pages (https://github.com/Dobbs-Lab/GTagHD, 
https://github.com/Dobbs-Lab/MEDJED, and https://github.com/Dobbs-Lab/MENTHU), 
which have detailed installation instructions. Each tool can also be downloaded as a Docker 
image from https://hub.docker.com/r/cmmann/. The GSS was built using a number of third-
party R packages: shiny (https://shiny.rstudio.com), shinyjs (https://deanattali.com/shinyjs), 
stringr (https://cran.r-project.org/web/packages/stringr), stringi (https://cran.r-
project.org/web/packages/stringi), plyr (https://cran.r-project.org/web/packages/plyr, (22)), 
rentrez (https://cran.r-project.org/web/packages/rentrez, (23)), rlist (https://cran.r-
project.org/web/packages/rlist), curl (https://cran.r-project.org/web/packages/curl), 
randomForest (https://cran.r-project.org/web/packages/randomForest, (24)), ggplot2 
(https://ggplot2.tidyverse.org, (25)), rhandsontable (https://cran.r-




(https://rstudio.github.io/DT), jsonlite (https://rdrr.io/cran/jsonlite, (26)), httr (https://cran.r-
project.org/web/packages/httr), and Bioconductor (https://bioconductor.org, (27)). All of 
these packages are freely available, and code to quickly install them is included in GSS 
installation instructions on GitHub. 
Plasmid maps for GeneWeld plasmids are available through GTagHD’s webpage. 
GeneWeld plasmids are available at AddGene: https://www.addgene.org/Jeffrey_Essner/. 
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CHAPTER 6.    CONCLUSIONS AND FUTURE DIRECTIONS 
6.1 Summary of Contributions 
In the course of my dissertation research, I created two novel software tools, 
RPIDisorder and MEDJED, and implemented two additional web tools, GTagHD [Wierson 
& Welker et al. 2019] and MENTHU [Ata et al. 2018], designed to facilitate new 
methodologies for gene editing. All of these tools are freely available online 
(www.rpidisorder.org and www.genesculpt.org), in addition to being available for download 
through GitHub and DockerHub (in the case of the Gene Sculpt Suite tools GTagHD, 
MEDJED, and MENTHU.) Each tool is thoroughly documented and posted with detailed 
instructions for installation, use, and trouble-shooting. The Gene Sculpt Suite is already 
heavily used by a global community (see Appendix D), even though only one of the tools in 
the suite had been published before this dissertation was completed. 
RPIDisorder and MEDJED represent the first steps in two distinct avenues of 
fascinating research. The remainder of this chapter will discuss future directions for these 
tools, and future development plans for the Gene Sculpt Suite. 
6.2 Future Directions: RPIDisorder 
RPIDisorder introduces several new directions for future research. In the short term, I 
plan to compare the performance of RPIDisorder to that of other available methods for 
predicting RNA-protein interaction partners using several published datasets. I also intend to 
investigate the efficacy of RPIDisorder in recapitulating human RNA-protein interaction 
networks using a new “true negative” dataset of my own creation. I will also investigate the 
effects of using different reduced alphabets and conjoint k-mer representations proposed by 
[Suresh et al. 2015] and [Jain et al. 2018] on prediction performance. In addition, there are 
 145  
 
several potential approaches to improving the impact of disorder-based features, such as 
testing different disorder prediction methods and identifying new ways to encode disorder 
information. 
I am currently generating a “true negative” dataset of RNA-protein pairs that do not 
interact, derived from high-throughput CLIP-seq experiments deposited in ENCODE [The 
Encode Consortium 2012] for several hundred proteins. Pre-processing was performed by 
POSTAR2 [Zhu et al. 2019]. I am generating true negative or “non-interacting” pairs by 
randomly pairing RNAs and proteins not found among the true positive or “interacting” pairs 
(from the from the same cell line). The logic here is that if protein A and RNA 1 are found to 
interact in HeLa cells, and protein B and RNA 2 also interact in HeLa cells, but a pairing of 
protein A with RNA 2 is not identified, then protein A and RNA 2 represent a “true” negative 
interaction, because protein A and RNA 2 should have had the opportunity to interact, but 
did not interact sufficiently to be cross-linked and immunoprecipitated. It is important to note 
that a failure to detect an interaction does not guarantee that protein A and RNA 2 do not 
interact. It is possible that a protein and RNA do not interact under the physiological 
conditions of a particular experiment, but can interact under other conditions. For example, 
the presence of disordered protein-RNA complexes in nuclear stress bodies and stress 
granules [Spector 2006] implies that some RPIs may occur only under stress conditions. 
Despite this caveat, this approach should be superior to randomly pairing proteins and RNAs 
drawn from a database with no consideration of their cellular or temporal expression patterns. 
Once complete, this new “true negative” dataset of RNA-protein pairs will be valuable due to 
the sheer number of interactions it will contain. Currently, the dataset includes ~200 proteins 
and thousands of transcripts mapping to every human chromosome across ten cell lines.   
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I intend to continue developing RPIDisorder and disorder-based RNA-protein 
interaction prediction after leaving Iowa State. My long-term goal is to teach Bioinformatics 
at a small liberal arts college. Further exploration of the influence of disorder on RNA-
protein recognition would serve as the foundation for a highly relevant and engaging 
undergraduate research program. 
6.3 Future Directions: MEDJED 
While the MEDJED chapter (see Chapter 4) in its current form is likely not of 
sufficient novelty for publication, it represents a step forward in identifying the sequence 
determinants of DSB repair pathways. The features identified as important for MEDJED 
predictions lend further support to the competition hypothesis for MMEJ-mediated repairs 
proposed by Ata et al. [Ata et al. 2018]. The fact that DSB repair outcomes, including non-
homologous end joining deletions and (apparently) insertions, are reproducible [Allen & 
Crepaldi et al. 2018] implies that DSB repair is non-random, and suggests that DNA 
sequence and/or structural determinants influence which repair pathway is activated. The 
large datasets made public by Allen et al. and Shen et al. [Allen & Crepaldi et al. 2018, Shen 
& Arbab et al. 2018] provide a wealth of data that can be mined to identify those 
determinants. 
6.4 Future Directions: The Gene Sculpt Suite 
I intend to continue developing the Gene Sculpt Suite (GSS). At the time I created it, 
it represented the very best of my coding abilities. Since then, I have gained the knowledge 
and to create a much more stable and less cumbersome tool than the current implementation. 
I will be working on that project in the weeks before I leave Iowa State. 
Several additional plasmid series for CRISPR-based precision gene editing are under 
development by the McGrail and Essner groups at Iowa State. These plasmids require 
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different processing methods than the pGTag and pPRISM plasmids currently handled by the 
GTagHD web tool. Therefore, in addition to stabilizing the GSS webserver, I will develop an 
updated version of GTagHD, to be called OCYRIS-C (Oligonucleotide deCYner for 
Rigorous Integration of Specialized Cassettes), which will handle oligonucleotide design for 
all of these plasmid series. The new name will also bring the olionucleotide designer tool in 
line with the Egyptian-deity themed names of Medjed (a mysterious deity which appears in 
two scrolls and is otherwise unmentioned in the Egyptian pantheon) and Menthu (an 
Egyptian god of competition and war).  
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APPENDIX A.     COMPUTATIONAL PREDICTION OF RNA-PROTEIN 
INTERACTIONS 
Originally published as a chapter in Methods in Molecular Biology, vol 1543 (2017): 
Promoter Associated RNA (Humana Press, New York, NY)  
DOI: 10.1007/978-1-4939-6716-2_8 
Carla M. Mann, Usha K. Muppirala, Drena Dobbs 
Abstract   
Experimental methods for identifying protein(s) bound by a specific promoter-associated 
RNA (paRNA) of interest can be expensive, difficult and time-consuming. This chapter 
describes a general computational framework for identifying potential binding partners in 
RNA-protein complexes or RNA-protein interaction networks. Protocols for using three web-
based tools to predict RNA-protein interaction partners are outlined. Also, Tables listing 
additional web servers and software tools for predicting RNA-protein interactions, as well as 
databases that contain valuable information about known RNA-protein complexes and 
recognition sites for RNA-binding proteins are provided. Although only one of the tools 
described, lncPro, was designed expressly to identify proteins that bind lncRNAs (including 
paRNAs), all three approaches can be applied to predict potential binding partners for both 
coding and non-coding RNAs (ncRNAs). 
Key Words:  
RNA-protein interactions; computational prediction; RPISeq; catRAPID; lncPRO; RNA-
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Introduction   
Our understanding of RNA-protein interactions has advanced dramatically over the 
past decade due to exciting advances in experimental technologies for identifying binding 
partners in RNA-protein complexes and RNA-protein interaction networks [1,2]. These 
include high-throughput CHIP and RNASeq based methods that can identify RNAs bound 
by specific proteins in vivo (reviewed in [3-5]} proteomics methods that can identify RNA 
binding proteins, their target RNAs, and their RNA binding sites on a genome-wide scale 
[6-9] and integrated biochemical and bioinformatics approaches that can identify the 
specific recognition sequences for RNA binding proteins [10].  A major motivation for these 
studies has been the search for cellular and molecular functions for non-coding RNAs 
(ncRNAs), many of which have been shown to play important roles in disease as well as 
normal development [11].  In particular, promoter-associated RNAs (paRNAs), the focus of 
this volume, not only regulate transcription [12], but also serve as epigenetic modulators that 
affect cellular differentiation (e.g., [13], protein localization [14], and gene regulation [15]. 
Genetic regulation by paRNAs or other ncRNAs is often mediated through interactions of the 
RNA with specific RNA-binding proteins; thus, identifying the binding partner of a newly 
discovered paRNA (or any ncRNA) can provide important clues to its function [16]. 
Despite the technical advances mentioned above, the experimental time, effort, and 
expense required to identify biologically relevant protein binding partners for a specific RNA 
(or vice versa) has created a demand for computational methods that can predict the most 
likely binding partners in RNA-protein complexes and/or identify novel candidate interaction 
partners in RNA-protein interaction networks. The goal of the chapter is to provide step-by-
step protocols to assist molecular biologists and other experts in accessing and utilizing 
available computational resources that provide access to existing information about specific 
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RNA-protein interactions, as well as software for predicting potential RNA-protein binding 
partners when experimental information is not available. For additional background and 
details regarding these and other published approaches, we refer the reader to recent reviews 
[17,18]. The methods outlined in this chapter are generally applicable to any RNA, coding or 
non-coding, small or large; thus, they can be valuable for quickly identifying potential 
protein binding partners for any specific paRNA. 
In this chapter, we focus on currently available web-based computational tools for 
partner prediction, i.e., predicting which protein binds to a specific RNA of interest in an 
RNA-protein complex or RNA-protein interaction network. Several available tools are also 
capable of predicting the converse, i.e., which RNA(s) bind to a specific protein of interest. 
Software and servers for interface prediction, i.e., predicting which specific amino acid 
residues and/or ribonucleotides are involved in recognition and binding are not described 
here, but have been reviewed elsewhere [19-21]. 
 
The protocol involves two major steps (illustrated in Figure 1): 
Step 1: Determine whether experimental data regarding the binding partner(s) of the query 
ncRNA or putative RNA-binding protein are already available. This step is described 
in Methods, Section 3.1, which outlines strategies for exploiting available online 
databases and servers (provided in Table 1 below) that focus on ncRNA or RNA-
protein interactions, or provide sequence and/or structural data regarding RNA-
protein complexes.   
Step 2: If known or potential interaction partners cannot be identified using available 
resources, or if the user wishes to identify additional potential binding partners, use 
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one (or preferably, all three) of the following web-based tools for predicting RNA-
protein interaction partners:  
• RPISeq (Section 3.2) - a machine learning-based approach developed by our 
group [22], which requires only sequence information for the RNA(s) and 
protein(s) of interest. This method was not specifically designed for predicting 
partners of promoter-associated RNAs (or ncRNAs), but it can readily predict 
these interactions. 
• lncPro (Section 3.3)  - a method developed by the group of Tingting Li [23], 
specifically for predicting the likelihood that a specific long non-coding RNA 
(lncRNA) interacts with one or more candidate protein sequences.  
• catRAPID (Section 3.4) – a suite of programs developed by the group of Gian 
Gaetano Tartaglia, including algorithms for estimating the binding propensity for 
individual RNA-protein pairs (catRAPID graphic) [24] and a server for large 
scale interactome predictions, e.g., for the interaction of a single RNA with an 
entire proteome or a single protein with an entire transcriptome (catRAPID 
omics) [25].  
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Figure A 1 Flowchart for identifying potential RNA-protein interaction partners 
The user is strongly encouraged to try all 3 web-based tools because the underlying 
algorithms and datasets used for training and performance evaluation are different in each 
case. Direct performance comparisons of the methods on various benchmark datasets indicate 
that the methods have different strengths and weaknesses [17,18,26]. The user should, of 
course, interpret all prediction results with caution: although each of these tools has been 
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shown to perform well “on average” in predicting RNA-protein interactions, a highly 
accurate prediction for any given RNA-protein pair cannot be guaranteed.  
 
2. Materials  
2.1 Databases of experimentally validated RNA-protein complexes and interactions  
Before making computational predictions, the user is advised to search for existing 
experimental evidence regarding the specific RNA-protein interaction of interest, both in 
published literature and in relevant specialized databases. At present, the availability of 
information regarding validated RNA-protein interactions is increasing rapidly as new 
experimental data are incorporated into web-based resources. These include databases 
containing evidence for physical or genetic interactions obtained from both “low” and 
“high” throughput experiments (e.g., NPInter or PRD), as well as databases of high 
resolution structural information regarding both the components and the interfaces in 
RNA-protein complexes (e.g., PDB or NDB). Table 1 provides an alphabetical listing of 
several valuable databases that contain information about RNA-protein complexes and 
interaction networks. A suggested strategy for utilizing selected resources from this list is 
provided in Section 3.1 below. 
2.2. Servers and Software for predicting RNA-protein partners 
At present there are only a few published methods for predicting partners in RNA-
protein complexes or interaction networks. Sections 3.2 - 3.5 focus on three published 
methods (RPISeq, catRAPID, lncPro) that are freely available on web-based servers.  
Table 2 below includes, in addition, several published approaches for which a web 
server is not yet available, but software is freely available for download.   
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Table A 1 Databases of RNA-Protein Interactions and Interfaces 
Database URL Description 
BioGRID [37]  http://thebiogrid.org/ 
Manually curated protein and genetic 
interactions for major model organisms 
IntAct [40] http://www.ebi.ac.uk/intact/ 
Manually curated molecular interactions, 
including comprehensive data about their 
source experiments 
NDB [30,31] http://ndbserver.rutgers.edu/ 
Nucleic acid and DNA/RNA-protein complex 
structures, including derived data for nucleic 
acids 
NPInter [35] http://www.panrna.org/NPInter/index.php 
Functional interactions of ncRNAs and 
protein-related biomolecules, classified into 
categories based on interaction type 
PDB [29] http://www.rcsb.org/pdb/home/home.do 
Experimentally determined three-dimensional 
structures 
PRD [36]  http://pri.hgc.jp/ 
RPIs from 22 species, focusing on gene-level 
information 
RBPDB [41] http://rbpdb.ccbr.utoronto.ca/ 
Experimental data on binding preferences and 
specificities of RBPs  
RPIntDB  http://pridb.gdcb.iastate.edu/RPISeq/ 
RPIs from databases and high-throughput 
experiments in literature 
 
Note: PRIDB [39], which was developed by our group, is not included in this list of 
recommended databases because it is no longer maintained. 
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Table A 2 Computational Methods for Predicting RNA-Protein Interaction Partners 
Method Training Dataset Features Description 
lncPro 
Lu et al. 
[23]  
322 interacting and 
327 non-interacting 
pairs of RNA-protein 





properties consisting of 
RNA secondary structure 
propensities, hydrogen-
bonding propensities, and 
van der Waals interaction 
propensities 
Propensities are calculated for the 
protein and RNA sequence and fed 
through a complex equation to generate 





Bellucci et al. 
[24] 
7,409 interacting 







bonding propensities, and 
van der Waals interaction 
propensities 
Propensities are calculated for each 
amino acid and ribonucleotide to 












Sequence composition of 
proteins, represented as 
conjoint triads, and 
RNAs, represented as 
tetrads 
Protein and RNA sequences encoded 
sequence-composition-based features 




Wang et al. 
[42] 
RPI 2241 generated 
by Muppirala et al. 
& 367 interacting 
pairs from NPInter 
Sequence composition of 
protein and RNA 
Input to NB and ENB classifiers is a 
combination of protein triads and RNA 
triad features similar to those used in 
RPISeq 












physical properties, gene 
physical properties, UTR 
properties, genetic 
interactions 
Protein and RNA sequences encoded 
using > 100 features are used to train 
SVM and RF classifiers 
RPI-Pred 
[44] 
1,807 interacting and 
1,436 non-interacting 
RNA-protein chain 
pairs from PDB 
1D protein block 
representation of 
predicted or actual 3D 
structure of RNA and 
protein combined with 
RNA and protein 
sequence 
Protein and RNA sequences encoded 
with 112 protein and 20 RNA vectors 




3. Methods  
3.1. Search the literature and databases for existing experimental evidence  
Before using computational approaches to predict potential interactions, the user should 
search published literature and existing databases (e.g., http://omictools.com/ [27]) for 
experimental evidence regarding interactions involving the RNA or protein of interest (see 
Note 1).  If the sequence of interest corresponds to a protein or RNA of unknown function, 
potential homologs can be identified via a BLAST search.  As outlined below, both the 
original query sequence and its homologs can be used to search databases of known RNA-
protein interactions, such as those listed in Table 1. 
1. Run the sequence or sequences through NCBI’s BLAST server, available at 
http://blast.ncbi.nlm.nih.gov/Blast.cgi  [28] or use similar genomics resources 
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elsewhere (see Note 2). BLAST, or Basic Local Alignment Search Tool, finds highly 
similar sequences in the NCBI or ENSEMBL databases. If the query sequence has 
been previously identified and/or analyzed, clues to its involvement in specific RNA-
protein interactions may be found in the NCBI “Gene” or “Protein” pages 
corresponding to the sequence (see Note 3). If the query sequence itself is not 
available in one of the NCBI databases, potential homologs identified by BLAST can 
be used as a starting point for subsequent searches in the databases listed in Steps 2 – 
5 below. 
2. Query NPInter, available at http://www.bioinfo.org/NPInter/index.htm{Yuan, 2014 
#198. NPInter v3.0 is the largest curated database of experimentally validated 
biomolecular interactions involving ncRNAs extracted from the literature. NPInter 
currently contains more than 900,000 ncRNA interactions, including interactions with 
proteins, as well as with DNA and both ncRNAs and mRNAs. Note, however, that 
tRNA and rRNA interactions are excluded (see Note 4). NPInter includes data from 
22 different organisms and provides an integrated USCS Genome Browser to assist 
the user in locating binding sites in the human, mouse and yeast genomes.  The 
database is searchable by molecule name, molecule type, or database ID and provides 
access to software and servers, including lncPro (described Section 3.3 below) for 
predicting lncRNA-protein interactions and the iRNA server for predicting RNA-
RNA interactions (see Note 5). 
3. Query the Protein-RNA Interaction Database (PRD), available at http://pri.hgc.jp/ 
{Fujimori, 2012 #413}. The PRD is smaller than NPInter, containing 10,817 
experimentally validated RNA-protein interactions, but is valuable because it includes 
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both rRNA and tRNA interactions, which are excluded from NPInter. The database 
offers flexible keyword searches (see Note 6). 
4. In every case, the user should search the Protein Data Bank (PDB), available at 
www.rcsb.org [29]. The PDB contains over 1,600 three-dimensional structures of 
RNA-protein complexes determined using experiments such as X-ray 
crystallography, nuclear magnetic resonance (NMR) imaging, and cryo-electron 
microscopy. The PDB has a powerful search engine that allows the database to be 
queried in a variety of ways, e.g., by RNA or protein name, sequence, or GO terms.  
The PDB also provides excellent structure visualization tools as well as links to 
valuable third-party resources for visualizing and analyzing the structures of 
macromolecules (see Note 7).  
5. In the same vein, the Nucleic Acid Database (NDB), available at 
http://ndbserver.rutgers.edu [30,31] is another valuable resource that focuses on 
experimentally determined three-dimensional structures of nucleic acids, including 
DNA-protein and RNA-protein complexes. Although the NDB contains only a subset 
of structures in the PDB, NDB makes it easier for the user to focus on structures that 
contain RNA-RNA, RNA-protein or RNA-drug interactions.  Also, the NDB provides 
convenient access to a wide variety of tools and software specifically designed for 
analyzing RNA sequences and structures (see Note 8).  
 
3.2. RPISeq – to predict binding partner(s) for any known RNA or protein sequence  
The RPISeq web server implements the RPISeq method developed by Muppirala et al. [22].  
RPISeq uses two types of machine learning classifiers, Random Forest (RF) and Support 
Vector Machine (SVM), to predict RNA-protein interactions using only sequence 
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information. RPISeq can be used to predict the interaction probabilities of any type of RNA 
(not just ncRNAs) with any protein(s) of known sequence (see Note 9).   
1. Access the RPISeq web server available at http://pridb.gdcb.iastate.edu/RPISeq/.   
A stand-alone version of RPISeq is also freely available (see Note 10). 
2. For single RNA – single protein predictions: The simplest function of the RPISeq 
server is to predict whether a specific known RNA interacts with a specific known 
protein. In this case, the user must enter the protein and RNA sequences (in FASTA 
format) in the appropriate text boxes on the homepage and click “Submit.”   
3. The RPISeq results, which are typically returned a few seconds after submission, 
include a display of the submitted input sequences along with the interaction 
probabilities predicted using both the RF and SVM classifiers.  A probability greater 
than 0.50 is usually considered to be a positive prediction, although more stringent 
thresholds can be chosen. 
4. For single RNA – multiple protein predictions: To predict the interaction 
probabilities for a single RNA with multiple potential protein partners, go to 
http://pridb.gdcb.iastate.edu/RPISeq/batch-rna.html. 
5. Enter the RNA sequence and click “Choose File” to upload a file of protein sequences 
in FASTA format (limited to 100 Mb) (see Note 10). Click “Submit.” 
6. The results are returned as a table listing the interaction probabilities for the input 
RNA with each protein in the FASTA input file. Probabilities greater than 0.50 are 
usually considered to be positive predictions. The results may take several minutes to 
display, depending on the number of protein sequences submitted. 
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7. For multiple RNA – single protein predictions: To predict the interaction 
probabilities for a single protein with multiple potential RNA partners, go to 
http://pridb.gdcb.iastate.edu/RPISeq/batch-prot.html.  
8. Enter the protein sequence in the text box and click “Choose File” to upload a file of 
RNA sequences in FASTA format (limited to 100 Mb) (see Note 10). Click 
“Submit.” 
9. The results are returned as a table listing the interaction probabilities for the input 
protein with each RNA sequence in the FASTA input file. Again, probabilities greater 
than 0.50 are usually considered to be positive predictions. The results may take 
several minutes to display if a large number of RNAs were submitted.  
 
3.3. lncPro  - to predict protein binding partner(s) for any known lncRNA  
The lncPro web server implements the lncPro method developed by Lu et al. [23]. lncPro is 
designed to predict whether a specific long non-coding RNA (lncRNA) interacts with one or 
more user-provided protein sequences. The method uses the hydrogen bonding and van der 
Waals propensities of the RNA and protein sequences, in addition to the predicted secondary 
structure of the RNA, to calculate the probability that a specific lncRNA and protein will 
interact with one another (see Note 11). 
1. Access the lncPro server homepage at bioinfo.bjmu.edu.cn/lncpro/.    
A stand-alone version of lncPro is also freely available for download (see Note 12). 
2. For single RNA – multiple protein predictions:  On the lncPro homepage, click on 
the “Predict” tab. The lncPro server takes as input a single RNA sequence in FASTA 
format and a file of multiple protein sequences in FASTA format.  
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3. Enter the RNA sequence and click “Choose File” to upload a file of protein sequences 
in FASTA format. Click “Submit.” 
4. The results are returned as a table listing the interaction probabilities for the input 
lncRNA sequence with each protein sequence in the FASTA input file. Probabilities 
greater than 0.50 are usually considered to be positive predictions.  
 
3.4. catRAPID  - to predict either individual or transcriptome/proteome wide 
interactions 
The catRAPID suite of RNA-protein interaction predictors includes methods for predicting 
the interaction propensity for individual RNA and protein partners (catRAPID graphic) [24]); 
identifying segments of RNA and protein that most likely participate in forming the RNP 
interface (catRAPID fragments); estimating the interaction strength of an RNA-protein pair 
in comparison to a reference set (catRAPID strength); and identifying the most probable 
interactions between a specific protein and a complete transcriptome, or between a specific 
RNA and a complete proteome, for eight model organisms [25]).  Additional catRAPID 
modules can predict pairs of co-expressed proteins and RNAs in human tissues (catRAPID 
express [32]) and whether a protein is likely to bind RNA (catRAPID signature [33]) (see 
Note 13).   
1. The suite website is located at http://service.tartaglialab.com/page/catrapid_group; 
extensive documentation and tutorials for all tools in the catRAPID suite are provided 
at: http://service.tartaglialab.com/static_files/shared/tutorial.html. 
2. For single RNA – single protein predictions: Navigate to the catRAPID group page 
at http://service.tartaglialab.com/page/catrapid_group and select "catRAPID graphic." 
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3. Enter the protein and RNA sequences (in FASTA format) in the text boxes provided. 
Note: The input protein sequence must be between 50 -750 amino acids in length; the 
input RNA sequence must be between 50 -1200 ribonucleotides in length.   
4. If desired, enter a name in the optional “Submission label” box and enter your email 
address in the optional “Email address” box for notification when results are 
available.  Click “Submit.” 
5. The results are returned as a graphical “heat map” representing the interaction score 
for individual amino acid and ribonucleotide pairs; this interaction score is derived 
from the interaction propensity, which is also reported. The interaction scores range 
from -3 to +3, with higher values (red) corresponding to a higher probability of 
interaction. catRAPID graphic also generates a discriminative power (DP) score, 
which is a confidence metric; a DP score greater than 50%, coupled with a positive 
interaction score, indicates that an interaction is likely to occur.  A DP score greater 
than 75% is a very high-confidence prediction. The results page also provides the 
server-generated ID for the job, the date and timestamp for the run, links for 
downloading the protein and RNA sequences submitted by the user, and the 
interaction heat map in .png format. 
6. For single RNA - proteome predictions: Navigate to the catRAPID group page at 
http://service.tartaglialab.com/page/catrapid_group and select "catRAPID omics."  
7. Select the second option: "catRAPID omics [transcript vs. nucleotide-binding 
proteome]" to open the submission page. The first text box is an optional box for a 
submission label, which should include the RNA name or other identifier for easy 
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identification of results.  Enter the query RNA sequence (which must be longer than 
50 ribonucleotides) in FASTA format. 
8. The user is then presented with nine radial buttons under the heading: "Which library 
would you like to analyze?" Select the proteome of the model organism of interest--
ideally, the source organism for the RNA query sequence (or its closest relative)--
from the 8 organism libraries available (see Note 14). The user can also create a 
custom proteome library (see Note 15).   
9. The user is then asked whether she/he would like to use nucleic acid binding 
domains. The default "No" option will query all proteins in the proteome (<750 
amino acids long), regardless of whether they possess a recognized RNA-binding 
domain. The "Yes" option will specifically examine and make predictions between 
the query RNA and proteins in the selected proteome that possess an RNA-binding 
domain. 
10. Select whether predictions should be made against RNA-binding proteins only or 
against both RNA- and DNA-binding proteins, and whether disordered proteins 
should be included in the prediction; the latter is recommended becaues disordered 
protein regions frequently bind RNA. 
11. A valid email address can be entered into the next text box for notification of when 
the job is completed. The user should then click "Submit query."  
12. catRAPID omics results may take a few hours to be generated, depending on the size 
of the selected proteome. The results page contains a section summarizing the input 
parameters and a pie chart showing the distribution of rankings (on a scale of 1-3) of 
the possible RNA-protein interactions. Red indicates a likely interaction; orange 
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indicates a moderately likely interaction, and yellow indicates an unlikely interaction. 
The next section consists of a 9-column table (see Fig. 2), in which the interactions 
are listed in order of highest to lowest scores (first column).  The "Ranking" 
displayed in the last column is a metric of the probability of interaction: 3 stars 
indicates a strong interaction probability; 0 stars indicates an unlikely interaction. 
Protein-RNA pairs with both a high star ranking (3) and high discriminative power 
(>75%) are predicted to interact. High star rankings with low discriminative power 
correspond to low-confidence predictions; as an example, note that in Fig. 2, the 
highest-scoring interaction has a very low discriminative power and is therefore 
considered to be unreliable (see Note 16). 
 
Figure A 2 Example of catRAPID omics results pages 
13. For single-protein - transcriptome predictions: Navigate to the catRAPID group 
page at http://service.tartaglialab.com/page/catrapid_group and select "catRAPID 
omics."  
14. On the subsequent page, select the first option: "catRAPID omics [transcript vs. 
coding and non-coding transcriptome]," which will open a submission page. The first 
text box is an optional box for a submission label, which should include the query 
 166  
 
protein name for easy identification of results. Enter the query protein sequence 
(which must be longer than 50 amino acids) in FASTA format. 
15. The user is then presented with nine radial buttons under the heading "Which library 
would you like to analyze?" Select the transcriptome of the model organism of 
interest, or its closest relative. The user can generate a custom transcriptome library, 
if desired (see Note 15). 
16.  The user is then asked whether she/he would like to use nucleic acid binding 
domains. If “No” is selected, the query protein must be <750 amino acids in length. In 
this case, the method will utilize the whole protein sequence instead of focusing on 
RNA- or DNA-binding domains. The "Yes" option will reveal two new sets of radial 
buttons; the first group allows the user to specify whether only RNA-binding domains 
should be selected, or whether both RNA- and DNA-binding domains should be 
examined. The second group allows the user to include predicted disordered regions 
in the query protein as part of the calculation (recommended). 
17. The last group of radial buttons allows the user to specify whether she/he wishes to 
query partners from the coding (mRNA) or non-coding (tRNA, rRNA, ncRNA, etc.) 
transcriptome. A valid email address can be entered for notification of job 
completion. The user should then click "Submit query." 
18. catRAPID omics results may take a few hours to be generated, depending on the size 
of the selected transcriptome. The results page is identical to that returned for the 
RNA vs. proteome predictions described in Step 12 above, and results are interpreted 
the same way (see Note 15).  
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4. Notes  
1. At present, none of the available computational tools for predicting RNA-protein 
interaction partners report whether experimental evidence for a specific interaction is 
available (i.e., even when an interaction partner is known, the software will make a 
prediction, which may or may not correspond to the experimentally validated 
interaction partner).  Thus, as a first step, the user should always search published 
literature (via search engines such as NCBI/PubMed (http://www.ncbi.nlm.nih.gov/) 
or Google Scholar (http://scholar.google.com) and relevant databases (see Section 
3.1) for existing experimental data regarding a specific RNA-protein interaction of 
interest. In addition to the resources described in Section 3.1 and Table 1, many 
additional valuable databases and servers that provide extensive information 
regarding in vivo RNA-protein complexes, RNA binding proteins and their 
recognition sites, RNA-protein complexes and RNA-protein interaction networks are 
becoming available. OMICtools (http://omictools.com) provides an extensive and up-
to-date directory of these resources [27]). 
2. According to OmicsTools (http://omictools.com)[27], the ENA (European Nucleotide 
Archive) Sequence Search tool (http://www.ebi.ac.uk/ena) [34], hosted by the 
EMBL-EBI, is a “nucleotide search tool which is far faster than BLAST for large 
datasets, with only a marginal loss in search sensitivity” (http://omictools.com/ena-
sequence-search-s2042.html).  
3. If the query sequence corresponds to a known protein or RNA, the NCBI “Gene” 
database (http://www.ncbi.nlm.nih.gov/gene) is an excellent starting point for 
investigating whether potential binding partners of the query have been previously 
identified.  (Tip:  Because proteins and RNAs from humans are usually better 
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annotated than those from other organisms, valuable information can be obtained by 
visiting the Gene page for the human homolog of a query sequence.) On the sidebar 
of the Gene full report page, the Table of Contents may include links to Pathways 
from BioSystems (for a protein query), and Interactions (for both protein and RNA 
queries).  In addition, the General Gene Information link provides a list of GO 
annotations, such as “RNA binding,” or under the GO Component heading, a list of 
specific macromolecular complexes with which the protein or RNA has been 
associated. Finally, the GenRifs section can provide direct access to the most relevant 
literature regarding RNAs bound by the query protein.  
4. Because NPInter [35] specifically excludes protein-ncRNA interactions that involve 
tRNA or rRNA, the user interested in such interactions should consult the PRD (see 
Section 3.1.3), as well as the PDB and NDB (see Section 3.1.4) because these 
databases contain many such interactions. 
5. NPInter [35] provides tools for: i) BLASTing a given protein or RNA sequence 
against every RNA or protein sequence in NPInter 
(http://www.bioinfo.org/NPInter/blast/blast_link.cgi); ii) predicting whether or not a 
specific lncRNA-protein interaction is likely, using lncPro 
(http://www.bioinfo.org/NPInter/lncPro.htm) (see Section 3.3); and iii) predicting 
whether two specific RNAs are likely to interact, using RIsearch 
(http://www.bioinfo.org/NPInter/RISearch.htm).  
6. The PRD [36] contains 10,817 documented physical interactions between RNA and 
proteins extracted from BioGRID [37], IntAct [37] and the PDB [29], including many 
interactions that involve tRNA or rRNA. 
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7. The PDB Advanced Search  
(http://www.rcsb.org/pdb/search/advSearch.do?search=new) is a powerful tool that 
allows the user to BLAST a sequence of interest against all structures in the database, 
to identify GO annotations, citations in publications, etc. In addition, the PDB offers 
several built-in visualization tools 
(http://www.rcsb.org/pdb/secondary.do?p=v2/secondary/visualize.jsp - RCSBviewer) 
as well as links to additional resources and software for analyzing macromolecular 
structures 
(http://www.rcsb.org/pdb/static.do?p=general_information/web_links/index.html). 
8. The NDB [30,31] focuses on structures that contain either DNA or RNA and provides 
links to many valuable RNA sequence and structure analysis tools 
(http://ndbserver.rutgers.edu/ndbmodule/services/index.html) as well as software for 
identifying RNA motifs and for predicting secondary and tertiary structures of RNA 
molecules (http://ndbserver.rutgers.edu/ndbmodule/services/softwares.html). 
9. RPISeq [22] consists of Random Forest (RF) and Support Vector Machine (SVM) 
machine-learning classifiers that predict the probability of interaction between an 
RNA and a protein based solely on their primary sequences. In this method, RNA 
sequences are encoded as normalized frequencies of RNA tetrads, and protein 
sequences are encoded using a conjoint triad feature (CTF) method originally 
proposed by Shen et al. for predicting protein-protein interactions [38]. Based on the 
propensity of the observed conjoint triads to bind the observed RNA tetrads, RPISeq 
outputs the probability that the submitted RNA and protein will interact. In 
performance evaluation experiments using 10-fold cross-validation on RPI2241 (a 
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non-redundant dataset including 2241 RNA-protein pairs derived from PRIDB [39]), 
the RPISeq SVM classifier achieved an accuracy of 87.1%, and the Random Forest 
classifier achieved an accuracy of 89.6%. Additional performance metrics and 
comparisons with other methods are provided in Muppirala et al. [22,17]. 
10. The RPISeq web server is currently capable of returning predictions for up to 100 
sequences (or up to 100 Mb) in a single run. For larger datasets, a stand-alone version 
of RPISeq is available upon request to the author (instructions available at 
http://pridb.gdcb.iastate.edu/RPISeq/contact.php). 
11. lncPro [23] encodes potentially interacting lncRNA and protein sequences as feature 
vectors of identical dimensions (based on secondary structure, hydrogen-bonding, and 
van der Waal’s interaction propensities observed in 41 RNP complexes from the 
PDB) and uses matrix multiplication to generate an interaction score for each RNA-
protein pair. The algorithm was trained and tested on a dataset of 726 non-redundant 
RNA-protein pairs extracted from 18 complexes in the PDB that contain RNAs 
longer than 100 nts. In 4-fold cross-validation experiments, the method obtained a 
Discriminative Power (DP) value of 90.3%. Additional performance metrics and 
comparisons with other methods (including catRAPID) are provided in [23]. 
12. A stand-alone version of lncPro is available at: 
http://bioinfo.bjmu.edu.cn/lncpro/#fragment-3. 
13. The original catRAPID graphic algorithm [24] generates predictions using 
interaction profiles of the query protein and RNA sequences, which are based on 
several physicochemical properties, including predicted secondary structure, 
hydrogen bonding, and van der Waals interaction propensities. On a non-redundant 
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dataset of 858 RNA-protein complexes from the PDB, the reported discriminative 
power was 78%. Additional performance metrics and comparisons with other 
methods are provided in [18]. 
14. Currently 8 proteome libraries are available, from: C. elegans, zebrafish, fruit fly, 
human, mouse, brown rat, yeast, and western clawed frog. The user also has the 
option of submitting a custom sequence library.  
15. To generate a custom library, the user should select the ninth radial button in the 
"library" section. This will cause a text box to appear along with a link to generate a 
library. Select the red-highlighted "Generate" text to navigate to the library generation 
tool. (Note that simply clicking on the link will open the library generation tool in the 
current tab, which may cause data loss. It is highly recommended that the user right-
click or command-click the link to open the library generation tool in a new window.) 
This takes the user to a library submission page, where she/he can label the library 
(with a descriptive name, including the source organism) and submit an email address 
for notification purposes. Select the button to upload a file of FASTA formatted 
sequences (≤ 500 sequences), click "Submit query" at the bottom of the page, and 
wait for the library to finish processing. The user will be provided with an ID 
reference for the library. 
16. The first column of the catRAPID omics result table (Fig. 2) lists the numerical 
rankings assigned to the protein-RNA interactions, from most to least probable. The 
first row of the table corresponds to the most highly ranked RNA-protein pairing. The 
second column contains the ID for protein being analyzed (with a clickable link to the 
protein's ENSEMBL entry). The third column contains the ID for the query RNA 
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sequence (linked to its sequence). The fourth column contains the normalized 
interaction propensity (Z-score), with higher values indicating a more likely 
interaction. The fifth column contains the discriminative power (%) score. The sixth 
column contains the interaction strength, which is an indicator of the specificity of the 
reaction; a low value for the interaction strength may indicate that the protein binds 
the RNA nonspecifically. The seventh column indicates whether the protein possesses 
a known RNA-binding domain; the eight indicates whether the RNA has any 
recognized protein-binding motifs. The ninth column is a "star ranking" of the results. 
The "star rank" of an interaction is a value from 0 to 3, calculated based on three 
criteria: i) whether the protein has an RNA-binding domain, or both a DNA-binding 
domain and a disordered region:  if both are present, 1 is added to the star rank; if the 
protein has only a DNA-binding domain or only a disordered region, 0.5 is added to 
the star rank. If the protein has neither an RNA- or DNA-binding domain and no 
disordered regions, 0 is added to the rank score; ii) whether the protein has any RNA-
binding motifs: if so, 1 is added to the score, and 0 otherwise; (iii) the predicted 
interaction propensity (which is normalized on a scale of 0 to 1) and added to the 
scores from (i) and (ii). 
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Abstract 
One key problem in precision genome editing is the unpredictable plurality of 
sequence outcomes at the site of targeted DNA double stranded breaks (DSBs). This is due to 
the typical activation of the versatile Non-homologous End Joining (NHEJ) pathway. Such 
unpredictability limits the utility of somatic gene editing for applications including gene 
therapy and functional genomics. For germline editing work, the accurate reproduction of the 
identical alleles using NHEJ is a labor intensive process. In this study, we propose 
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Microhomology-mediated End Joining (MMEJ) as a viable solution for improving somatic 
sequence homogeneity in vivo, capable of generating a single predictable allele at high rates 
(56% ~ 86% of the entire mutant allele pool). Using a combined dataset from zebrafish 
(Danio rerio) in vivo and human HeLa cell in vitro, we identified specific contextual 
sequence determinants surrounding genomic DSBs for robust MMEJ pathway activation. We 
then applied our observation to prospectively design MMEJ-inducing sgRNAs against a 
variety of proof-of-principle genes and demonstrated high levels of mutant allele 
homogeneity. MMEJ-based DNA repair at these target loci successfully generated F0 mutant 
zebrafish embryos and larvae that faithfully recapitulated previously reported, recessive, loss-
of-function phenotypes. We also tested the generalizability of our approach in cultured 
human cells. Finally, we provide a novel algorithm, MENTHU 
(http://genesculpt.org/menthu/), for improved and facile prediction of candidate MMEJ loci. 
We believe that this MMEJ-centric approach will have a broader impact on genome 
engineering and its applications. For example, whereas somatic mosaicism hinders efficient 
recreation of knockout mutant allele at base pair resolution via the standard NHEJ-based 
approach, we demonstrate that F0 founders transmitted the identical MMEJ allele of interest 
at high rates. Most importantly, the ability to directly dictate the reading frame of an 
endogenous target will have important implications for gene therapy applications in human 
genetic diseases. 
Author Summary 
New gene editing tools precisely break DNA at pre-defined genomic locations, but 
cells repair these lesions using diverse pathways that often lead to unpredictable outcomes in 
the resulting DNA sequences. This sequence diversity in gene editing outcomes represents an 
important obstacle to the application of this technology for human therapies. Using a 
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vertebrate animal as a model system, we provide strong evidence that we can overcome this 
obstacle by selectively directing DNA repair of double-stranded breaks through a lesser-
described pathway termed Microhomology-mediated End Joining (MMEJ). Unlike other, 
better-understood pathways, MMEJ uses recurring short sequence patterns surrounding the 
site of DNA breakage. This enables the prediction of repair outcomes with improved 
accuracy. Importantly, we also show that preferential activation of MMEJ is compatible with 
effective gene editing. Finally, we provide a simple algorithm and software for designing 
DNA-breaking reagents that have high chance of activating the MMEJ pathway. We believe 
that the MMEJ-centric approach to be broadly applicable for a variety of gene editing 
applications both within the laboratory and for human therapies. 
Introduction 
Programmable nucleases such as TALEN (Transcription Activator-like Effector 
Nuclease) and CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) 
systems have enabled a new era of scientific research [1, 2]. Instead of relying on knock-
down models or expensively outsourced knock out lines, laboratories across the world now 
have tools with which to generate indels (insertions and deletions) of varying sizes on the 
gene(s) of interest. However, DNA Double-strand Break (DSB) repairs largely result in 
diverse sequence outcomes owing to the unpredictable nature of the most commonly used 
Non-homologous End Joining (NHEJ) pathway [3, 4] (Fig 1). This significantly confounds 
experimental readouts as knock-out cell lines often harbor more than just one desired 
frameshift mutation. In the case of model organisms such as zebrafish (Danio rerio), the F0 
founders are genetically mosaic, warranting a complex and time-consuming series of 
outcrossing to establish molecularly defined lines before any biological questions can be 
addressed [5, 6]. 
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Figure 1 MMEJ is a unique DSB repair pathway that results in highly efficient and highly 
stereotyped mutagenesis. 
DSB by conventionally designed Programmable Nucleases typically proceeds through a 
versatile yet unpredictable classical non-homologous end joining (NHEJ) pathway. As a 
result, a rather diverse cohort of mutant alleles are generated, making the subsequent 
selection process labor intensive to enrich for the allele of interest. The resulting genetic 
composition of the specific loci are often complex, requiring careful molecular 
characterization of each allele. Efficient activation of microhomology-mediated end joining 
(MMEJ) pathway, on the other hand, can greatly limit allelic diversity and enable the 
intentional generation of a particular deletion allele of interest at a high rate. Consequently, 
the downstream applications become more streamlined with facile generation of homozygous 
frameshift allele in diploid cells. 
https://doi.org/10.1371/journal.pgen.1007652.g001 
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In contrast to NHEJ, the MMEJ (Microhomology-mediated End Joining) DNA repair 
pathway utilizes a pair of locally available direct sequence repeats on both sides of a DSB 
that are apposed, annealed and extended [7–10]. As such, DSB repair outcomes are highly 
stereotyped (Fig 1), resulting in deletion of the intervening sequence as well as one of the 
repeats. Consequentially, there is an increasing interest in utilizing MMEJ for precision 
genome engineering applications [11–14]. To date, however, effective harnessing of this 
pathway remains challenging due to the paucity of genetic and mechanistic understanding 
[8]. 
Bae et al. [14] developed a sequence-based scoring system to estimate the frequency 
of MMEJ-associated deletions induced by DSBs in human cells. While this improved the 
predictability of MMEJ activation, the DSB repair outcomes tended to consist of a 
heterogeneous population of multiple MMEJ alleles. In this study, we sought to improve 
upon the existing algorithm with the goal of developing tools to more reliably predict target 
loci that would be predisposed to generate a more homogeneous mutant allele population 
through MMEJ. We demonstrate the feasibility and utility of such reagent design on the 
molecular level (i.e., DNA repair outcomes) and on the physiological level (i.e., F0 
phenotype). We further demonstrate that our approach can be applied to generating highly 
homogeneous MMEJ alleles in cultured human cells, suggesting our findings may be broadly 
translatable to multiple model systems. We believe our approach can inform and benefit 
applications such as rapid phenotype-genotype correlation in F0 animals, with an eye toward 
applications in human gene therapy and facilitation of resource sharing & recreation of 
various cell and animal lines on a global scale. 
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Results 
MMEJ is an active repair pathway in the genetically unaltered zebrafish embryo 
Prior works examining MMEJ activation in vertebrate organisms primarily focused 
on in vitro models [8–10, 14–18]. Initial analyses using a targeted knock-in strategy 
suggested that MMEJ was operational in the zebrafish embryo, though the efficiency of these 
MMEJ outcomes was rather modest [13]. Importantly, while previous studies reported 
incidental identification of several zebrafish genomic loci that repaired preferentially through 
MMEJ when using programmable nucleases [19, 20], no consortium–small or large–of 
genomic loci that repair primarily through NHEJ vs MMEJ has been compiled. To this end, 
we examined the repair outcomes of previously designed TALEN and CRISPR-Cas9 
genomic reagents (S1 Table). The plurality of custom enzymes induced diverse sequence 
outcomes, consistent with the idea that NHEJ is being used as the primary DNA repair 
pathway at these loci. However, a few reagents induced sequence outcomes satisfying the 
following criteria, suggesting that MMEJ was the preferred pathway: 1) most predominant 
mutant allele is the top predicted allele by the Bae et al. algorithm [14], 2) most predominant 
mutant allele comprises ≥ 50% of the total mutant allele population, and 3) mutagenic 
efficiency > 20%. For the purpose of this study, a programmable nuclease satisfying all these 
criteria is referred to as a Predominant MMEJ Allele (PreMA) reagent. Three sticky-end 
generating TALEN (chrd, mitfa #4 & surf1) and two blunt-end generating CRISPR-Cas9 
(surf1 & tyr #2) reagents fell into this category (S1 Table, Fig 2A, Fig 3A). 
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Figure 2 PreMA TALEN reagent can be used to recapitulate previously reported loss-of-
chrd-function phenotype in 1 dpf F0, injected larvae. 
A. Top–Wildtype chrd sequence with TALEN binding sites annotated in teal. The dotted red 
boxes are MH arms predicted to be used most frequently. Raw sequence alignment of the 
whole PCR amplicon demonstrates that the majority of reads are the expected 7 bp deletion 
allele. Bottom–summary data from subcloning analyses. 50% of the mutant allele recovered 
were of the predicted MH allele. B. Previously reported chrd loss-of-function phenotype was 
successfully recapitulated using this TALEN pair. Phenotype severity was graded by the 
degree of Intermediate-Cell-Mass expansion in the tail and by the reduced head size by 1 dpf. 
Box plot demonstrating phenotypic penetrance is provided with each experiment denoted by 
a unique marker shape. N = 3 biological and technical replicates. At least 29 injected animals 
were scored in each experiment. 
https://doi.org/10.1371/journal.pgen.1007652.g002 
Injecting the chrd TALEN pair (37.5 pg/arm) resulted in characteristic chrd loss of 
function phenotypes: Intermediate-Cell-Mass expansion and a smaller head by 1 day post-
fertilization [21] (1 dpf; Fig 2B). Median penetrance for Moderate and Severe phenotypes 
was 15.8% and 20.0%, respectively (Fig 2B, S2 Table). Strong MMEJ activation by this 
TALEN pair was confirmed by subcloning analysis (Fig 2A)– 16/32 recovered mutant reads 
corresponded to the top predicted 7 bp deletion allele. Similarly, perturbing tyr gene with a 
CRISPR-Cas9 reagent recapitulated a previously reported, loss of melanin production 
phenotype, observable by 2 dpf [22] (Fig 3B). Ribonucleoprotein (RNP) delivery at the dose 




Figure 3 PreMA sgRNA against tyr can be used to recapitulate loss-of-melanophore 
phenotype in 2 dpf, injected F0 larvae. 
A. Top–Wildtype tyr sequence with the #2 sgRNA target site annotated in green. The dotted 
red boxes are MH arms predicted to be used most frequently. Raw sequence alignment of the 
whole PCR amplicon demonstrates that the majority of reads are the expected 4 bp deletion 
allele. Bottom–summary data from subcloning analyses. 88% of the mutant allele recovered 
were of the predicted MH allele. B. Previously reported tyrloss-of-function phenotype was 
successfully recapitulated using this CRISPR-Cas9. Phenotype severity was graded by the 
loss of retinal pigmentation. Partial loss of retinal pigmentation was considered a Weak 
phenotype, whereas complete loss of pigmentation in one or both eyes were considered 
Moderate and Severe phenotypes, respectively. Box plot demonstrating phenotypic 
penetrance is provided with each experiment denoted by a unique marker shape. N = 3 
biological and technical replicates. At least 12 injected animals were scored in each 
experiment. 
https://doi.org/10.1371/journal.pgen.1007652.g003 
of 300 pg tyr #2 sgRNA and 660 pg Cas9 resulted in Moderate and Severe loss of 
pigmentation phenotypes in 22.7% and 50.0% of embryos respectively (Fig 3B, S2 Table). 
Subcloning analysis showed 21/24 (88%; Fig 3A) of resulting alleles contained a 4 bp 
deletion consistent with a strong MMEJ activation by this CRISPR-Cas9. Together with 
the chrd TALEN results, these data support that MMEJ can be an effective repair pathway in 
F0 embryos at some genomic loci, irrespective of programmable nucleases used. 
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Many Bae et al. predicted MMEJ loci are preferentially repaired by NHEJ 
A subset of these zebrafish reagents described above was prospectively designed 
using the Bae et al. algorithm (S1 Table). This algorithm calculates the strength of each pair 
of microhomology arms (i.e., Pattern Score) according to the length and GC content of each 
pair, as well as the length of the intervening sequence. The additive sum of all the 
possible Pattern Scores is then returned as Microhomology Score. This latter score was found 
to have positive correlation with the rate of MMEJ activation in HeLa cells [14]. All fourteen 
prospectively designed reagents had a Microhomology Score of at least 4000 –a median score 
found on human BRCA1 gene. However, only four of these reagents induced majority MMEJ 
outcomes as judged by the Microhomology Fraction (S1 Table, S1 Note). We therefore 
retrospectively analyzed the repair outcomes of these reagents to identify additional factor(s) 
that would enhance predictability of MMEJ induction. 
Rate of Pattern Score change as a discrimination factor for MMEJ induction in 
vivo and in vitro 
Intriguingly, when the pattern score values clustered closely to one another (i.e., a 
flatter Slope Value as calculated according to S2 Note), this was indicative of an unfavorable 
target for MMEJ activation in zebrafish embryos. Conversely, loci at which Pattern 
Scores dropped precipitously (i.e., a steeper Slope Value) were good candidates of MMEJ 
activation in vivo (p = 0.0048; S1 Fig). Based on these observations, we hypothesized that 
locally available microhomology pairs are in direct competition with one another such that 
overabundance of these pairs is a negative predictor of MMEJ activation. In other words, 
MMEJ activation is more favorable at loci with one or two predominant microhomology 
pair(s) (Low Competition loci) rather than many strong microhomology pairs (High 
Competition loci). 
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To determine whether the zebrafish-based hypothesis was generalizable to human 
cells (HeLa), we re-analyzed the deep sequencing dataset used to generate the Bae et al. 
algorithm [14]. Available results from 90 genomic loci were sorted alphabetically by the 
names of target genes then divided into two groups: first 50 and the remaining 40. The first 
group was then used for a retrospective, correlative analysis while the latter was used for an 
analysis compatible with a prospective study design. Outcomes from the first 50 targets 
showed a correlation similar to that observed in zebrafish; higher Microhomology 
Fractions generally correlated with low Slope Values (p = 0.00001; S2A Fig). This 
correlation was lost when microhomology arms of 2 bp were included in the analysis (p = 
0.2644; S2B Fig); accordingly, microhomology arms of less than 3 bp were excluded from 
subsequent analyses. The remaining 40 targets were then binned into High, Medium and Low 
Competition groups based on quartile distribution of the Slope Value (S2C Fig). In 
agreement with our Competition Hypothesis, the median Microhomology Fraction was 
significantly higher in the Low Competition group than in the High Competition group (0.300 
vs 0.105, p = 0.011; S2D Fig). 
Competition hypothesis predicts new PreMA reagents 
Based on this Competition Hypothesis, we designed 20 Low Competition sgRNA 
targets across 9 genes and analyzed the DSB repair outcomes (S3 Table). Slope 
Values smaller than -40 was used as the cut-off for Low Competition, as 3 out of 4 
previously designed zebrafish targets produced majority MMEJ outcomes in this range (S1 
Table and S1 Fig). For initial assessments, we used TIDE (Tracking Indels by 
DEcomposition) analysis–a chromatogram analyzing tool that estimates proportions of length 
varying mutant alleles present in a pool of mixed alleles [23]–which revealed that 5 of these 
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sgRNAs against 3 genes (mtg1, tdgf1, ttn.2 #1, ttn.2 #2, and ttn.2 N2B #1) were in the 
PreMA class. These results were subsequently confirmed by subcloning analyses (S3 Table). 
Perturbation of tdgf1 (alternatively known as One-eyed Pinhead) causes aberrant, 
“pinhead” morphology and cyclopia as judged by reduced forebrain protrusion by 1 dpf [24] 
(Fig 4B). RNP injections of CRISPR-Cas9 at the dose of 300 pg sgRNA and 660 pg Cas9 
resulted in highly homogeneous DSB repair outcomes, generating the top-predicted 4bp 
allele in 28 of 39 clones analyzed (Fig 4A). Aberrant head morphology alone was classified 
as Weak whereas that in combination with varying degrees of forebrain protrusion was 
classified as Moderate or Severe phenotypes. Median penetrance for Moderate and Severe 
morphology was 21.8% and 11.4% (Fig 4B, S2 Table), consistent with the subcloning 
results. 
 
Figure 4 Prospectively designed PreMA reagent against tdgf1 can be used to reproduce gross 
developmental defect in 1 dpf, injected F0 larvae. 
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A. Top–Wildtype tdgf1 sequence with sgRNA target site annotated in orange. The dotted red 
boxes are MH arms predicted to be used most frequently. Raw sequence alignment of the 
whole PCR amplicon demonstrates that the majority of reads are the expected 4 bp deletion 
allele. Bottom–summary data from subcloning analyses. 72% of the mutant allele recovered 
were of the predicted MH allele. B. Previously reported tdgf1 loss-of-function phenotype was 
successfully recapitulated using this CRISPR-Cas9. Phenotype severity was graded by the 
“pinhead” morphology and cyclopia. Pinhead morphology alone was classified as Weak, 
whereas Moderate and Severe phenotypes also presented with varying degrees of cyclopia 
judged by the distance of forebrain protrusion. In the Severe class, the forebrain does not 
separate the eyes, and they are fused together. Box plot demonstrating phenotypic penetrance 
is provided with each experiment denoted by a unique marker shape. N = 4 with 3 biological 
and 4 technical replicates. At least 42 injected animals were scored in each experiment. 
https://doi.org/10.1371/journal.pgen.1007652.g004 
We next explored whether these PreMA reagents are useful for recapitulating a more 
subtle phenotype beyond aberrant gross morphologies observed in the tdgf1 mutants. Splice 
blockade at the N2B exon of ttn.2 gene by a synthetic morpholino oligonucleotide was 
previously reported to reduce the cardiac contractility by ~70% on 2 dpf [25], phenocopying 
the pickwickm171 mutation [26]. RNP delivery at the dose of 300 pg ttn.2 N2B #1 sgRNA + 
660 pg Cas9 resulted in reduction of the shortening fraction to a comparable degree (Fig 5B). 
Importantly, RNP delivery of NHEJ-inducing ttn.2 N2B #2 sgRNA at the same dose only 
resulted in a more attenuated phenotype, despite it targeting the same exon and having 
comparable activity (Fig 5; S4 Table). Due to the high editing efficiency, animals injected 
with these doses of ttn.2 N2B #1 RNP were not viable in post larval phases. For this reason, 
animals injected at the lower dose of 75 pg sgRNA + 165 pg Cas9 protein were raised to 
adulthood. Two F0 founders were successfully outcrossed to wildtype zebrafish. 
Heterozygous offspring were identified using the dsDNA heteroduplex-cleaving Surveyor 
assay [27], and the transmission of the top predicted 5 bp deletion allele was confirmed from 
both founders by subcloning analyses (S3 Fig). 
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Figure 5 PreMA reagent against ttn.2 N2B results in specific reduction of shortening fraction 
in 2 dpf F0 zebrafish. 
A. Top–Wildtype ttn.2 sequence at the N2B exon with sgRNA target site annotated in red. 
The dotted red boxes are MH arms predicted to be used most frequently. Raw sequence 
alignment of the whole PCR amplicon demonstrates that the majority of reads are the 
expected 5 bp deletion allele. Bottom–summary data from subcloning analyses. 86% of the 
mutant allele recovered were of the predicted MH allele. B. Previously 
reported pickwick phenotype was successfully recapitulated using this CRISPR-Cas9. 2 dpf 
zebrafish were immobilized in 3% methylcellulose for live recording of cardiac functions. 
Whereas injections with Cas9 only (660 pg), N2B #1 sgRNA only (300 pg), or tyr #2 sgRNA 
RNP (300 pg sgRNA + 660 pg Cas9) did not result in changes in shortening fraction at this 
age, MMEJ-inducing RNP injection targeting N2B #1 (300 pg sgRNA + 660 pg Cas9) 
resulted in a specific reduction in shortening fraction by 78.4%. In contrast, NHEJ-inducing 
RNP injection targeting N2B #2 (300 pg sgRNA + 660 pg Cas9) resulted in attenuated 
effects on shortening fraction (53.3% reduction), despite similarly high edit efficiency. Each 
data point represents an individual animal scored with the shape of the marker denoting 
unique experiment. N ≥ 3 biological and technical replicates, except for N2B #2 where N = 
2. At least 5 injected animals were scored in each experiment. P-values calculated by 
Wilcoxon’s Each Pair Calculation (adjusted for multiple comparisons). 
https://doi.org/10.1371/journal.pgen.1007652.g005 
We also designed an sgRNA against exon 13 of ttn.2 (ttn.2 #2 sgRNA), expected to 
produce a 12 bp deletion allele as a proof-of-principle for in-frame gene correction (Fig 6A). 
RNP delivery at the dose of 300 pg sgRNA + 660 pg Cas9 resulted in the induction of this 12 
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bp deletion allele in 72.7% of the clones. While the injected animals presented with mild 
cardiac edema evident by 2 dpf (median rate: 50.0%; Fig 6B, S2 Table), unlike the N2B #1 
sgRNA CRISPR-Cas9 injected animals, these were viable to adult age. 
 
Figure 6 PreMA reagent can be used for in-frame gene alteration. 
A. Top–Wildtype ttn.2 sequence with sgRNA target site annotated in red. The dotted red 
boxes are MH arms predicted to be used most frequently. Raw sequence alignment of the 
whole PCR amplicon demonstrates that the majority of reads are the expected 12 bp deletion 
allele. Bottom–summary data from subcloning analyses. 73% of the mutant allele recovered 
were of the predicted MH allele. B. 2 dpf zebrafish larvae injected with ttn.2 #2 sgRNA RNP 
(300 pg sgRNA + 660 pg Cas9) grossly appear normal with the exception of mild cardiac 
edema. Median penetrance was 50%. N = 3 biological and technical replicates. At least 9 
injected animals were scored in each experiment. 
https://doi.org/10.1371/journal.pgen.1007652.g006 
Low competition plus proximity of microhomology arms strongly predicts PreMA 
reagents: V2 
These data implicate the utility of PreMA reagents for various applications that 
require precision gene editing. However, sgRNA design based on the Competition 
Hypothesis only yielded 5 PreMA reagents out of 20 that were tested (S3 Table, S3 Note). 
While this represented an improvement over the initial approach solely relying on 
the Microhomology Score (1 out of 14; S1 Table), we sought to further fine-tune the 
predictability for the PreMA targets. To this end, we pooled the results from all the 
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programmable nucleases described above (S1 and S3Tables) and seven Medium ~ High 
Competition sgRNAs designed as controls based on the Competition Hypothesis (S4 Table). 
In so doing, we noted that PreMA outcomes were only observed if the two arms of the top 
predicted microhomology were separated by no more than 5 bp. We subsequently identified 
the second parameter: high ratio (≥ 1.5) of the Pattern Scoresbetween the top predicted and 
second predicted MMEJ alleles for a given locus (Fig 7). Seven out of eight reagents that 
satisfied both of these parameters were PreMA. Of the nine reagents that satisfied the first 
parameter but not the second, two were PreMA. All the other thirty reagents that failed to 
meet the first parameter failed to induce the top predicted MMEJ allele strongly. Most 
importantly, all the failed cases (i.e., incorrect predictions according to the original 
Competition Hypothesis) can be explained using our revised approach (Competition 
Hypothesis V2; Fig 7C). The Version 2 also captured three PreMA reagents that would have 
been missed by the original Competition Hypothesis alone, and one PreMA reagent that 
would have been missed by the Microhomology Score alone. Similar trends were observed 
using independently collected, previously published deep sequencing dataset from zebrafish 
[28] and HeLa cells [14] (S4 Fig). 
Mechanism of MMEJ-activation may be conserved in vertebrates 
To test the generalizability of our findings, we prospectively designed 11 sgRNAs 
against the human genome (S5 Table) and delivered as RNPs to HEK293T cells. Of the 5 
active guides cutting above 20% efficiency, DSBs induced by GJB2 #1 and #2 guides 
resulted in more homogeneous repair outcomes (Fig 8A and 8B) than any of the 92 guides 
tested by Bae et al. (S4B Fig) [14]. DSBs at AAVS1 #2 and MYO7A #3, on the other hand, 
repaired primarily through 1bp indels, consistent with the report by Bae et al. using HeLa 
cells. Intriguingly, the second most prevalent class of repair at these loci was the top  
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Figure 7 Competition hypothesis version 2. 
A. Outlier plot summarizing repair outcomes from 47 genomic targets using TALEN and 
CRISPR-Cas9. Close proximity of top predicted MH arms (Groups 3 and 4) appears to be the 
primary determinant for generating PreMA type outcomes as no target from Groups 1 and 2 
had Top MH Fraction exceeding 0.5. When the top predicted allele had at least 50% 
higher Pattern Score than the second predicted allele (Groups 2 and 4), it was a strong 
indicator for inducing MMEJ-class repairs. B. Top Definition for each of the 4 groups used in 
Panel A. Each and every zebrafish genomic locus was segmented into these 
categories. Pattern scores were derived using RGEN online tool. Bottom P-values calculated 
by Wilcoxon’s Each Pair Calculation (adjusted for multiple comparisons). C.Graphical 
representation of each group detailed in Panel A. Groups 1 and 2 are prone to activate NHEJ-
type outcomes, presumably because the yet-unidentified MMEJ factor fails to localize to 
suitable microhomology arm pairs, limited by how far apart these arms are. Group 4 is most 
suitable for strong MMEJ activation because it satisfies the proximity requirement AND the 
relative strength requirement. The latter may aid in the kinetics of the yet-unidentified MMEJ 
factor binding to the microhomology arms. Our data suggest that Group 3 is an intermediate 
group in terms of MMEJ activation. Perhaps extragenetic factors, such as cell cycle and 
epigenetic status may determine how favorable the loci are for MMEJ inductions. 
https://doi.org/10.1371/journal.pgen.1007652.g007 
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predicted MMEJ allele (Fig 8C and 8D), as identified by subcloning analyses. We thus 
conclude that the specific trigger for efficient MMEJ-activation may be conserved in 
vertebrate organisms, albeit with nuances that are yet to be elucidated. 
 
 
Figure 8 Competition hypothesis V2 targets trigger primary repair by MMEJ in HEK293T 
cells. 
A & B. Top–Wildtype human GJB2 sequences with sgRNA target sites annotated. The 
dotted red boxes denote the top predicted MH arms. Summary TIDE analysis outcomes are 
also presented showing ~ 45% Top MH Fractions for GJB2 #1 and #2 sgRNA. Red bar 
indicates the predicted deletion allele. Calculations for Adjusted Prevalence conform to 
calculations for Top MH Fractions detailed in S3 Note. Bottom–summary data from 
subcloning analyses for GJB2 #1 sgRNA (A) and #2 sgRNA (B). C & D. Top–Wildtype 
human AAVS1 and MYO7A sequences with sgRNA target sites annotated. The dotted red 
boxes denote the top predicted MH arms. Bottom–summary data from subcloning analyses 
for AAVS1 #2 sgRNA (A) and MYO7A #3 sgRNA (B). 
https://doi.org/10.1371/journal.pgen.1007652.g008 
Accessing the PreMA algorithm through MENTHU (MMEJ kNockout Target Heuristic 
Utility) 
The broad potential utility of this updated PreMA Algorithm for MMEJ prediction led 
us to develop a web-based automated analysis tool called MENTHU 
(http://genesculpt.org/menthu/). The tool can also be downloaded and installed on a local 
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computer (www.github.com/Dobbs-Lab/menthu/). MENTHU accepts a user-specified DNA 
sequence and targeting scheme as input, and outputs recommended CRISPR gRNA target 
sites that are predicted to result in PreMA type outcomes. We validated the accuracy and 
functionality of MENTHU against select gRNA sites used in this study using whole exonic 
sequences as inputs (S6 Table); importantly, the software identified novel PreMA candidate 
loci against surf1 and tdgf1 where only Group 3 gRNA loci had been found by previous 
methods. Finally, we conducted a preliminary assessment to examine the prevalence of 
PreMA loci and found roughly 10% prevalence of such loci among all possible NGG PAM 
on human CSF2 as well as zebrafish tp53 genes (S7 Table). 
Discussion 
To date, precision genome engineering is limited by the ability to predictably, 
efficiently, and reproducibly induce the identical sequence alterations in each and every cell. 
Here, we demonstrate the feasibility and utility of creating allelic consistency by an MMEJ-
centric approach for designing programmable nucleases. While the precise cellular 
components of the molecular machinery involved in MMEJ remain incompletely understood 
[8], we provide evidence that we can enrich for MMEJ events by strictly sequence-based 
queries. 
We also demonstrate that MMEJ predominant repairs do not operate at the cost of 
overall mutagenic efficiency; median edit efficiency for PreMA reagents was 91.4% in 
zebrafish. As genetically unaltered wildtype zebrafish were used throughout the study, we 
have no reason to believe that NHEJ should have failed at any tested loci. This is in contrast 
to the proposal that MMEJ is a back-up pathway to NHEJ [7, 8, 16, 17, 29]. Our findings, on 
the other hand, are compatible with a previous report wherein MMEJ-specific factors such as 
PolQ are abundantly expressed in embryonic zebrafish [20]. Interestingly, maternally zygotic 
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PolQ mutant embryos failed to repair DSB at two out of three MMEJ loci, leading to 
premature deaths [20]. The third locus–which preferentially used a 2 bp microhomology and 
exhibited more heterogeneous DSB repair outcomes–was able to be repaired at a measurable 
rate, though significantly less so than in WT embryos. Thus NHEJ and MMEJ may be non-
competing, parallel processes with unique triggers. 
Based on the data presented here, we speculate that there is a reaction-limiting factor 
for MMEJ that is involved in identifying compatible microhomology pairs on both sides of 
the DNA double stranded break. In the case of abundantly available local microhomology 
pairs, this factor may fail to localize to a single suitable pair, thus rejecting the MMEJ 
activation. As end-resection is required for MMEJ and not for NHEJ [9, 17, 18], this yet 
identified factor may be the deciding factor for committing DSB repair through one End 
Joining pathway to another. This view is similar to a recent report wherein CtIP/Artemis 
dependent limited end resection was a key trigger for a slow-kinetic Lig1/3 independent 
NHEJ event that frequently utilized Microhomology to repair a reporter plasmid [30]. In our 
analysis, the primary driver of this decision making process is the proximity of 2 
microhomology arms, further aided by the lack of competing microhomology arms. 
Successful deployment of the PreMA reagents makes it possible to directly dictate the 
reading frame or to do in-frame gene manipulations on endogenous targets. Even assuming a 
somewhat modest outcome of 50% edit efficiency in which 50% of the mutant allele pool is 
of the desirable allele, more than 10% of the cell population will be homozygous for this 
desired allele. Conversely, many real-life gene editing applications would require only one of 
the diploid copies to be corrected. In these settings under the same assumptions, just 11 
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viable cells are needed to achieve 95% confidence for establishing the right clone, bringing 
the idea of precision molecular surgery closer to reality. 
Our present study expands upon the current state-of-art understanding for MMEJ 
activation and demonstrates the ability to prospectively design robustly active PreMA 
reagents in-vivo. We also provide evidence that this 2-component approach may be broadly 
applicable beyond zebrafish; testing of the true generalizability of our approach will be 
facilitated by our web-based application, MENTHU (http://genesculpt.org/menthu/). 
Importantly, MENTHU allows users to flexibly define a PAM sequence and the cut site (in 
nts from PAM) so as to accommodate potential future variants of the CRISPR system. Active 
investigations are underway to accommodate alternative or more lax PAM requirements, 
such as the case with xCas9–a recently described variant of Cas9 that may function 
efficiently on an NG PAM [31]. As MMEJ-based loci are inherently restricted to genomic 
locations that leverage endogenous sequence contexts, availability of more flexible 
programmable nucleases will become the key for broadening the utility of PreMA reagents. 
We provide strong evidence to support the utility of the MMEJ-centric approach 
beyond phenotype-genotype correlations in F0 animals. We envision this approach to be 
useful for: 1) studying the effects of homozygous gene knock-out in culture cells (as opposed 
to more common, compound heterozygous loss-of-function cell lines), 2) rapid small 
molecule screening in F0 animals as a complimentary approach to studying in germline 
mutant animals, 3) globally sharing and reproducing gene knock-out cell and animal lines, 4) 
pathway dissection for MMEJ, and finally, 5) human gene therapy. 
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Materials and methods 
Ethics statement 
The animal studies were conducted following guidelines and standard procedures 
established by the Mayo Clinic Institutional Animal Care and Use Committee (Mayo 
IACUC). The Mayo IACUC approved all protocols involving live vertebrate animals 
(A23107, A 21710 and A34513). 
Microhomology arms 
For the purpose of this study, microhomology is defined as any endogenous direct 
sequence repeats of ≥ 3 bp surrounding a DSB site. ≤ 2 bp direct sequence repeats were not 
considered sufficient substrates of MMEJ activation based on our initial analyses of the DSB 
repair outcomes by previously designed programmable nucleases. Correlation 
for Microhomology Fraction vs the Slope Value was tangentially stronger when only ≥ 3 bp 
arms were considered (r2 = 0.382 vs r2 = 0.353; S1 Fig) in zebrafish, whereas the correlation 
was lost when 2 bp arms were considered in HeLa cells (r2 = 0.339 vs r2 = 0.034; S2 Fig). 
Zebrafish husbandry 
All zebrafish (Danio rerio) were maintained in accordance with protocols approved 
by the Institutional Animal Care and Use Committee at Mayo Clinic. Zebrafish pairwise 
breeding was set up one day before microinjections and dividers were removed the following 
morning. Following microinjections, the fertilized eggs were transferred to Petri dishes with 
E3 media [5 mM NaCl, 0.17 mM KCl, 0.33 mM CaCl2, and 0.33 mM MgSO4 at pH 7.4] and 
incubated at 28.5 °C. All subsequent assays were conducted on fish less than 3 dpf, with the 
exception of assessing for germline transmission. In this case, injected founders were raised 
to adulthood per the standard zebrafish husbandry protocol. 
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DNA oligonucleotide preparation 
All of the oligonucleotides used for this study were purchased from IDT (San Jose, 
CA). Upon arrival, they were reconstituted into 100μM suspensions in 1x TE and stored at -
20 °C until use. 
sgRNA expression vector synthesis 
pT7-gRNA was a gift from Wenbiao Chen (Addgene plasmid # 46759). Given that 
the minimum requirement for the T7 promoter is a single 5’ G, the GG start on this vector 
was mutagenized via site-directed mutagenesis (SDM) to accommodate GA, GC, GT starts, 
using Forward and Reverse primers given (S8 Table). Platinum Pfx DNA Polymerase 
(Invitrogen 11708013. Carlsbad, CA) was used for 20 cycles of PCR amplification with the 
Tm of 60 °C and extension time of 3 minutes. DpnI (NEB R0176. Ipswich, MA) was 
subsequently added to reaction prior to transforming DH5α cells. The target sequence was 
cloned in as previously described, with the exception of conducting oligo annealing and T4 
ligation (NEB M0202. Ipswich, MA) in 2 separate steps. In each case, transformed cells were 
cultured with Carbenicillin, and plasmids were purified with Plasmid Mini Kit (Qiagen 
12123. Hilden, Germany). 
TALEN synthesis 
TALEN constructs were generated using the FusX kit (Addgene # 1000000063) as 
previously described [32]. In short, RCIscript-GoldyTALEN was linearized with BsmBI 
(NEB R0580. Ipswich, MA) along with 6 triplet RVD (Repeat-Variable Diresidue) plasmids. 
Subsequently, they were ligated together in one reaction by a modified Golden-Gate 
Assembly. Blue-White colony screening with X-Gal/IPTG, colony PCR and finally pDNA 
sequencing were done to ascertain the correct assembly. 
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In-vitro transcription and RNA preparation 
pT3TS-nCas9n (a gift from Wenbiao Chen: Addgene plasmid # 46757) was 
linearized with XbaI (NEB R0145. Ipswich, MA), whereas TALEN constructs were 
linearized with SacI-HF (NEB R3156. Ipswich, MA) and sgRNA vector with BamHI-HF 
(NEB R3136. Ipswich, MA). Tyr sgRNA #2 –a construct made in the Essner Lab–was 
linearized with HindIII (NEB R0104. Ipswich, MA). RNA was made using T3 mMessage 
mMachine kit (Ambion AM1348. Foster City, CA) or HiScribe T7 High Yield RNA 
synthesis kit (NEB E2040. Ipswich, MA) according to manufacturer’s protocols with the 
addition of RNA Secure to the reaction (Ambion AM7010. Foster City, CA). To purify RNA, 
phenol-chloroform extraction was performed using Acid Phenol, Chloroform, and MaXtract 
High Density Tubes (Qiagen 129046. Hilden, Germany). RNA was then precipitated with 
Isopropanol at -20 °C, pelleted, air dried and resuspended into nuclease free water. The 
quality and quantity of RNA were ascertained by using a Nanodrop spectrophotometer and 
running aliquot on agarose gel. Each batch of RNA was aliquoted into small single use tubes 
and stored at -80 °C until the morning of microinjections. 
CRISPR-Cas9 RNP preparation for microinjections 
sgRNA was thawed on ice in the morning of microinjections. This was then diluted to 
the concentration of 300 ng/μL in Duplex Buffer [100 mM KCH3COO, 30 mM HEPES at pH 
7.5]. Appropriate folding of sgRNA was induced by heating it to 95 °C for 5 minutes and 
gradually cooling the solution to room temperature. Equal volumes of sgRNA and 0.66 
mg/mL Alt-R S.p. Cas9 Nuclease 3NLS (IDT 1074181. San Jose, CA) in Cas9 Working 
Buffer [20 mM HEPES, 100 mM NaCl, 5 mM MgCl2, 0.1 mM EDTA at pH 6.5] were mixed 
and incubated at 37 °C for 10 minutes. RNP solutions were subsequently kept on ice until 
immediately before use. 
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TALEN and CRISPR-Cas9 RNA preparation for microinjections 
RNA was thawed on ice in the morning of microinjections. TALEN mRNA was 
diluted to working concentrations in the range of 12.5 ng/μL to 100 ng/μL in Danieau 
solution [58 mM NaCl, 0.7 mM KCl, 0.4 mM MgSO4, 0.6 mM Ca(NO3)2, 5.0 mM HEPES at 
pH 7.6]. sgRNA and nCas9n mRNA were mixed and diluted to the final concentrations of 
150 ng/μL and 100 ng/μL, respectively, in Danieau solution. These were all kept on wet ice 
until immediately before use. 
Microinjections 
Microinjections were carried out as previously described [33]. In short, 1-cell stage 
fertilized embryos were harvested and aligned on an agarose plate with E3 media. In the case 
of CRISPR-Cas9 reagents, either 1 or 2 nL was delivered to the cell. In the case of TALEN 
reagents, 1 ~ 3 nL was delivered to the yolk mass. They were then transferred to Petri dishes 
in E3 media for incubation at 28.5 °C. Dead and/or nonviable embryos were counted and 
removed each subsequent morning. 
Phenotype scoring 
Each experiment was conducted in at least a technical triplicate and a biological 
duplicate. Detailed outcomes are provided in S4 Table. Gross phenotypes were scored 
visually on either 1 dpf or 2 dpf using a standard dissecting microscope. Subsequently, 
representative pictures were taken with Lightsheet Z.1 (Zeiss 2583000135. Oberkochen, 
Germany). Shortening Fractions were scored as previously reported [34]. In short, live 2 dpf 
larvae were immobilized and positioned in 3% methylcellulose. An Amscope camera 
(MU1403. Irvine, CA) mounted on a Leica Microscope (M165. Wetzlar, Germany) was used 
to capture a 15 second clip of the beating heart at 66 fps. These clips were subsequently used 
to measure the distance of the long axis along the ventricle at maximum dilation and 
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maximum contraction using ImageJ software [35]. Shortening Fraction was calculated as 
below: 
 
Shortening Fractions from 5 cycles were averaged for each animal. 
Zebrafish DNA extraction and assessing mutagenic outcomes 
Typically, 8 uninjected wildtype fish and 8 injected fish were randomly collected 
without prior screening for phenotype. Chorion was predigested with 1 mg/mL Pronase at 
room temperature as needed. 1 ~ 3 dpf animals were then sacrificed for individual DNA 
extractions in 100 mM NaOH for 15 minutes at 95 °C. Equal volumes of 8 fish DNA from 
the same condition were then mixed and used as templates for PCR with either MyTaq 
(Bioline BIO-21108. London, UK), Phusion (NEB M0530. Ipswich, MA), or KOD (EMD 
Millipore 71085. Burlington, MA) polymerases per manufacturer’s protocols. The PCR 
amplicon was resolved on agarose gel, gel extracted with either Monarch DNA Gel 
Extraction Kit (NEB T1020. Ipswich, MA) or QiaEx II Gel Extraction Kit (Qiagen 20021. 
Hilden, Germany), and subsequently sent out for sequencing. The chromatograms from both 
uninjected and injected amplicons were used for TIDE analysis [23]. Alternatively, purified 
amplicons were used for subcloning analysis with either Topo-TA Cloning Kit (Thermo 
Fisher Scientific 451641. Waltham, MA) or StrataClone PCR Cloning Kit (Agilent 240205. 
Santa Clara, CA) per manufacturer’s protocols. Resultant white to pale blue colonies by 
Blue-White screening were subjected to colony PCR with M13F and R primers, using 
MyTaq polymerase. Once successful amplification was confirmed on agarose gel, these 
amplicons were sent out for sequencing either with M13F, M13R or endogenous gene target 
primers. 
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Germline transmission for 5 bp deletion generated by N2B sgRNA #1 
RNP containing N2B sgRNA #1 was prepared at 4x diluted dose as described above. 
Following microinjections, viable fish were raised to sexual maturity. Both F0 founders we 
attempted to out cross successfully mated and produced viable embryos. DNA was extracted 
from all viable embryos on 1 dpf, and individual DNA was used as template for PCR 
amplification using MyTaq Polymerase. Once the thermocycling ran to completion, the 
amplicons were melted by heating to 95 °C and re-annealed by a gradual step-wise cooling. 
Surveyor assay [27] was conducted per the manufacturer’s protocol (IDT 706025. San Jose, 
CA), and the results were analyzed by resolving the post-digest amplicons on agarose gel. 
Amplicons from 4 heterozygous offspring each were subcloned, and 5 colonies each were 
sent for Sanger Sequencing to confirm successful transmission of the 5 bp deletion allele. 
Reanalyses of previously published deep sequencing dataset 
For zebrafish dataset, sgRNA screen SRA files were obtained from NCBI’s Short 
Read Archive (Accession: PRJNA245510) [28]. These files were converted to the fastq 
format with fastq-dump command using—split-spot function under SRA Toolkit (NCBI. 
Bethesda, MD). The fastq files were then uploaded onto Cas-Analyzer 
(http://www.rgenome.net/cas-analyzer/) and analyzed with Comparison range of 25 ~ 40 and 
Minimum frequency of 1 [36]. Following number of reads were recorded: total, total mutant, 
total top predicted allele. A top predicted allele was allowed to be included so long as the 
read contained no more than 2 polymorphisms on the analysis window AND the 
polymorphisms did not fall on the microhomology arms. Subsequently, the calculated 
mutagenic efficiency was plotted against the reported efficiency (r2 = 0.306). Of 122 targets 
designed by Gangnon, et al, following were excluded to arrive to the 34 targets that were 
used for analysis presented in S4 Fig Panel A: non-NGG targets (36 loci), targets that did not 
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align to WT consensus sequence (GRCz11; 8 loci), targets with total recovered read counts 
less than 1% of expected (7 loci), high rate of permutation outside of the target site (1 locus), 
targets that did not have good agreements between calculated and reported (i.e., fell beyond 
99% Confidence Interval; 10 loci), targets that had less than 5% calculated AND reported 
mutagenic efficiencies (26 loci). 
The HeLa cell dataset [14] was obtained from Dr. Kim in the form of excel spread 
sheet with aligned sequence outputs +/- 25 bp of the predicted cut site. Following number of 
reads were recorded: total, total mutant, total top predicted allele with 2 bp microhomology, 
and total top predicted allele with 3 bp or longer microhomology. As with zebrafish dataset, 
top predicted allele was allowed to be included so long as the read contained no more than 2 
polymorphisms on the analysis window AND the polymorphisms did not fall on the 
microhomology arms. Of the 92 targets, following were removed to arrive to 74 targets that 
were used for analyses presented in S2 Fig and S4 Fig Panel B: targets with total recovered 
read counts less than 1% of expected (2 loci), and targets that had less than 20% mutagenic 
efficiency (16 loci). There were no targets with non-NGG PAM, no alignment against 
consensus sequence, nor a high rate of permutation outside of the predicted cut site. 
Cell culture and RNP transfection 
HEK293T cell line was purchased from ATCC (Manassas, VA) and maintained in 
DMEM (Invitrogen. Carlsbad, CA) with 10% Fetal Bovine Serum (Sigma. St. Louis, MO). 
DAPI stain was used to check for mycoplasma contamination. 
RNP transfection was conducted as follows in a 48-well format using Lipofectamine 
CRISPRMAX reagent (Invitrogen CMAX00015. Carlsbad, CA). In vitro transcribed sgRNA 
was diluted to 2 μM concentration in Duplex Buffer. Secondary structure was induced by 
heating it to 95 °C for 5 minutes and gradually cooling it to room temperature. 3.0 μL of 
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sgRNA was then complexed with 3.0 μL of 2 μM Alt-R S.p. Cas9 Nuclease V3 (IDT 
1081058. San Jose, CA) in 42.8 μL OPTI-MEM (Life Technologies. Carlsbad,CA) and 1.2 
μL Cas9 Plus Reagent. This mixture was incubated for 5 minutes at 25 °C. 2.4 μL of 
CRISPRMAX reagent and 47.6 μL OPTI-MEM was then added to the RNP, transferred to 
empty wells, and further incubated for 20 minutes at 25 °C. 200 μL cell suspension at 
400,000 cells / mL in complete medium were subsequently added to each well. The dosing of 
RNP was consistent for all targets except for both GJB2 targets wherein 1 μM each of 
sgRNA and Cas9 protein was used. 
HEK293T cell DNA extraction and assessing mutagenic outcomes 
HEK293T cells were harvested 24 hour post transfection for gDNA extraction using 
DNeasy Blood & Tissue Kit (Qiagen 69506. Hilden, Germany). 20 ng of gDNA was used as 
a template for PCR with KOD polymerase per manufacturer’s protocol. The PCR amplicon 
was resolved on agarose gel, gel extracted with Monarch DNA Gel Extraction Kit and 
subsequently sent out for sequencing. The chromatograms from both uninjected and injected 
amplicons were used for TIDE analysis [23]. 
For sgRNAs that showed > 20% activity by TIDE, single A overhang was added to 
the 3’ end of purified amplicons by incubating them with MyTaq polymerase at 72 °C for 15 
minutes. They were then used for subcloning analysis with StrataClone PCR Cloning Kit. 96 
resultant white to pale blue colonies by Blue-White screening were subjected to colony PCR 
with endogenous primers using MyTaq polymerase. Once successful amplification was 
confirmed on agarose gel, these amplicons were subjected to T7E1 assay [27]. Briefly, 2.5 
μL each of colony PCR amplicon and wildtype amplicon were heteroduplexed in 1x NEB 2.0 
Buffer (25 μL). This was incubated for 15 minutes at 37 °C with 0.5 μL T7 Endonuclease I 
(NEB m3020. Ipswich, MA) and 4.5 μL dH2O. The digested amplicon was resolved on 2% 
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agarose gel. Number of colony PCR-positive clones and digest positive clones are reported 
in S5 Table. Some of the digest positive clones were then sent for sequencing to ascertain the 
nature of mutation. 
2 targets (CSF2 #1 and MYO7A #4) that did not meet the 20% edit efficiency cutoff 
nonetheless produced statistically significant aberrant sequence peaks by TIDE analysis (p < 
0.001). Summary outcomes for Top MH Fraction calculation based on estimated alleleic 
prevalence is given in S5 Table. 
MENTHU 
We developed a software tool, MENTHU (MMEJ kNockout Target Heuristic Utility), 
to automate calculations required to implement the 2-component PreMA strategy: 1) 
identification of top predicted microhomology arms separated by ≤ 5 bp of intervening 
sequence, and 2) identification of “low competition” target sites (i.e., with a #1-ranked to #2-
ranked Pattern Score ratio ≥ 1.5). We designed MENTHU to first compute two of same 
sequence-based parameters (Pattern Score and Microhomology Score) used in the algorithm 
of Bae et al., (which are computed online by the RGEN online tool, http://www.rgenome.net) 
To do so, we used R [37] to re-implement and modify the original Python source code 
provided in S3 Fig of the original publication [14]. The MENTHU webserver operates under 
R version 3.4.1 and RShiny [38] v1.0.5. The MENTHU code was built through RStudio [39] 
v1.1.442. Details regarding specific R package versions, complete documentation and a full 
downloadable version of MENTHU for local installation are provided 
at www.github.com/Dobbs-Lab/menthu/. MENTHU v2.0 can be freely accessed online 
at http://genesculpt.org/menthu/. 
To preliminarily assess the abundance of PreMA loci, MENTHU was locally run to 
screen the sequences of two genes: human colony stimulating factor 2 (CSF2; Gene ID– 
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1437) and zebrafish tumor protein p53 (tp53; Gene ID– 30590). MENTHU was run twice on 
each gene: exonic target screen and whole gene target screen. A custom R script was used to 
mine the MENTHU results in a .csv format to determine both the amounts of total targetable 
sites by spCas9 (i.e., total number of unique cut sites with NGG PAM on either strand) and 
the subset of those predicted to be PreMA. 
Statistical analyses 
All of the statistical analyses were carried out using JMP software (SAS Institute. 
Cary, NC). In all instances, p-values were calculated assuming non-Gaussian Distributions. 




Figure S1 Overabundance of Microhomology arms is a negative predictor of MMEJ 
activation in zebrafish. 
A Box plot showing the distribution of Slope Values across 19 zebrafish genomic 
targets. BScatter plot of MH Fraction against Slope Value, focused only on microhomology 
arms of ≥ 3 bp. Linear fit with 95% Confidence Interval (shade) is shown. r2 = 0.382, p = 
0.0048. C Scatter plot of MH Fraction against Slope Value including 2 bp microhomology 
arms. Linear fit with 95% Confidence Interval (shade) is shown. r2 = 0.353, p = 
0.0073. Pattern Scores and Microhomology Scores were derived using RGEN online tool 
(http://www.rgenome.net). 
https://doi.org/10.1371/journal.pgen.1007652.s001 




Figure S2 Overabundance of Microhomology arms is a negative predictor of MMEJ 
activation in HeLa cell. 
A Scatter plot of MH Fraction against Slope Value, focused only on microhomology arms of 
≥ 3 bp using the first 50, alphabetically sorted HeLa cell targets. Linear fit with 95% 
Confidence Interval (shade) is shown. r2 = 0.339, p = 0.0001. B Scatter plot of MH 
Fraction against Slope Value including microhomology arms of 2 bp using the first 50, 
alphabetically sorted HeLa cell targets. Linear fit with 95% Confidence Interval (shade) is 
shown. r2 = 0.034, p = 0.2644. C Box plot showing the distribution of Slope Values across 
the first 50, alphabetically sorted HeLa cell targets. D Box plot showing the MH 
Fractions for High and Low competition sites amongst the remaining 40 HeLa cell targets, 
focused only on microhomology arms of ≥ 3 bp. p = 0.011. Targets with < 20% overall edit 
efficiency were excluded in all panels. Pattern Scores and Microhomology Scores were 
derived using RGEN online tool (http://www.rgenome.net). 
https://doi.org/10.1371/journal.pgen.1007652.s002 




Figure S3 Microhomology allele generated by ttn.2 N2B sgRNA #1 is germline transmitted. 
Agarose gel showing PCR amplicon post Surveyor digest. 752 bp band is the whole 
amplicon. The expected cleavage products due to mutations at the CRISPR site are denoted 
by yellow arrowheads. The red asterisk denotes positive digest band due to a background T -
> A SNP at position 389 from the 5’ end of the amplicon. Heterozygous animals are bolded 
and underlined. Genotypes of the first 4 heterozygous progenies from each founder were 
ascertained by subcloning analyses. 
https://doi.org/10.1371/journal.pgen.1007652.s003 
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Figure S4 Fitting Competition Hypothesis Version 2 using independently collected zebrafish 
dataset and HeLa cell dataset. 
A Outlier plot summarizing independently collected repair outcomes from 34 zebrafish 
targets. All three Group 4 targets as well as some Group 3 targets yielded PreMA outcomes, 
validating our own training dataset. Importantly, none of Groups 1 and 2 targets were of this 
class. BOutlier plot summarizing repair outcomes from 90 genomic targets using CRISPR-
Cas9. Similar to the findings in zebrafish, close proximity of the top predicted MH arms 
(Groups 3 and 4) appears to be the primary determinant for utilizing this MH pair efficiently. 
When the top predicted allele had at least 50% higher Pattern Score than the second 
predicted allele (Groups 2 and 4), median Top MH Fractions trended higher compared to 
Group 1 and 3, respectively. P-values calculated by Wilcoxon’s Each Pair Calculation 
(adjusted for multiple comparisons). Targets with < 20% overall edit efficiency were 
excluded from analysis. Pattern Scores were derived using RGEN online tool 
(http://www.rgenome.net). 
https://doi.org/10.1371/journal.pgen.1007652.s004 
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Table S1 List and summary mutagenic outcomes of TALEN and CRISPR-Cas9 reagents that 
were designed primarily using the Bae et al. algorithm [14]. 
Underlined & italicized bases in sgRNA sequence denote mismatched bases due to the 
promoter requirement. Pattern Scores and Microhomology Scores were derived using RGEN 
online tool (http://www.rgenome.net). MH: Microhomology, SC: Subcloning. * Reagents 
prospectively designed according to Bae et al. algorithm [14]. † No raw sequencing data were 
available. However, the outcome had been compiled into a table prior to conception of this 
study. ‡ Injected with sgRNA and Cas9 mRNA (150 pg and 100 pg, respectively). ^ Gift from 
Wenbiao Chen (addene # 46761). 
https://doi.org/10.1371/journal.pgen.1007652.s005 
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Table S2 Summary gross phenotyping outcomes from PreMA reagent injections. 
For tdgf1, Experiments 1a and 1b correspond to technical replicates using WT 1 as reference, 
uninjected control. chrd and tdgf1 phenotypes were scored on 1 dpf, 
whereas tyr, ttn.2 N2B, ttn.2 phenotypes were scored on 2 dpf. 
https://doi.org/10.1371/journal.pgen.1007652.s006 
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Table S3 List and summary sequence outcomes of Low Competition sgRNA that were 
designed around the Competition Hypothesis. 
Underlined & Italicized bases in gRNA sequence denote mismatched bases due to the 
promoter requirement. Pattern Scores and Microhomology Scores were derived using RGEN 
online tool. MH: Microhomology, SC: Subcloning, TIDE: Tracking Indels by 
DEcomposition. †Injected RNP at the dose of 115 pg sgRNA and 245 pg Cas9 due to poor 
viability at higher doses. 
https://doi.org/10.1371/journal.pgen.1007652.s007 
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Table S4 List and summary sequence outcomes of Medium ~ High Competition sgRNA that 
were designed around the Competition Hypothesis. 
Underlined & Italicized bases in sgRNA sequence denote mismatched bases due to the 
promoter requirement. Pattern Scores and Microhomology Scores were derived using RGEN 
online tool (http://www.rgenome.net). MH: Microhomology, SC: Subcloning, TIDE: 
Tracking Indels by Decomposition. † Injected RNP at the dose of 115 pg sgRNA and 245 pg 
Cas9 due to poor viability at higher doses. 
https://doi.org/10.1371/journal.pgen.1007652.s008 
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Table S5 List and summary sequence outcomes of human CRISPR-Cas9 targets that were 
designed around the Competition Hypothesis V2. 
Underlined & Italicized bases in sgRNA sequence denote mismatched bases due to the T7 
promoter requirement. For loci wherein mutagenic efficiency and/or Top MH Fraction was 
calculated based on subcloning results, number of mutant/top predicted allele colonies are 
given in numerator and the total number of colonies analyzed are given in the 
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Table S6 Example MENTHU output from select CRISPR-Cas9 targets used in this study, 
focusing only on out-of-frame mutations. 
The output was obtained by using the entire target exon sequence with 40 bp intronic 
sequence each on both 5’ and 3’ ends. The MENTHU output provides a 3’ NGG PAM 
sequence for each gRNA targets (italicized and underlined). MENTHU gRNA outputs that 
matched the target sequences used in this study are bolded. Criteria 1 and 2 refer to 1) if top 
predicted microhomology arm is separated by 5 bp or less, and 2) if the ratio of top to second 
predicted Pattern Scores is at least 1.5. MENTHU is programmed to terminate calculations if 
the target site is negative for Criterion 1. As a result, no gRNA sequence output is obtained 
for chrd #1 and mitfa #2. Importantly, in two instances (surf1 and tgdf1) where we only had 
Group 3 reagents, novel candidate PreMA sites were identified. * Result obtained by 
adjusting the value for Criterion 2 to 1.0 as these were Group 3 guides that, by definition, 
does not satisfy Criterion 2 of 1.5 or higher. ^ in-frame mutation by the experimental 
design. † 16 other candidate loci identified on this 3771 bp exon; only a partial list for 
alternate loci is given. ‡ 16 other candidate loci identified on this 822 bp exon; only a partial 
list for alternate loci is given. 
https://doi.org/10.1371/journal.pgen.1007652.s010 
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Table S7 Preliminary analyses on the prevalence of PreMA loci reveal that about 10% of the 
CRISPR-Cas9 targetable loci on both human CSF2 and zebrafish tp53 genes fall in this 
category. 
This holds true for both at the gene and exonic levels. As expected, roughly two thirds of the 




Table S8 List of primers used in this study. 
All the primer sequences are provided in 5’ -> 3’ order. For urod Reverse primer, M13F 
primer sequence was added at the 5’ end of the endogenous target sequence (bolded and 
italicized). For SDM primers, intended point mutation is indicated by bold and italic. * No 
endogenous primer was used to sequence the genomic loci of interest. 
https://doi.org/10.1371/journal.pgen.1007652.s012 
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S1 Note Calculation of Microhomology Fraction 
1) When the mutagenic outcomes were assessed by subcloning, the Microhomoloy  
Fraction was calculated according to the formula below: 
MH Fraction =  
(# 𝑜𝑓 𝑚𝑢𝑡𝑎𝑛𝑡 𝑐𝑜𝑙𝑜𝑛𝑖𝑒𝑠 ℎ𝑎𝑟𝑏𝑜𝑟𝑖𝑛𝑔 3𝑏𝑝 𝑚𝑖𝑐𝑟𝑜ℎ𝑜𝑚𝑜𝑙𝑜𝑔𝑦 𝑜𝑟 𝑙𝑜𝑛𝑔𝑒𝑟)
(# 𝑜𝑓 𝑡𝑜𝑡𝑎𝑙 𝑚𝑢𝑡𝑎𝑛𝑡 𝑐𝑜𝑙𝑜𝑛𝑖𝑒𝑠 𝑟𝑒𝑐𝑜𝑣𝑒𝑟𝑒𝑑)
 
2) When the mutagenic outcomes were assessed by TIDE analysis, the Microhomology 
Fraction was not calculated 
3) For HeLa cell data, Microhomology Fraction was calculated as below, discarding any 
alleles with allele frequency of < 0.1%. 
MH Fraction =  
(# 𝑜𝑓 𝑚𝑢𝑡𝑎𝑛𝑡 𝑟𝑒𝑎𝑑𝑠 ℎ𝑎𝑟𝑏𝑜𝑟𝑖𝑛𝑔 3𝑏𝑝 𝑚𝑖𝑐𝑟𝑜ℎ𝑜𝑚𝑜𝑙𝑜𝑔𝑦 𝑜𝑟 𝑙𝑜𝑛𝑔𝑒𝑟)
(# 𝑜𝑓 𝑡𝑜𝑡𝑎𝑙 𝑚𝑢𝑡𝑎𝑛𝑡 𝑟𝑒𝑎𝑑𝑠 𝑟𝑒𝑐𝑜𝑣𝑒𝑟𝑒𝑑)
 
S2 Note Calculation of Slope Values 
The Slope Values were calculated for each target locus as follows: 
1) Input 80bp endogenous gene sequence flanking the predicted DSB site into the 
Microhomology-Predictor (http://www.rgenome.net/mich-calculator/){Bae, 2014 
#1}. 
a. In the case of CRISPR-Cas9 reagents, phosphodiester bond between the 3rd 
and 4th base pairs distal to the PAM was chosen as the presumptive DSB site. 
Subsequently, 40bp each on both sides of this break site was used as the input 
sequence. 
b. In the case of TALEN reagents with even number of bases in the Spacer 
region, the phosphodiester bond between the 5’ and 3’ halves of the Spacer 
was chosen as the presumptive DSB site. Subsequently, 40bp each on both 
sides of this break site was used as the input sequence. 
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c. In the case of TALEN reagents with odd number of bases in the Spacer 
region, the center-most base that bridges 5’ and 3’ halves was identified. 
Subsequently, a 79bp sequence containing this center-most base and 39bp 
each on both sides of this base was used as the input sequence. 
2) Ranked the top 10 candidates by the Pattern Score in a descending order. 
a. In the dataset wherein only microhomology arms of 3bp or greater were 
considered, candidate mutant alleles harboring only 2bp microhomology arms 
were omitted from further analysis. 
b. In the dataset wherein microhomology arms of 2bp or greater were 
considered, no candidate mutant alleles were omitted. 
3) Plotted the Pattern Scores against the numerical rank on Scatter Plot using Microsoft 
Excel 
a. Drew simple linear regression 
b. The “a” in the fitted line formula y = a ∗ x + b is the Slope Value 
4) The steeper (i.e. larger absolute value for a) the slope, the lower influence there is 
from the competing locally available microhomology arms. For zebrafish, the cutoff 
used for Low Competition sites was -40. 
5) The flatter (i.e. values closer to 0 for a) the slope, the more influence there is from the 
competing locally available microhomology arms. For zebrafish, the cutoff used for 
High Competition sites was -20. 
S3 Note Calculation of Top Microhomology Fraction 
1) When the mutagenic outcomes were assessed by subcloning, the Top Microhomoloy  
Fraction was calculated according to the formula below: 
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Top MH Fraction =  
(𝑜𝑓 𝑐𝑜𝑙𝑜𝑛𝑖𝑒𝑠 𝑤𝑖𝑡ℎ 𝑚𝑢𝑡𝑎𝑡𝑖𝑜𝑛 𝑐𝑜𝑟𝑟𝑒𝑠𝑝𝑜𝑛𝑑𝑖𝑛𝑔 𝑡𝑜 
𝑡𝑜𝑝 𝑝𝑟𝑒𝑑𝑖𝑐𝑡𝑒𝑑 𝑎𝑙𝑙𝑒𝑙𝑒 𝑤𝑖𝑡ℎ 3𝑏𝑝 𝑚𝑖𝑐𝑟𝑜ℎ𝑜𝑚𝑜𝑙𝑜𝑔𝑦 𝑜𝑟 𝑙𝑜𝑛𝑔𝑒𝑟)
(# 𝑜𝑓 𝑡𝑜𝑡𝑎𝑙 𝑚𝑢𝑡𝑎𝑛𝑡 𝑐𝑜𝑙𝑜𝑛𝑖𝑒𝑠 𝑟𝑒𝑐𝑜𝑣𝑒𝑟𝑒𝑑)
 
2) When the mutagenic outcomes were assessed by TIDE analysis, the Top 
Microhomology Fraction was calculated according to the formula below: 
Top MH Fraction
=  
(% 𝑚𝑢𝑡𝑎𝑡 𝑝𝑜𝑝𝑢𝑙𝑎𝑡𝑖𝑜𝑛 𝑐𝑜𝑟𝑟𝑒𝑠𝑝𝑜𝑛𝑑𝑖𝑛𝑔 𝑤𝑖𝑡ℎ 𝑡ℎ𝑒 𝑠𝑎𝑚𝑒 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑏𝑎𝑠𝑒𝑠 
𝑑𝑒𝑙𝑒𝑡𝑒𝑑 𝑎𝑠 𝑡𝑜𝑝 𝑝𝑟𝑒𝑑𝑖𝑐𝑡𝑒𝑑 𝑎𝑙𝑙𝑒𝑙𝑒 𝑤𝑖𝑡ℎ 3𝑏𝑝 𝑚𝑖𝑐𝑟𝑜ℎ𝑜𝑚𝑜𝑙𝑜𝑔𝑦 𝑜𝑟 𝑙𝑜𝑛𝑔𝑒𝑟)
(100% −  % 0𝑏𝑝 𝑐ℎ𝑎𝑛𝑔𝑒 𝑝𝑜𝑝𝑢𝑙𝑎𝑡𝑖𝑜𝑛)
 
 
e.g) ttna sgRNA #1 (See below for TIDE output) 
Top MH Fraction =  
29.7%
(100% −  56.2%)
 
 
           =  0.678 
 
 
3) For HeLa cell data, Microhomology Fraction was calculated as below, discarding any 
alleles with allele frequency of < 0.1%. 
Top MH Fraction =  
( 𝑜𝑓 𝑟𝑒𝑎𝑑𝑠 𝑤𝑖𝑡ℎ 𝑚𝑢𝑡𝑎𝑡𝑖𝑜𝑛 𝑐𝑜𝑟𝑟𝑒𝑠𝑝𝑜𝑛𝑑𝑖𝑛𝑔 𝑡𝑜 
𝑡𝑜𝑝 𝑝𝑟𝑒𝑑𝑖𝑐𝑡𝑒𝑑 𝑎𝑙𝑙𝑒𝑙𝑒 𝑤𝑖𝑡ℎ 3𝑏𝑝 𝑚𝑖𝑐𝑟𝑜ℎ𝑜𝑚𝑜𝑙𝑜𝑔𝑦 𝑜𝑟 𝑙𝑜𝑛𝑔𝑒𝑟)
(# 𝑜𝑓 𝑡𝑜𝑡𝑎𝑙 𝑚𝑢𝑡𝑎𝑛𝑡 𝑟𝑒𝑎𝑑𝑠 𝑟𝑒𝑐𝑜𝑣𝑒𝑟𝑒𝑑)
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S1 Data Sanger sequencing file used for the study. 
Whole amplicon sequencing outcomes are deposited as .ab1 files for chrd TALEN 
and tyr #2, tdgf1, ttn.2 N2B #1, ttn.2 #2 sgRNA targets. Other sequencing outcomes, 
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APPENDIX C.    GeneWeld: A METHOD FOR EFFICIENT TARGETED 
INTEGRATION DIRECTED BY SHORT HOMOLOGY 
Wesley A. Wierson, Jordan M. Welker, Maira P. Almeida, Carla M. Mann, Dennis A. 
Webster, Trevor J. Weiss, Melanie E. Torrie, Macy K. Vollbrecht, Merrina Lan, Kenna C. 
McKeighan, Zhitao Ming, Alec Wehmeier, Christopher S. Mikelson, Jeffrey A. Haltom, 
Kristen M. Kwan, Chi-Bin Ghien, Darius Balciunas, Stephen C. Ekker, Karl J. Clark, Beau 
R. Webber, Branden Moriarity, Staci L. Solin, Daniel F. Carlson, Drena L. Dobbs, Maura 
McGrail, Jeffrey J. Essner 
 
This manuscript is in preparation for submission to Development.  
It describes the protocol GTagHD was designed to facilitate.   
 
A pre-print of this paper is available at: 
https://www.biorxiv.org/content/10.1101/431627v1 
 
I wrote the portion of the manuscript describing the GTagHD web tool. I created and 
programmed the entirety of the GTagHD web tool. 
 
 
 225  
 
APPENDIX D.    GENE SCULPT SUITE USAGE STATISTICS 
I implemented Google Analytics tracking for each Gene Sculpt Suite web tool. 
Google Analytics (GA) collects a (terrifyingly) large amount of data about each user visiting 
the web tools and is able to localize users based on their IP addresses and Internet Service 
Providers, in addition to identifying unique users through browser cookies. GA is adept at 
filtering out bot traffic and can differentiate between pageviews and sessions. A pageview 
implies that a user visited a page but did not interact with it. A session is the period of time in 
which a user is actively engaged with the page (i.e., using the tool.) 
I began tracking MENTHU in January of 2018 in conjunction with the expected 
release of a pre-print in March. MEDJED and GTagHD were tracked starting in April of 
2018. Here I present the GA usage statistics for each tool as of April 4, 2019, prior to the 
publication of all three methods in the NAR webserver issues (July 2019). 
 
MEDJED 
MEDJED is an unpublished method, which has been presented at conferences but is 
not available as a pre-print, and as such experiences less traffic than GTagHD or MENTHU. 
MEDJED has 169 pageviews and 114 sessions, initiated by 69 users from the United States, 
Canada, Germany, Singapore, Spain, Hong Kong, Israel, and Japan (see Fig. I-1). Those 
users are engaged with MEDJED for, on average, 3:51m. 
Within the United States, MEDJED is heavily utilized by users in Ames, but also has 
users in locations including (but not limited to) Ashburn, VA (possibly from the HHMI 
Janelia Research Campus), Ithaca, New York (from the Cornell University network), and St. 
Paul Minnesota (University of Minnesota). 




Figure I-1 Country-of-origin of MEDJED users. The overwhelming majority of MEDJED 
users are located in the United States. 
 
MEDJED does not experience high traffic, but it does experience relatively consistent 
traffic with an average of 14 sessions per month (see Fig I-2).  
 
Figure I 2 MEDJED users per day between April 01 2018 and April 04 2018. 
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GTagHD 
GTagHD is also unpublished, but the protocol it is used in, GeneWeld, was posted as 
a pre-print on bioRxiv on Oct 3, 2018: 
https://www.biorxiv.org/content/biorxiv/early/2018/10/03/431627 
GTagHD has recorded 839 sessions from 384 users in 21 different countries and 
territories including the United States, Canada, Germany, China, the United Kingdom, 
Singapore, Japan, Austria, Switzerland, the Netherlands, Belgium, South Korea, Norway, 
Australia, Spain, Israel, Morocco, Argentina, Hungary, Serbia, and Sweden (see Fig. I-3). 
Although 71 of the 287 US-based users are located in Ames (GTagHD is used in Iowa State 
University undergraduate classes that employ pGTag plasmids), the remaining users are 
spread over at least 28 states (including Iowa). 19 users (with a total of 42 sessions between 
them) trace back to the Longwood Medical and Academic Area Network in Boston, 
Massachusetts, which serves, amongst other institutions, Harvard’s Medical School and 
teaching hospitals, the Dana-Farber Cancer Institute, Massachusetts College of Pharmacy and 
Health Sciences, and Boston Children’s Hospital; another 7 users accessed the site from 
Cambridge (home to Harvard and MIT.) Another 15 users initiating 30 sessions trace back to 
Davis, California.  
All told, users are engaged with GTagHD for an average of 2:10 minutes per session. 
GTagHD is used, on average, 71 times per month (see Fig. I-4). 
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Figure I-3 Country-of-origin of GTagHD users. GTagHD users hail from 21 different 
countries around the world. 
 
Figure I-4 GTagHD users per day from Apr 01 2018 to Apr 04 2018 
 
MENTHU 
MENTHU was published as part of a PloS Genetics paper by Ata et al. in Oct 2018, 
but was posted online as a pre-print in March of 2018. As a published method, it experiences 
fairly heavy traffic from 481 users located in 28 countries and territories including the US, 
China, Japan, Austria, France, Australia, the UK, Canada, Germany, Hong Kong, the 
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Netherlands, Spain, Sweden, South Korea, Switzerland, Hungary, Belgium, India, Iran, 
Russia, Argentina, Brazil, Colombia, Ireland, Mexico, Norway, New Zealand, and Singapore 
(see Fig. I-5). 
Of the 285 users located in the US, the majority (93) originate from Ashburn, VA, 
where they have a total of 190 sessions. Only 40 users are located in Ames (though they are 
responsible for 141 sessions among them); other users are spread across 26 states in cities 
including Iowa City, IA, Coralville, IA, Boston, MA, New York City, NY, St. Paul, MN, 
Chicago, IL, Baltimore, MD, Berkeley, CA, Bethesda, MD, Minneapolis, MN, Madison, WI. 
MENTHU’s users have logged 943 sessions between them, lasting on average 2:40 
(see Fig. I-6). 
 
Figure I-5 Country-of-origin for MENTHU users. 
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Figure I-6 MENTHU daily users between Jan 20, 2018 and Apr 04, 2019. 
 
Conclusions 
These usage statistics demonstrate that the Gene Sculpt Suite is actively and widely 
used not only at Iowa State but (literally) around the world. Even though MEDJED and 
GTagHD are as-yet unpublished, they have been used (collectively) by more than 400 
people, more than 900 times. MENTHU, as a published method, has seen even greater use. 
This level of use demonstrates that the tools in the Gene Sculpt Suite are of sufficient interest 
and utility to justify continued development of the Gene Sculpt Suite webserver. 
 
